Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ACTN2 ENSG00000077522 "Actinin alpha 2" P35609 1 236686454-236764631 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4" "Cell line enhanced" "Detected in some" "HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 59.7" "Low region specificity" "Detected in all" "HPA006035, HPA008315" Enhanced Uncertain "Actin filaments" 69000000 "Actin filaments" "HPA006035: AB_1078095, HPA008315: AB_1844543" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (2.41e-2)" "unprognostic (1.69e-3)" "unprognostic (2.91e-1)" "unprognostic (4.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.80e-1)" "unprognostic (2.97e-1)" "unprognostic (2.66e-1)" "unprognostic (2.71e-11)" "unprognostic (1.30e-2)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" 3.5 0.6 1.6 0.6 10.7 0.6 0.7 0.3 2.5 0.6 0.6 5.1 0.0 0.6 0.7 4.4 3.7 0.7 0.7 141.3 2.5 1.4 0.6 0.6 0.9 0.6 4.7 1.4 0.7 0.7 0.6 0.1 0.6 2.7 2.8 0.6 0.0 4.9 0.6 320.9 0.6 0.7 1.5 3.9 0.6 0.7 0.9 4.3 0.0 3.5 75.4 4.8 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.7 11.9 0.0 7.5 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 10.7 0.3 2.5 2.5 1.4 4.7 1.4 2.7 4.3 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavourable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 11.8 26.9 7.3 8.0 9.4 13.6 18.5 10.2 30.4 7.5 10.5 12.4 15.7 5.5 31.6 9.1 24.3 4.4 10.8 10.0 8.2 5.6 9.4 9.8 11.5 10.5 6.6 27.2 11.9 8.0 5.2 7.7 14.6 5.9 15.0 13.2 4.4 21.9 7.6 10.0 3.8 9.1 24.0 14.1 17.5 32.1 8.0 5.2 11.1 12.9 17.6 7.7 13.3 10.3 9.9 11.0 76.0 9.8 8.4 18.1 6.0 13.8 12.9 17.3 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Cell line enriched" "Detected in some" 4 "HEK 293: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced "HPA074550: " "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.8 0.2 0.0 0.3 0.1 0.0 1.3 0.4 0.7 0.2 0.1 0.3 0.0 0.0 3.6 0.0 0.4 1.4 20.5 0.2 0.4 0.3 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.1 4.1 0.0 2.4 0.8 1.3 2.8 0.0 0.3 0.0 0.1 3.7 1.9 0.0 0.1 1.0 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" "Plasma membrane" "HPA030866: , HPA030867: AB_10602428, HPA030868: " "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 4.9 0.7 2.0 0.0 5.9 12.2 0.0 12.9 1.0 4.4 11.1 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.4 4.8 0.5 0.1 0.0 7.9 0.0 0.9 0.0 10.3 14.9 0.0 29.2 0.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.8 0.0 1.5 1.3 0.1 13.3 0.1 8.8 1.5 0.0 0.2 0.0 0.0 0.0 15.9 5.3 28.8 25.7 0.0 0.1 0.0 22.1 0.0 9.8 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9555792 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, CAB025906, HPA051575" Approved Supported Cytosol "Intracellular and membrane" 27000 Cytosol "CAB025906: , HPA010738: AB_1078100, HPA051575: " "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavourable (4.23e-5)" 18.6 11.0 13.6 15.4 13.8 21.9 14.7 20.4 15.5 14.0 11.7 13.8 8.3 8.7 14.2 15.8 18.7 10.7 17.4 13.4 11.2 12.4 12.4 7.8 24.7 15.0 11.6 11.7 18.1 9.6 10.9 11.9 29.0 11.2 8.2 9.4 10.6 12.5 9.8 12.3 16.7 11.1 13.9 14.3 21.4 8.9 17.4 12.3 14.7 12.5 13.9 20.3 12.3 14.4 7.0 7.7 16.0 10.2 6.0 7.9 6.0 7.7 12.7 13.4 13.9 26.5 19.8 24.2 8.1 13.8 9.4 13.9 11.2 18.7 22.1 11.8 10.2 14.2 9.9 17.2 12.9 8.8 9.9 11.3 9.6 9.9 37.5 11.0 12.7 22.1 17.4 15.0 29.1 23.5 15.3 8.5 10.0 7.3 8.3 11.1 11.1 5.2 9.6 13.2 10.5 12.5 12.9 7.9 19.8 9.1 11.1 19.3 5.7 14.2 18.8 16.7 8.7 11.7 15.4 11.1 10.0 19.2 13.8 7.1 19.8 16.0 9.8 7.6 6.1 10.2 7.9 7.0 5.0 5.1 7.7 5.1 4.5 4.6 11.8 6.0 9.5 4.3 5.7 6.0 13.6 13.8 20.4 13.1 11.2 12.4 11.6 11.7 11.2 12.3 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell line enriched" "Detected in some" 8 "CAPAN-2: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" "Plasma membrane" Mitochondria "HPA074034: " "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favourable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.7 0.2 0.7 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell line enhanced" "Detected in many" "ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Uncertain Approved "Plasma membrane" "Secreted to extracellular matrix" 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: " "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 60.9 15.1 3.7 71.0 24.8 12.3 8.1 0.0 0.0 0.0 4.9 22.5 1.3 0.8 3.6 21.7 0.0 22.6 0.0 7.4 0.0 11.7 2.8 0.0 16.9 0.0 49.0 44.6 5.0 1.2 0.0 36.4 0.0 0.3 0.0 4.0 2.8 0.0 28.1 0.2 41.6 4.0 0.0 5.5 3.3 0.0 0.3 0.1 0.7 5.1 17.5 0.9 27.2 10.5 0.1 0.0 0.0 14.4 0.0 5.3 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184308-161199056 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.7;HUVEC TERT2: 12.9;SH-SY5Y: 7.2;TIME: 10.8;U-251 MG: 9.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" "Nuclear speckles" "CAB025876: , HPA051296: , HPA068374: " "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 58.0 9.7 2.6 18.1 20.7 1.8 14.6 1.5 10.7 7.8 6.3 33.4 0.0 1.9 5.8 2.0 7.7 14.2 16.4 19.5 3.4 2.3 3.1 11.0 15.7 2.7 28.6 3.5 35.7 10.6 4.7 4.9 4.4 20.5 5.8 3.4 0.0 1.7 1.7 7.7 1.7 3.0 12.0 15.5 1.9 8.1 1.7 15.7 0.0 7.5 1.2 1.4 8.7 4.0 0.5 8.0 1.0 0.2 0.4 0.6 0.2 0.0 0.0 0.2 0.1 6.0 3.8 0.5 4.8 0.2 0.4 2.8 0.1 0.1 0.2 4.1 1.5 0.1 0.0 0.0 1.7 0.1 0.3 0.1 0.4 1.2 0.6 0.0 0.1 4.2 0.0 10.7 0.1 12.9 0.1 0.3 0.3 0.1 0.0 0.2 4.8 0.0 0.1 4.7 0.1 0.0 0.1 0.1 7.2 0.0 0.1 0.1 0.2 0.5 10.8 6.8 0.1 0.3 9.6 0.2 0.1 0.1 2.1 0.1 0.1 0.7 0.2 0.2 0.6 0.1 0.3 0.3 0.3 0.3 0.1 0.5 0.4 0.4 1.0 0.4 0.1 8.0 0.3 0.2 2.6 20.7 1.5 10.0 3.4 2.3 28.6 3.5 20.5 15.7 ADIPOQ "ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28" ENSG00000181092 "Adiponectin, C1Q and collagen domain containing" Q15848 3 186842690-186858463 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hormone "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 176.7;breast: 79.4" "Cell line enriched" "Detected in single" 670 "ASC diff: 84.1" "Group enriched" "Detected in some" 8 "breast cancer: 6.5;pancreatic cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB046467, HPA051767" Uncertain "Secreted to blood" 11285000000 1000000000 "CAB046467: AB_1078104, HPA051767: " "unprognostic (1.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.20e-2)" "unprognostic (6.99e-3)" "unprognostic (1.87e-1)" 176.7 1.9 0.0 16.7 0.0 0.1 79.4 0.0 0.1 0.1 23.2 0.0 0.4 0.1 0.1 1.3 0.3 0.1 13.2 5.8 0.0 0.0 0.5 0.1 0.1 6.1 0.0 0.0 0.2 1.3 0.1 0.0 0.1 0.0 0.4 1.4 0.0 14.7 0.6 2.0 1.5 2.1 0.4 0.0 0.1 0.6 0.1 0.0 0.0 0.7 9.5 0.3 1.0 0.9 0.8 0.6 2.4 0.4 0.7 0.5 0.1 0.0 0.0 0.0 0.0 84.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.6 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.3 0.5 1.9 0.7 0.4 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Cell line enhanced" "Detected in many" "CACO-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Group enriched" "Detected in many" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm Nucleoplasm "CAB004308: AB_626655, HPA053891: " "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.0 4.3 1.3 2.7 1.0 0.6 3.7 0.3 1.6 2.6 3.1 4.2 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 0.6 0.5 1.0 1.0 1.0 3.3 0.3 1.3 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.3 1.3 0.3 0.8 1.9 5.8 0.2 2.1 2.9 3.2 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 122.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 64.6;U-138 MG: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 20.7" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced "Intracellular and membrane" 1800000000 "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 16.6 14.1 23.6 5.2 31.1 4.2 34.2 4.2 25.3 12.9 8.2 25.0 13.9 7.2 7.0 15.4 4.0 20.6 9.9 4.7 23.2 24.3 9.6 19.4 29.6 4.2 45.1 19.7 24.6 15.3 122.5 11.9 5.3 31.5 14.0 6.6 3.0 17.9 17.5 0.9 5.9 7.3 10.8 35.3 3.0 14.2 2.3 43.8 2.2 25.6 2.7 6.2 9.9 5.5 3.5 20.7 3.7 3.2 0.4 1.6 2.0 38.4 14.8 10.7 5.4 16.2 7.1 0.1 31.5 18.4 20.3 28.6 0.1 8.0 2.7 13.1 44.3 29.8 1.7 25.0 60.2 2.5 2.6 0.3 11.4 0.7 18.2 15.6 0.1 12.6 18.7 26.0 64.6 22.3 0.0 4.6 26.6 2.6 2.2 5.7 2.2 16.8 1.4 0.9 0.1 30.8 4.3 7.7 21.5 3.2 3.1 2.0 6.0 10.3 46.2 77.9 26.6 3.4 37.2 0.0 0.0 0.2 17.7 3.3 33.2 0.0 3.2 2.4 0.4 1.5 1.4 3.5 1.1 0.7 20.7 2.2 0.2 0.2 3.7 0.4 0.8 7.4 1.6 2.0 23.6 31.1 4.2 24.6 23.2 24.3 45.1 19.7 31.5 43.8 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046152: " "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.5 1.2 2.7 9.3 3.5 1.5 3.3 4.3 2.2 5.0 2.4 0.5 0.1 0.2 1.2 2.7 1.4 7.2 0.3 4.2 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.3 0.7 3.2 1.7 0.0 1.2 2.0 0.0 0.1 4.3 0.4 4.3 1.6 2.9 0.7 0.0 0.3 5.8 1.2 9.4 3.1 1.0 12.3 3.5 3.6 3.0 1.1 0.1 5.8 3.4 1.8 0.2 0.0 0.0 1.8 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 ANK1 "ANK, SPH1" ENSG00000029534 "Ankyrin 1" P16157 8 41653220-41896762 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 166.5;tongue: 58.3" "Group enriched" "Detected in some" 4 "HEL: 37.1;K-562: 39.0;RH-30: 49.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 20.1" "Group enriched" "Detected in some" 8 "memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 7 "B-cells: 10.6;dendritic cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004842, HPA056953" Supported Supported "Intracellular and membrane" 33000000 "HPA004842: AB_1844827, HPA056953: " "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (4.22e-3)" "unprognostic (2.31e-3)" "unprognostic (1.76e-7)" "unprognostic (2.03e-1)" "unprognostic (2.15e-1)" "unprognostic (2.52e-1)" "unprognostic (2.95e-1)" "unprognostic (3.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-1)" "unprognostic (1.40e-1)" "unprognostic (3.86e-1)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" 1.2 0.3 0.6 0.7 0.6 14.8 0.3 20.1 3.8 0.2 0.2 0.0 0.0 0.4 0.2 2.7 1.8 0.2 0.3 18.0 0.6 1.2 0.3 0.2 0.4 0.9 4.0 0.4 0.2 0.3 4.3 0.3 0.8 8.3 0.9 0.2 0.5 2.9 0.3 166.5 0.2 0.3 0.2 1.0 0.7 1.1 0.3 0.0 0.0 1.0 58.3 3.8 0.3 0.4 10.6 3.5 1.0 0.2 0.1 0.9 0.7 0.0 5.0 0.1 0.0 0.0 0.9 0.0 1.4 10.0 0.4 0.2 0.0 0.0 2.3 0.4 1.0 0.8 0.2 0.1 0.2 0.9 0.0 37.1 0.2 0.0 0.0 0.1 0.1 1.3 0.2 0.1 0.0 0.0 39.0 0.8 0.6 0.1 0.0 0.4 0.5 0.0 0.2 49.4 0.2 0.2 0.1 0.7 0.4 0.0 0.7 0.0 0.6 0.9 0.2 0.1 0.2 8.5 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.5 10.6 0.3 0.5 0.1 9.1 0.0 0.0 0.5 0.1 0.0 3.5 0.9 0.7 0.6 0.6 20.1 3.8 0.6 1.2 4.0 0.4 8.3 0.0 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell line enhanced" "Detected in many" "ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" "Plasma membrane" "CAB015178: AB_2242828, HPA008007: , HPA035970: " "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavourable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.2 4.2 16.1 22.5 0.0 1.0 1.8 0.7 2.0 4.0 0.0 4.2 1.4 3.6 0.0 7.5 0.4 0.6 1.9 6.2 2.4 0.0 1.7 1.0 1.0 0.7 9.6 1.6 0.9 3.9 0.0 0.0 6.9 3.4 0.1 0.2 0.0 5.3 1.7 0.5 30.8 0.0 0.1 0.0 8.3 15.5 0.1 0.3 5.3 0.1 0.6 0.0 3.2 1.7 0.2 1.9 4.1 1.1 0.6 12.7 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 ASPH "BAH, CASQ2BP1, HAAH, JCTN" ENSG00000198363 "Aspartate beta-hydroxylase" Q12797 8 61500556-61714640 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Dioxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055161, HPA059303" Uncertain Enhanced "Endoplasmic reticulum" 900000 "Endoplasmic reticulum" "HPA055161: , HPA059303: " "unprognostic (8.07e-2)" "prognostic unfavourable (8.07e-5)" "unprognostic (1.73e-2)" "unprognostic (4.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.82e-2)" "prognostic unfavourable (3.61e-4)" "unprognostic (6.39e-2)" "unprognostic (3.64e-1)" "prognostic unfavourable (1.75e-4)" "unprognostic (9.50e-2)" "prognostic unfavourable (1.57e-5)" "unprognostic (8.96e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (2.74e-2)" 104.6 60.4 27.3 15.0 29.5 4.8 84.3 35.2 31.3 22.3 23.8 10.6 18.3 14.0 16.8 17.8 22.4 16.5 19.1 33.9 26.1 22.4 19.0 23.0 22.5 10.9 21.1 22.2 20.5 13.8 12.5 15.7 14.7 20.5 17.3 26.8 23.6 28.8 23.4 103.1 12.0 13.9 26.1 16.7 12.8 30.5 6.4 19.6 2.9 31.7 36.0 13.7 30.0 25.4 3.3 21.0 15.9 5.2 4.9 3.4 2.3 50.0 72.7 10.2 6.2 45.8 43.5 3.5 89.8 83.5 38.5 40.4 12.4 66.7 3.8 6.2 52.6 18.7 6.3 31.3 65.8 1.4 6.4 8.9 44.2 34.0 29.4 1.3 1.4 35.7 7.1 21.4 27.3 16.2 2.4 3.6 33.8 10.6 0.3 1.8 5.8 42.9 2.4 11.0 0.8 23.5 41.5 10.6 3.7 27.9 13.2 11.1 5.4 2.4 50.8 39.0 20.0 35.6 31.6 2.3 2.9 0.1 102.6 0.8 26.0 1.1 5.2 0.1 1.6 1.9 3.1 3.3 2.3 1.6 6.1 3.3 3.4 1.6 15.9 4.9 1.0 21.0 2.3 2.3 27.3 29.5 35.2 31.3 26.1 22.4 21.1 22.2 20.5 19.6 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 176.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favourable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 25.0 23.8 33.8 17.4 39.3 30.6 31.7 31.5 76.0 35.0 24.0 22.1 13.0 10.0 30.8 25.5 21.4 22.7 23.9 19.3 35.5 36.7 48.7 30.0 30.2 37.9 32.1 34.7 22.3 16.3 176.7 16.1 30.2 37.8 26.4 25.0 21.0 16.8 31.8 8.7 24.0 16.8 35.7 27.8 22.6 15.8 11.9 17.2 16.2 56.1 12.6 19.1 25.7 20.0 16.1 53.2 60.8 78.0 20.0 29.6 85.8 14.7 19.3 14.1 19.0 93.6 59.6 8.8 33.2 51.5 24.5 28.7 11.1 24.2 8.5 16.5 48.4 15.2 21.7 25.8 33.5 16.6 17.1 10.6 18.8 10.7 34.4 18.8 19.8 51.6 34.6 30.1 24.2 32.6 10.7 23.0 37.0 18.5 8.1 16.4 13.0 21.8 7.7 24.8 28.5 31.6 16.5 10.2 9.5 32.3 20.1 20.2 26.1 17.3 32.0 30.9 16.9 36.8 11.1 7.1 12.3 8.4 25.5 15.9 24.0 34.4 78.0 60.8 25.9 55.1 27.0 16.1 26.4 26.6 53.2 15.7 29.6 27.0 39.5 20.0 54.1 19.3 24.7 85.8 33.8 39.3 31.5 76.0 35.5 36.7 32.1 34.7 37.8 17.2 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.6 9.6 14.7 32.0 34.5 0.4 21.2 18.5 10.3 8.4 3.6 6.2 0.7 5.2 38.3 6.9 10.3 6.1 8.5 2.3 5.5 2.3 7.9 4.3 15.8 0.8 0.5 29.9 9.5 13.2 12.8 8.9 0.8 0.4 18.9 14.2 0.6 1.9 6.2 10.4 1.8 4.3 0.8 4.4 2.2 12.5 14.0 7.9 1.0 2.3 10.2 2.7 12.1 18.6 2.0 19.4 6.8 0.3 0.3 0.4 8.7 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 BACE2 "AEPLC, ALP56, CEAP1, DRAP" ENSG00000182240 "Beta-site APP-cleaving enzyme 2" Q9Y5Z0 21 41167801-41282518 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 16.9;SK-BR-3: 28.6;SK-MEL-30: 22.2;WM-115: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 4.8;eosinophil: 8.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.4" "Low region specificity" "Detected in all" HPA035416 Approved "Intracellular and membrane" "HPA035416: " "unprognostic (1.71e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (5.23e-2)" "unprognostic (8.12e-3)" "prognostic unfavourable (5.86e-4)" "unprognostic (1.52e-2)" "unprognostic (2.58e-2)" "unprognostic (2.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (8.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (5.83e-2)" 16.1 2.5 1.4 5.9 1.6 0.9 13.8 0.9 2.0 9.0 11.0 3.4 5.6 5.1 10.3 10.7 13.0 6.8 38.9 7.2 1.7 1.6 11.4 4.4 4.9 21.6 2.7 0.5 8.4 29.0 3.3 2.2 17.2 4.4 22.7 7.4 8.7 28.3 4.4 10.6 5.5 5.4 7.8 5.9 7.0 31.6 5.1 1.4 1.3 9.9 7.6 14.3 11.8 33.6 1.0 0.0 8.4 0.0 0.3 0.0 0.0 16.9 1.6 5.7 0.0 1.5 1.6 0.0 4.2 0.0 2.9 2.5 0.0 6.5 0.0 8.0 5.3 5.3 0.0 10.0 1.0 0.0 8.4 3.3 1.9 0.0 0.7 0.0 8.0 4.1 1.9 0.3 2.1 8.4 0.0 0.0 4.0 3.1 1.9 0.0 4.4 8.7 0.6 0.0 6.3 5.2 1.1 0.2 0.0 0.3 28.6 22.2 8.0 0.0 8.3 4.7 3.4 3.8 6.0 0.0 0.0 0.0 9.8 0.0 20.3 4.8 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.9 2.0 1.7 1.6 2.7 0.5 4.4 1.4 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168447 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026332 Approved "CAB026332: AB_566386" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 10.0 7.9 4.9 18.9 5.6 24.8 17.9 1.6 4.7 6.9 15.7 5.1 17.7 5.3 7.9 6.6 10.8 7.8 10.3 7.0 3.8 3.0 14.6 16.3 9.7 46.7 5.5 4.1 12.2 15.1 12.2 21.3 13.3 4.6 8.6 8.8 7.8 11.4 21.8 13.9 6.2 13.7 3.8 4.2 31.5 7.2 19.1 5.5 40.4 32.3 8.6 16.0 10.3 11.8 4.9 3.4 8.3 8.2 2.4 9.5 2.2 3.5 1.3 5.0 4.5 3.9 2.0 13.4 0.6 0.9 1.4 1.4 3.6 10.8 13.5 3.3 0.5 4.0 4.2 1.6 1.0 10.4 8.5 16.2 3.4 4.4 2.1 6.0 4.2 2.0 4.5 1.8 1.7 1.9 8.5 20.8 0.3 2.8 7.1 6.1 5.8 3.4 8.5 4.4 17.8 1.9 5.8 4.6 11.6 4.8 6.2 3.7 2.7 13.4 0.9 0.9 5.9 1.7 1.8 41.0 7.9 19.1 1.3 4.3 0.7 6.1 5.6 3.3 2.6 3.8 3.0 4.9 3.9 3.1 3.4 3.2 2.7 2.1 8.3 2.4 8.2 0.7 9.5 2.2 4.9 5.6 1.6 4.7 3.8 3.0 5.5 4.1 4.6 5.5 BSG "CD147, EMMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583493 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles 3400000 Vesicles "CAB002427: AB_563501, HPA036048: , HPA074870: " "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favourable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavourable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favourable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 53.0 74.8 60.0 33.3 73.0 86.3 42.3 36.2 103.0 41.7 93.4 57.8 37.3 50.1 56.0 62.2 35.1 48.8 52.0 205.8 58.5 45.9 78.5 39.1 36.1 22.6 57.6 44.0 51.3 64.2 28.2 48.2 96.2 57.9 49.5 39.6 109.4 44.0 48.4 97.4 38.1 45.5 52.9 34.9 28.3 63.9 76.8 30.4 31.8 61.9 45.9 31.2 48.5 31.5 22.0 43.8 89.4 58.7 30.9 44.5 65.5 63.7 86.1 41.1 92.3 122.3 52.6 87.4 53.1 66.4 64.1 55.8 68.6 69.1 22.9 61.7 48.0 104.1 41.6 64.5 22.2 48.0 89.2 15.7 72.8 92.8 77.3 37.9 74.0 54.7 65.5 36.8 41.1 45.9 73.9 108.2 37.6 114.5 27.6 72.7 96.4 44.1 55.5 33.6 75.4 75.7 47.9 63.7 58.0 110.2 44.5 78.8 46.7 117.3 50.5 61.5 39.1 101.9 80.1 69.8 70.2 21.7 116.7 52.6 76.1 32.0 58.7 62.0 44.5 45.2 39.5 22.0 30.2 42.6 39.9 18.3 23.1 29.1 89.4 30.9 48.3 43.8 35.1 65.5 60.0 73.0 36.2 103.0 58.5 45.9 57.6 44.0 57.9 30.4 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory beta subunit" Q8WZ55 1 54998193-55011784 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 3.9;kidney: 12.3;salivary gland: 4.2" "Cell line enriched" "Detected in single" 20 "RPMI-8226: 12.9" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.9 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.3 0.2 0.5 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.9 0.1 0.4 0.2 0.1 0.1 C1QTNF9 "AQL1, C1QTNF9A, CTRP9, MGC48915" ENSG00000240654 "C1q and TNF related 9" P0C862 13 24307166-24322535 "Predicted secreted proteins, Transporters" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 15.2;skeletal muscle: 14.1" "Cell line enhanced" "Detected in some" "MCF7: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056632 Uncertain "Secreted to blood" 209845000 "HPA056632: " "unprognostic (1.18e-2)" "unprognostic (3.22e-2)" "unprognostic (2.44e-2)" "unprognostic (3.14e-3)" "unprognostic (9.22e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-2)" "unprognostic (3.63e-2)" "unprognostic (1.03e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-2)" "unprognostic (4.16e-2)" "unprognostic (3.29e-4)" "unprognostic (1.38e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" 5.6 0.3 0.2 2.4 0.9 0.3 4.9 0.1 0.2 0.7 2.8 0.1 0.1 1.1 1.6 1.6 4.8 0.3 1.9 15.2 0.9 0.3 0.3 0.8 0.4 0.4 0.2 0.1 0.4 1.2 0.5 0.2 4.8 0.1 2.6 0.7 0.1 0.9 1.0 14.1 0.6 1.2 1.8 0.2 0.6 1.1 1.6 0.1 0.3 0.5 5.2 0.9 1.0 7.1 0.5 0.7 0.7 0.3 0.0 0.2 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.5 0.1 0.9 0.0 1.3 0.7 0.5 0.3 0.0 0.2 0.1 0.0 0.5 0.5 0.8 0.0 0.4 0.0 0.0 0.2 0.5 0.3 0.1 0.0 0.5 0.0 0.3 1.7 0.0 1.9 0.7 1.2 0.2 1.4 0.2 0.2 0.0 0.6 0.5 0.1 0.2 0.5 0.0 0.2 0.4 0.3 0.0 0.4 0.6 1.1 0.4 0.9 0.4 0.6 0.7 0.7 1.1 0.1 0.1 0.0 0.2 0.1 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.7 0.0 0.0 0.2 0.9 0.1 0.1 0.9 0.3 0.2 0.1 0.1 0.1 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 CACNA2D1 "CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3" ENSG00000153956 "Calcium voltage-gated channel auxiliary subunit alpha2delta 1" P54289 7 81946444-82443798 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.1;HUVEC TERT2: 24.7;SH-SY5Y: 28.7;TIME: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008213, HPA008621" Enhanced "Intracellular and membrane" 310000000 "HPA008213: AB_1845862, HPA008621: AB_1845863" "unprognostic (5.07e-3)" "unprognostic (2.21e-1)" "unprognostic (4.27e-3)" "unprognostic (2.92e-2)" "unprognostic (2.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.70e-1)" "unprognostic (3.22e-1)" "unprognostic (3.76e-1)" "unprognostic (2.05e-1)" "unprognostic (6.24e-3)" "unprognostic (2.23e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (4.28e-3)" "unprognostic (2.13e-1)" "unprognostic (9.18e-2)" "unprognostic (1.03e-4)" 9.9 13.4 15.7 4.2 18.1 0.7 4.3 8.8 20.8 5.7 11.3 7.3 1.0 5.0 7.1 2.9 5.4 4.1 6.3 25.8 12.7 14.9 8.0 1.8 3.6 2.2 6.3 15.6 7.8 2.0 1.9 8.3 4.2 8.6 12.8 5.3 1.9 3.3 6.6 59.0 4.7 3.5 13.0 5.6 4.3 5.5 3.7 8.0 0.0 16.9 14.6 3.3 6.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.8 0.0 8.5 10.8 0.0 10.5 6.8 5.2 5.1 0.0 1.5 0.0 0.0 9.1 0.0 5.0 0.0 6.9 0.0 6.8 0.3 6.8 0.0 5.6 2.3 0.0 6.3 0.0 18.1 0.0 24.7 0.0 0.1 11.6 0.0 0.0 0.0 5.7 2.2 1.0 0.9 0.0 0.4 0.4 9.7 28.7 2.0 0.0 0.0 0.0 0.0 17.7 9.3 7.0 9.2 0.0 0.0 0.0 0.0 7.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 18.1 8.8 20.8 12.7 14.9 6.3 15.6 8.6 8.0 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 64.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: " "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavourable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 6.2 64.9 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.0;HAP1: 2.7;HeLa: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.6 0.2 13.7 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 CACNB2 "CACNLB2, MYSB" ENSG00000165995 "Calcium voltage-gated channel auxiliary subunit beta 2" Q08289 10 18140677-18543557 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 10.5;HSkMC: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035326 Enhanced Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA035326: AB_10669903" "unprognostic (3.03e-3)" "unprognostic (3.04e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (4.58e-3)" "unprognostic (4.67e-4)" "unprognostic (8.03e-2)" "unprognostic (3.76e-2)" "unprognostic (8.10e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-4)" "unprognostic (1.40e-1)" "prognostic favourable (3.56e-5)" "unprognostic (3.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.03e-1)" "unprognostic (8.16e-2)" 2.7 15.6 10.5 4.2 16.4 2.1 2.8 27.0 25.8 7.0 11.6 1.9 7.4 3.4 9.6 5.8 9.7 7.8 4.6 15.8 8.8 9.7 4.6 4.0 2.7 1.8 4.3 11.8 18.1 8.6 2.7 16.9 1.3 9.2 9.7 8.7 10.0 7.1 18.0 2.1 5.6 9.4 31.1 2.4 1.7 6.5 2.0 3.2 0.1 2.5 0.0 1.0 13.4 12.8 1.9 0.8 4.0 0.7 1.0 3.7 0.2 0.2 1.4 0.9 0.7 0.7 0.4 0.6 0.4 0.0 0.1 0.4 0.6 0.6 1.1 0.2 0.3 0.9 10.5 0.0 0.0 0.4 3.2 1.0 1.8 1.9 2.7 0.8 1.9 13.2 0.0 0.0 0.0 0.0 1.1 2.2 0.0 0.8 1.1 1.2 3.8 0.1 0.9 1.0 1.0 0.0 1.1 5.3 1.5 0.1 0.1 0.4 0.2 1.1 0.2 0.7 2.4 0.4 0.7 2.4 2.3 2.2 0.3 1.5 0.5 4.0 0.5 0.6 1.0 0.7 1.4 1.3 1.1 0.5 0.1 1.9 1.8 2.6 0.7 1.0 0.7 0.8 3.7 0.2 10.5 16.4 27.0 18.3 8.8 9.7 4.3 11.8 9.2 3.2 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in many" "U-937: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.7" "Lineage enriched" "Detected in single" 9 "T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA059515: " "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 3.8 3.7 27.4 2.9 22.4 1.2 4.2 18.5 42.9 11.9 9.1 1.5 3.0 3.8 22.6 8.1 11.6 16.1 6.7 2.6 16.4 12.2 3.9 1.3 6.1 1.7 10.0 14.5 24.1 2.1 2.8 4.2 5.3 4.4 5.7 7.8 3.4 4.5 9.1 2.1 7.8 5.8 20.4 2.4 2.2 4.7 4.7 2.3 4.6 6.1 3.4 3.6 7.5 6.9 0.2 0.5 0.0 0.3 0.0 4.7 0.5 6.8 5.4 9.1 18.5 11.1 7.9 5.5 7.0 14.8 10.4 6.2 1.7 5.6 0.8 9.2 11.7 7.3 8.2 7.6 3.9 7.9 2.5 3.6 4.4 0.2 4.4 0.6 3.9 5.0 4.6 4.3 2.1 11.8 0.5 2.9 6.7 17.0 8.4 0.9 5.6 4.6 9.7 2.0 2.7 7.5 12.9 12.9 12.8 2.1 15.5 5.1 10.6 3.0 11.3 6.6 9.4 3.2 3.8 3.3 1.3 0.2 5.5 45.1 2.0 0.0 0.3 0.0 0.9 0.1 0.4 0.2 1.8 1.8 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.4 4.7 0.5 27.4 22.4 18.5 42.9 16.4 12.2 10.0 14.5 4.4 2.3 CACNB4 EJM4 ENSG00000182389 "Calcium voltage-gated channel auxiliary subunit beta 4" O00305 2 151832768-152099475 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 20.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in all" 4 "basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.0" HPA015601 Approved "HPA015601: AB_1845873" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" "unprognostic (3.70e-1)" "unprognostic (9.42e-4)" "unprognostic (1.23e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.55e-2)" "unprognostic (7.26e-3)" "unprognostic (3.93e-2)" "unprognostic (9.55e-3)" "unprognostic (2.45e-1)" 1.6 1.7 5.2 1.3 28.0 1.7 3.2 35.7 28.0 1.4 1.2 2.6 0.0 1.2 1.4 1.7 3.1 1.1 2.1 1.1 4.5 4.4 2.8 0.9 3.9 1.1 4.3 10.9 1.3 1.2 1.0 3.8 2.1 9.8 3.9 1.4 0.9 2.1 3.9 0.8 11.7 1.1 4.2 3.0 1.2 1.6 4.1 3.4 0.0 3.1 0.0 2.2 3.5 0.8 0.4 1.3 7.0 0.6 0.2 0.1 0.1 0.0 0.0 0.7 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.3 3.2 0.0 0.1 4.0 0.0 0.2 20.7 0.2 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.3 0.5 0.6 1.8 0.2 0.6 1.2 0.6 1.4 0.7 0.0 0.0 0.0 3.3 0.8 0.0 1.9 2.1 0.6 0.4 0.4 0.0 0.0 0.5 4.8 0.1 1.2 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.4 0.1 0.1 7.0 0.2 0.0 1.3 0.0 0.1 5.2 28.0 35.7 21.7 4.5 4.4 4.3 10.9 9.8 3.4 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044590-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 126.7" "Group enriched" "Detected in some" 5 "HSkMC: 8.1;SH-SY5Y: 2.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.0" "Not detected" "Not detected" "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 5.7 0.4 0.3 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 126.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.7 25.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36563921-36703558 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 30.7" "Group enriched" "Detected in some" 8 "SCLC-21H: 7.6;SH-SY5Y: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.7 2.7 5.6 0.8 6.4 0.9 0.7 30.7 21.9 0.6 0.7 0.3 0.0 0.8 0.6 0.6 0.7 0.6 0.6 0.6 3.8 4.7 0.7 0.7 0.7 0.7 2.9 7.8 0.6 1.1 0.6 2.7 0.7 6.9 0.7 0.7 0.1 0.6 0.6 1.0 0.8 0.8 0.7 1.7 0.7 0.7 1.0 0.8 0.0 0.7 0.0 0.6 0.7 0.1 0.3 1.0 1.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 7.6 3.4 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.3 0.2 0.0 0.3 0.4 0.4 1.0 0.3 0.2 1.0 0.2 0.1 5.6 6.4 30.7 12.3 3.8 4.7 2.9 7.8 6.9 0.8 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.0" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 95.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved Cytosol Cytosol "HPA005803: , HPA065370: " "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 3.8 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 3.8 0.0 0.0 0.1 2.0 0.0 2.6 3.8 95.2 0.8 2.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell line enhanced" "Detected in some" "A549: 12.4;EFO-21: 21.8;HHSteC: 5.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA056615: " "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.0 0.0 21.8 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 2.5 0.0 0.0 0.0 3.0 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell line enhanced" "Detected in some" "AF22: 28.8;HMC-1: 22.4;NTERA-2: 7.6;SH-SY5Y: 17.7;U-2 OS: 6.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 28.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 22.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 1.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.2;TIME: 12.9" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.9 2.3 0.5 0.0 1.0 0.0 21.2 0.3 0.0 0.0 0.2 2.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.0 12.9 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavourable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.7 6.5 0.0 0.2 0.0 1.2 0.2 0.1 0.2 0.0 0.0 8.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.2 0.0 0.0 51.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.6 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190556-160201886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 320.9;tongue: 83.5" "Group enriched" "Detected in some" 9 "BEWO: 10.4;HDLM-2: 19.8;RT4: 35.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA007845, CAB015170, HPA026823" Enhanced Uncertain Nucleoplasm,Mitochondria "Intracellular and membrane" "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favourable (8.93e-5)" 6.1 0.1 0.5 0.0 0.3 0.1 0.2 0.3 2.0 0.1 0.1 0.0 0.1 0.0 0.1 11.9 3.9 0.2 0.1 4.0 0.4 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.0 1.3 0.0 0.2 4.5 0.4 320.9 0.1 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.0 0.9 83.5 4.7 0.4 0.1 0.9 0.0 0.9 0.7 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.2 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.1 0.0 35.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.1 0.1 0.0 0.0 0.9 0.7 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.9 0.1 0.1 0.9 0.2 0.1 0.0 0.3 0.0 0.5 0.3 0.3 2.0 0.4 0.3 0.2 0.0 0.0 0.0 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524785-116561184 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 142.2;BJ hTERT+: 149.8;HBEC3-KT: 145.9;LHCN-M2: 152.1;U-138 MG: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 10.6;memory B-cell: 6.0" "Group enriched" "Detected in many" 37 "B-cells: 6.0;granulocytes: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" "Golgi apparatus" "CAB003791: AB_562068, HPA049326: " "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavourable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 143.9 2.3 2.4 27.5 5.9 0.0 70.5 1.0 3.8 73.8 57.4 2.6 32.3 4.3 84.6 40.9 51.1 31.4 42.0 60.2 2.7 2.3 5.7 4.2 132.7 8.6 7.9 4.5 26.6 3.8 2.0 1.9 92.0 4.2 42.3 13.7 13.6 12.8 26.5 33.3 21.7 18.6 104.0 5.5 28.6 30.1 21.5 5.2 2.8 92.1 34.7 6.6 85.9 33.7 6.0 0.1 10.6 0.0 0.0 0.2 1.1 27.4 22.4 0.6 0.2 92.9 142.2 1.3 65.5 149.8 36.2 38.2 0.1 40.9 0.0 23.2 77.0 51.8 0.1 145.9 55.1 1.8 1.2 0.0 8.9 0.0 12.8 0.0 0.1 48.5 31.0 52.8 35.0 109.0 0.0 1.5 152.1 2.8 0.0 0.0 2.1 10.8 0.3 1.5 15.6 20.5 0.1 0.0 0.0 20.1 1.3 3.2 0.1 0.2 83.7 121.4 13.9 46.3 18.0 6.1 0.9 0.1 48.9 0.0 43.8 10.6 0.0 0.0 0.0 0.0 0.0 6.0 0.2 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 2.4 5.9 1.0 3.8 2.7 2.3 7.9 4.5 4.2 5.2 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832843-839831 "Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported 680000 "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavourable (5.58e-4)" "prognostic unfavourable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favourable (6.92e-4)" "unprognostic (7.83e-2)" 63.1 28.1 7.4 19.1 8.1 3.4 133.2 7.9 11.3 39.8 36.0 9.5 37.8 23.2 55.7 45.3 43.1 29.3 63.0 85.2 7.3 7.9 52.8 47.2 45.8 16.3 7.5 10.3 29.8 82.7 27.8 14.1 58.6 10.7 52.0 16.5 31.2 62.9 41.1 19.2 17.1 46.0 62.4 6.7 15.8 31.7 20.8 5.5 2.4 43.2 27.1 16.1 35.9 34.9 2.1 8.1 14.9 14.3 5.2 4.8 6.5 39.5 54.8 7.9 23.7 113.5 47.2 12.4 62.0 42.3 31.3 26.5 28.5 56.5 0.0 24.8 92.6 36.1 7.0 54.7 7.9 14.8 26.9 10.9 16.9 21.7 43.2 8.8 15.2 45.6 36.6 18.3 32.3 36.9 13.3 5.1 46.7 22.2 0.2 10.4 5.2 65.8 2.0 16.4 8.5 69.6 11.5 10.9 12.2 57.4 32.0 10.8 12.9 10.7 63.1 42.6 21.1 13.7 34.3 6.9 7.1 0.4 42.0 9.2 23.5 14.9 12.0 9.6 4.2 12.6 4.8 2.1 3.5 3.6 8.1 1.5 1.5 2.2 5.7 5.2 14.3 1.3 2.1 6.5 7.4 8.1 7.9 11.3 7.3 7.9 7.5 10.3 10.7 5.5 CD53 "MOX44, TSPAN25" ENSG00000143119 "CD53 molecule" P19397 1 110873154-110899928 "CD markers, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 146.7;lymphoid tissue: 103.0" "Cell line enhanced" "Detected in some" "Daudi: 85.8;HDLM-2: 36.9;HMC-1: 54.0;Karpas-707: 33.7;U-266/70: 46.6;U-698: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047216 Enhanced "HPA047216: " "unprognostic (2.93e-2)" "unprognostic (1.25e-2)" "unprognostic (7.45e-3)" "unprognostic (1.02e-3)" "unprognostic (8.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.96e-1)" "unprognostic (6.07e-2)" "unprognostic (2.83e-2)" "unprognostic (2.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.62e-1)" "prognostic unfavourable (2.60e-4)" "unprognostic (9.58e-2)" "unprognostic (4.95e-2)" "unprognostic (1.33e-1)" "unprognostic (7.72e-2)" 29.7 8.1 6.1 50.6 10.3 20.4 6.6 1.6 5.8 4.5 9.6 7.6 1.2 6.7 4.3 6.0 5.5 9.9 11.0 6.4 6.4 5.9 9.6 8.8 28.9 93.8 13.3 2.7 4.7 3.8 0.8 3.1 10.6 8.5 5.2 10.5 4.5 10.1 2.3 2.3 2.2 35.2 10.0 14.9 103.0 7.5 4.8 10.0 37.2 4.6 4.1 82.1 15.2 4.0 97.5 74.6 138.0 97.0 59.2 91.8 146.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 4.5 0.0 0.0 0.0 10.3 54.0 0.0 0.0 0.0 0.0 0.0 1.9 33.7 0.0 0.0 17.4 12.2 0.0 0.0 16.9 0.1 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 3.0 0.0 0.0 0.0 0.0 46.6 21.1 26.6 0.2 11.9 0.6 138.0 87.0 54.1 91.8 93.3 82.8 97.5 67.5 80.8 74.6 83.3 49.2 70.8 136.2 59.2 97.0 61.4 85.0 146.7 6.1 10.3 1.6 5.8 6.4 5.9 13.3 2.7 8.5 10.0 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 272.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356" Supported Supported Vesicles "Intracellular and membrane" Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323" "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavourable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 115.3 88.2 42.5 44.9 37.2 67.4 106.3 13.7 33.1 80.6 84.7 34.4 71.5 39.9 99.7 177.9 70.9 60.4 102.7 154.4 36.9 39.0 106.6 92.5 109.6 113.8 49.8 27.2 93.8 187.1 33.3 49.3 176.9 50.8 82.9 81.8 102.1 105.0 83.7 92.7 38.5 72.4 88.2 43.6 107.7 74.8 52.1 30.5 17.6 108.1 50.7 47.4 96.3 82.2 9.6 40.3 147.4 50.8 58.4 29.8 56.6 21.9 38.3 21.0 20.4 272.1 170.6 27.7 89.3 163.9 52.9 57.7 42.7 44.3 6.3 28.5 133.0 20.4 15.2 37.0 68.1 17.8 14.3 34.5 29.9 23.5 108.3 15.3 82.2 125.6 36.8 58.8 53.9 58.3 19.4 44.2 168.3 35.1 3.1 20.8 19.1 44.5 6.9 46.1 15.8 89.5 74.8 8.2 21.0 24.5 18.5 160.6 26.1 51.2 43.3 34.2 25.0 47.2 29.9 18.1 11.2 4.4 98.1 9.9 62.5 89.6 50.8 147.4 29.8 38.5 21.8 9.6 11.9 23.7 40.3 6.5 5.3 18.1 55.7 58.4 26.1 27.0 10.0 56.6 42.5 37.2 13.7 33.1 36.9 39.0 49.8 27.2 50.8 30.5 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397419 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 231.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 41.4;naive B-cell: 37.6" "Lineage enriched" "Detected in all" 4 "B-cells: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane" 1900000 "Plasma membrane" "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 102.5 43.7 52.8 40.1 57.0 9.6 79.3 31.7 63.2 124.7 88.9 75.8 261.4 21.1 143.5 141.5 56.8 123.1 86.8 101.2 46.6 52.8 65.5 123.9 107.4 82.4 70.4 51.3 77.9 62.4 41.4 42.9 61.2 63.0 89.3 34.0 46.6 59.7 263.3 22.6 59.6 39.7 138.9 59.3 64.5 52.1 57.6 53.3 25.3 66.3 38.5 37.9 93.5 80.2 41.4 2.1 5.7 1.8 3.5 9.9 2.7 24.5 25.5 20.5 31.3 231.4 131.6 17.2 46.5 103.0 37.6 38.0 23.9 0.1 21.0 16.8 130.3 32.3 12.6 33.1 15.5 9.9 38.9 3.2 9.7 0.0 76.6 13.6 27.6 95.6 47.3 15.3 23.3 35.9 14.3 36.9 52.5 18.8 11.5 17.4 24.6 20.7 23.7 10.3 13.4 40.4 16.6 22.1 24.5 14.8 39.0 28.0 12.9 24.9 47.8 19.2 14.2 35.9 15.9 27.3 6.2 38.3 27.9 8.1 32.8 0.2 0.9 5.7 6.0 1.4 9.9 41.4 4.3 9.4 0.6 37.6 2.6 5.0 0.3 3.5 1.8 2.1 3.0 2.7 52.8 57.0 31.7 63.2 46.6 52.8 70.4 51.3 63.0 53.3 CD9 "BA2, MIC3, MRP-1, P24, TSPAN29" ENSG00000010278 "CD9 molecule" P21926 12 6199715-6238271 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 127.8;HUVEC TERT2: 82.6;RT4: 94.7;TIME: 188.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "basophil: 137.8;eosinophil: 98.3" "Lineage enriched" "Detected in many" 24 "granulocytes: 137.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002490 Supported Supported "Plasma membrane" 68000000 "Plasma membrane" "CAB002490: AB_563643" "unprognostic (1.38e-1)" "unprognostic (6.36e-3)" "unprognostic (8.27e-3)" "unprognostic (6.98e-3)" "unprognostic (3.89e-1)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (2.90e-1)" "unprognostic (2.60e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.30e-1)" "prognostic favourable (6.49e-5)" "unprognostic (6.10e-2)" "unprognostic (1.77e-1)" "prognostic favourable (8.93e-5)" "unprognostic (9.26e-2)" 38.1 44.5 20.0 24.1 36.2 3.1 48.2 6.8 29.6 55.0 68.3 63.1 151.6 19.5 36.2 43.4 139.8 38.4 23.2 39.2 30.3 15.6 39.9 12.2 61.1 8.2 43.3 23.3 14.1 23.3 89.5 15.2 13.0 28.7 77.9 73.5 25.5 91.6 180.4 11.3 60.1 29.6 62.2 48.9 12.2 27.7 10.4 47.7 6.0 63.6 112.3 85.8 54.5 76.0 1.9 0.9 137.8 5.6 0.2 1.1 5.6 33.9 14.9 0.3 9.2 14.7 15.1 12.9 20.1 40.2 6.9 10.6 10.9 127.8 0.1 5.0 4.3 74.5 7.8 40.2 5.3 1.7 5.5 0.1 11.3 2.3 6.3 0.1 42.8 0.0 29.9 12.6 10.9 82.6 1.5 0.1 4.3 48.6 0.1 3.7 11.6 15.0 0.3 24.6 43.2 67.6 94.7 0.0 2.9 20.0 16.6 17.2 7.7 3.5 188.9 0.7 18.9 0.7 2.4 0.1 0.1 5.1 11.8 0.0 18.6 137.8 5.6 98.3 0.1 1.8 0.2 0.5 0.1 0.1 0.9 1.9 0.4 1.1 2.6 0.2 0.0 0.3 0.0 5.6 20.0 36.2 6.8 29.6 30.3 15.6 43.3 23.3 28.7 47.7 CHP1 "CHP, p22, p24, Sid470p, SLC9A1BP" ENSG00000187446 "Calcineurin like EF-hand protein 1" Q99653 15 41230839-41281890 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006616 Approved Approved Vesicles Vesicles "HPA006616: AB_1857461" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (2.84e-1)" "prognostic favourable (9.63e-4)" "unprognostic (7.29e-2)" "unprognostic (3.74e-1)" "prognostic favourable (4.07e-6)" "unprognostic (2.20e-1)" "unprognostic (7.46e-2)" "unprognostic (3.26e-2)" "unprognostic (1.26e-3)" "unprognostic (2.79e-1)" "prognostic favourable (2.79e-6)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-3)" "unprognostic (2.04e-1)" 39.4 32.5 21.2 17.0 21.5 25.7 32.3 13.5 34.1 17.0 51.0 19.0 18.9 41.0 13.4 16.4 39.1 11.2 38.8 27.3 22.7 23.8 35.6 82.3 31.6 14.4 22.4 15.6 13.6 31.1 27.1 13.9 12.2 32.1 16.8 37.6 15.2 28.7 23.1 42.2 24.2 55.6 15.8 19.0 12.6 52.5 7.5 11.3 10.3 23.6 34.2 24.7 21.7 22.5 8.6 30.5 52.5 47.4 11.0 11.8 19.4 21.4 21.0 8.1 31.1 34.5 32.8 12.7 16.7 21.0 13.1 14.1 18.6 41.5 3.6 18.7 21.9 26.4 15.7 25.3 14.6 15.2 5.9 14.4 17.4 28.8 26.9 19.0 22.8 33.6 27.6 15.1 15.1 23.5 23.3 23.7 14.4 11.8 7.9 19.4 8.8 11.3 11.3 13.3 10.3 25.6 39.4 5.5 13.7 28.4 52.5 13.9 31.0 18.0 33.6 14.8 16.0 23.2 10.9 13.9 36.8 17.6 26.5 11.7 13.4 42.9 47.4 52.5 10.7 40.0 11.0 8.6 10.1 10.7 30.5 6.8 6.5 9.3 35.6 11.0 38.5 19.2 11.8 19.4 21.2 21.5 13.5 34.1 22.7 23.8 22.4 15.6 32.1 11.3 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423560-54441431 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Approved Vesicles Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavourable (8.95e-4)" 32.2 32.3 24.3 19.9 24.9 11.7 27.7 20.6 28.0 23.5 31.0 18.9 22.5 35.8 25.4 20.3 28.7 25.2 27.5 31.0 21.6 22.9 29.4 83.6 26.1 36.2 23.5 18.9 22.0 26.3 12.3 31.2 21.0 20.5 26.9 35.8 23.2 20.5 23.2 25.1 14.3 32.1 46.2 25.5 17.1 20.7 16.7 16.2 26.3 24.1 27.3 27.8 40.6 20.0 23.6 31.7 7.6 31.2 15.6 30.7 31.6 41.1 25.2 21.2 23.8 57.4 73.5 19.7 50.1 64.3 43.4 49.9 14.9 58.1 52.0 33.4 37.9 41.3 38.4 36.4 54.3 19.8 22.5 19.9 16.2 27.0 57.7 24.0 16.8 59.7 45.5 40.4 57.3 40.7 19.4 17.7 48.3 22.7 26.5 18.3 15.6 51.2 20.4 35.6 17.3 49.1 30.8 17.8 19.8 29.2 23.5 55.5 36.2 26.2 26.1 36.6 36.4 30.6 30.1 11.1 23.9 25.2 44.4 20.6 32.3 1.9 31.2 3.8 12.9 23.7 21.5 23.6 22.8 18.4 31.7 18.9 30.7 20.5 7.6 15.6 18.2 17.8 23.2 31.6 24.3 24.9 20.6 28.0 21.6 22.9 23.5 18.9 20.5 16.2 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278190-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 74.5" "Cell line enhanced" "Detected in some" "AF22: 8.9;NTERA-2: 8.3;SCLC-21H: 34.7;SH-SY5Y: 16.0" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavourable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 1.5 6.5 33.9 1.5 37.6 3.2 1.4 8.4 49.5 1.2 1.4 6.2 0.0 2.1 1.5 1.3 1.3 2.0 1.5 1.2 74.5 17.3 1.2 1.2 1.4 1.4 9.6 15.5 1.2 4.2 1.6 8.8 2.0 4.6 1.4 1.6 0.0 1.3 1.2 1.2 3.1 1.6 1.6 2.4 1.6 2.8 2.6 4.7 0.5 1.3 0.0 1.3 1.3 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.4 8.9 7.7 0.1 0.1 1.1 0.5 0.6 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.0 0.0 0.1 0.8 0.7 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.5 7.5 1.2 0.1 8.3 0.6 3.6 0.0 0.0 0.0 0.4 34.7 16.0 0.0 4.3 0.3 7.5 0.1 0.0 1.0 0.4 0.2 0.3 0.2 0.2 0.3 2.3 0.2 5.8 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.1 0.8 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 33.9 37.6 8.4 36.5 74.5 17.3 9.6 15.5 4.6 4.7 CNTN2 "AXT, TAG-1, TAX, TAX1" ENSG00000184144 "Contactin 2" Q02246 1 205042937-205078284 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cell adhesion" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 78.5" "Group enriched" "Detected in some" 7 "NTERA-2: 5.6;SCLC-21H: 14.0" "Cancer enriched" "Detected in some" 9 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001397, HPA012497" Approved "Secreted in brain" 13000 "HPA001397: AB_1847146, HPA012497: AB_1847147" "unprognostic (1.90e-1)" "unprognostic (1.86e-1)" "unprognostic (2.87e-2)" "unprognostic (4.52e-3)" "unprognostic (2.98e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (1.43e-2)" "unprognostic (8.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (5.62e-2)" "unprognostic (1.73e-7)" "unprognostic (9.82e-3)" "unprognostic (1.19e-1)" "unprognostic (3.35e-2)" "unprognostic (3.07e-2)" 2.0 2.4 15.6 2.1 52.5 1.6 1.6 11.0 68.8 1.8 2.3 78.5 0.0 1.7 1.6 1.7 1.9 1.7 1.8 1.7 27.4 15.9 1.6 1.6 1.6 1.7 59.8 22.0 1.6 1.6 1.6 2.7 1.6 41.9 1.8 2.3 0.0 2.2 2.4 1.6 2.3 2.2 1.8 55.4 1.7 1.7 9.1 48.3 0.0 1.6 0.0 2.0 1.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 15.6 52.5 11.0 28.4 27.4 15.9 59.8 22.0 41.9 48.3 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.0;pancreas: 136.8" "Cell line enhanced" "Detected in many" "HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 63.0" "Group enriched" "Detected in some" 13 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in many" 20 "B-cells: 24.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6" HPA065086 Supported Vesicles "Secreted to extracellular matrix" 88000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 1.1 1.4 2.1 1.1 63.0 1.3 0.9 1.1 2.3 4.0 0.8 1.4 1.6 0.6 0.6 1.0 0.6 2.2 1.2 0.9 1.2 2.9 1.8 0.5 0.5 3.1 0.8 1.9 0.6 136.8 0.4 3.3 0.9 2.1 14.7 1.0 0.8 1.8 21.8 0.6 4.6 0.7 0.7 1.4 0.8 0.8 1.8 7.9 0.0 0.6 0.7 2.4 1.1 7.8 24.0 0.0 0.1 0.3 0.0 1.1 0.6 0.0 11.0 1.0 0.0 0.2 0.0 6.9 0.0 0.0 2.0 5.5 6.5 0.3 0.1 0.5 0.0 0.0 6.9 0.0 3.4 0.0 30.1 5.5 2.5 19.7 0.0 0.5 2.3 0.4 0.0 0.2 0.0 0.1 38.7 1.6 0.5 0.2 2.7 32.1 3.7 1.1 8.1 0.0 0.2 0.3 1.0 35.7 9.6 0.8 0.1 0.0 0.0 15.0 0.2 0.0 0.0 0.1 0.0 1.8 4.7 3.4 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.6 2.1 63.0 1.1 2.3 1.2 2.9 0.8 1.9 2.1 7.9 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299300 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 12.3 12.6 30.0 10.2 34.5 9.6 14.2 42.1 37.7 19.9 17.8 32.3 17.0 16.1 15.4 8.8 30.2 12.7 12.9 13.8 26.9 19.2 21.0 18.6 12.9 10.6 32.9 27.3 18.7 11.9 28.2 19.8 15.1 29.1 12.1 20.2 10.4 16.5 14.7 18.7 13.7 18.4 15.3 32.2 8.8 16.7 11.1 39.4 14.7 34.6 13.9 14.8 13.8 15.7 3.7 2.9 2.9 1.0 1.4 3.9 1.5 46.9 7.4 14.8 26.8 12.2 11.5 15.1 16.8 15.4 16.9 19.9 21.7 20.3 13.7 48.2 16.6 31.0 13.5 26.1 32.6 3.7 9.0 12.0 11.5 15.8 12.1 11.9 11.9 10.3 14.2 15.5 34.0 21.2 9.7 16.7 40.6 18.2 17.7 4.6 11.6 14.3 9.5 17.9 9.8 17.6 19.9 7.3 12.3 26.3 17.5 19.1 40.0 9.2 20.1 45.9 12.1 12.6 28.3 26.5 19.0 17.8 16.9 18.2 14.3 0.0 0.9 2.9 1.5 1.0 3.9 3.7 2.9 2.7 2.2 2.0 3.0 3.1 1.1 1.4 0.4 2.9 2.9 1.5 30.0 34.5 42.1 37.7 26.9 19.2 32.9 27.3 29.1 39.4 DLG4 "PSD-95, PSD95, SAP-90, SAP90" ENSG00000132535 "Discs large MAGUK scaffold protein 4" P78352 17 7189890-7219702 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 83.2" "Cell line enhanced" "Detected in many" "HMC-1: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001999, CAB002000, HPA010122" Enhanced "Intracellular and membrane" "CAB001999: , CAB002000: , HPA010122: AB_1855169" "unprognostic (7.08e-2)" "unprognostic (1.06e-2)" "unprognostic (3.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.23e-2)" "unprognostic (1.80e-1)" "unprognostic (7.18e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" "prognostic favourable (8.82e-6)" "unprognostic (3.45e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.12e-2)" "unprognostic (2.83e-2)" "unprognostic (3.68e-2)" "unprognostic (4.77e-3)" 5.5 16.0 58.3 7.5 73.3 4.1 4.5 47.4 83.2 9.7 4.1 5.4 4.3 4.7 13.8 5.0 5.0 9.2 10.7 8.9 58.7 24.2 3.3 3.1 6.0 4.2 14.4 53.9 12.8 4.6 11.5 15.1 8.7 14.8 7.3 3.8 3.1 6.3 12.5 3.6 4.0 4.4 10.7 11.3 7.8 5.7 10.1 17.0 1.7 5.8 0.0 3.5 7.0 4.2 0.0 1.6 0.0 0.9 0.0 1.6 0.6 0.2 7.7 19.3 6.5 7.4 10.9 0.5 10.2 8.8 7.6 7.3 0.3 3.2 1.4 4.5 8.7 0.7 1.1 4.0 3.7 10.1 1.9 5.7 13.8 0.9 6.2 0.1 32.3 12.1 0.5 6.4 6.6 8.9 2.3 5.2 11.4 0.2 4.4 3.5 2.8 0.5 8.0 0.8 0.7 5.5 0.2 7.9 6.3 0.2 0.4 1.2 4.6 3.6 11.0 18.3 8.9 3.7 5.3 0.8 0.5 0.7 13.8 3.7 5.6 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.3 0.1 0.0 0.0 0.1 1.6 0.0 0.6 58.3 73.3 47.4 71.2 58.7 24.2 14.4 53.9 14.8 17.0 DMD "BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85" ENSG00000198947 Dystrophin P11532 X 31097677-33339441 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.1;Hep G2: 14.7;RH-30: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.6;naive B-cell: 4.9;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 18 "B-cells: 4.9;dendritic cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000119, HPA002725, HPA023885" Enhanced "CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931" "unprognostic (3.91e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-2)" "unprognostic (1.09e-1)" "unprognostic (2.17e-1)" "unprognostic (7.58e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-4)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (5.84e-3)" "unprognostic (2.38e-1)" "unprognostic (1.15e-2)" "unprognostic (8.76e-3)" "unprognostic (1.82e-1)" "unprognostic (9.83e-2)" "unprognostic (1.51e-2)" 19.8 11.8 12.5 11.6 11.1 0.7 11.8 15.6 11.6 18.9 25.6 6.8 30.3 4.5 22.2 10.0 13.1 12.5 22.3 27.5 10.0 7.6 4.4 36.2 5.9 3.7 8.5 9.8 11.7 34.5 4.9 4.1 10.3 7.8 14.5 6.8 10.7 19.7 31.6 57.7 8.5 7.4 48.2 6.1 1.9 11.9 4.6 7.4 0.0 6.2 34.5 4.7 32.6 7.9 4.9 1.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 16.1 0.0 0.1 0.1 4.8 3.2 0.3 1.7 1.9 8.0 0.0 0.2 0.0 8.8 5.4 6.4 8.2 2.7 4.7 5.1 0.2 7.3 14.7 9.3 0.0 1.5 2.1 6.0 3.0 11.3 4.3 0.6 0.1 4.6 0.3 2.5 0.0 8.1 7.4 0.1 20.3 0.0 0.1 1.3 0.3 4.5 0.0 1.2 2.3 1.1 0.0 0.5 0.1 0.0 0.2 3.3 0.1 6.6 0.3 0.4 0.0 8.8 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.7 4.9 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.5 11.1 15.6 11.6 10.0 7.6 8.5 9.8 7.8 7.4 DNM2 "CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII" ENSG00000079805 "Dynamin 2" P50570 19 10718079-10833488 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Phagocytosis" "Hydrolase, Motor protein" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054246 Supported Approved "Golgi apparatus,Cytosol" 500000 "Golgi apparatus, Cytosol" "HPA054246: " "unprognostic (2.30e-1)" "unprognostic (5.23e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "prognostic favourable (8.91e-4)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.03e-1)" "unprognostic (3.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.75e-2)" "unprognostic (5.35e-2)" "unprognostic (5.47e-2)" "unprognostic (5.40e-3)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" 23.8 32.6 18.5 29.3 31.2 53.4 20.4 25.7 29.7 20.1 51.4 57.5 46.0 32.1 20.4 16.8 29.9 19.7 27.0 35.0 20.8 18.0 38.5 25.1 39.2 28.2 48.3 18.0 17.9 32.2 19.5 20.0 32.3 32.2 24.0 42.5 24.5 24.7 37.7 46.6 40.6 50.8 18.6 43.1 37.6 48.2 23.3 36.4 39.1 23.5 21.1 41.5 35.7 31.5 3.4 11.1 8.6 9.8 10.1 5.8 4.6 34.9 28.9 21.2 16.9 21.9 21.5 27.2 23.4 22.2 34.7 29.5 28.8 23.1 25.4 42.2 25.2 30.7 28.9 25.4 29.1 31.1 23.0 48.7 25.8 32.2 27.0 26.7 46.3 22.0 19.6 26.5 25.0 33.7 39.1 43.7 21.3 42.3 37.2 25.5 24.1 35.0 37.8 23.0 28.6 22.8 52.7 30.6 20.0 26.7 22.9 16.7 18.4 31.8 30.5 38.1 12.9 53.5 30.9 36.2 36.9 23.4 28.5 40.9 18.8 3.0 4.5 8.6 5.6 8.2 5.1 3.4 4.2 5.8 5.3 3.1 2.4 4.1 8.5 10.1 9.8 11.1 4.8 4.6 18.5 31.2 25.7 29.7 20.8 18.0 48.3 18.0 32.2 36.4 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845752 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.6;brain: 30.3;pancreas: 23.4" "Cell line enhanced" "Detected in some" "AF22: 5.0;HAP1: 7.5;HMC-1: 5.3;NTERA-2: 4.5;RT4: 8.0;SCLC-21H: 11.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain "HPA048767: " "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.7 15.6 13.4 1.1 15.9 0.9 0.9 1.9 30.3 1.3 3.6 7.9 0.0 2.4 1.4 0.8 0.8 0.9 1.9 0.8 17.5 9.9 1.1 0.9 1.0 0.7 7.1 21.3 0.9 23.4 0.7 1.5 1.8 10.8 0.8 4.6 0.0 1.0 0.8 0.7 0.9 2.4 1.9 12.7 0.7 1.5 2.1 10.3 0.0 1.6 0.0 0.8 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.0 11.9 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.9 1.9 30.3 17.5 9.9 7.1 21.3 10.8 10.3 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.0" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported "HPA050509: " "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 1.6 7.2 15.4 1.4 32.5 1.3 1.5 26.6 45.7 2.3 6.8 8.7 0.0 1.6 24.5 3.1 1.5 4.6 1.3 1.4 26.6 15.2 3.6 1.2 2.2 1.3 14.0 22.7 1.3 4.0 1.2 4.9 1.3 18.8 1.5 2.4 0.4 1.3 8.1 4.6 3.7 2.0 15.8 7.2 4.2 3.5 7.9 10.0 0.0 24.1 0.0 1.2 1.3 0.4 0.6 0.6 1.9 0.9 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.4 0.7 0.4 0.6 0.7 0.6 0.6 0.4 0.4 0.6 0.7 0.7 1.6 0.9 0.9 0.6 0.5 0.3 15.4 32.5 26.6 32.4 26.6 15.2 14.0 22.7 18.8 10.0 EMB MGC71745 ENSG00000170571 Embigin Q6PCB8 5 50396192-50443248 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1" "Cell line enhanced" "Detected in many" "THP-1: 68.9;U-937: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.01e-3)" "unprognostic (8.65e-2)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (8.31e-2)" "unprognostic (2.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (2.76e-5)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (1.22e-2)" "unprognostic (8.86e-3)" 15.0 16.4 1.7 21.7 2.0 43.3 8.4 1.1 2.9 2.7 18.9 1.4 0.5 21.7 1.6 5.6 6.5 4.7 6.1 16.7 2.2 4.7 4.2 1.9 10.6 44.1 3.8 1.4 2.7 1.8 15.2 8.0 6.6 4.5 9.5 3.6 4.0 7.4 6.9 2.7 15.9 42.2 2.5 3.3 20.6 3.7 10.5 1.8 15.9 13.7 3.6 17.0 5.3 2.9 9.9 11.4 16.4 14.7 16.4 26.1 16.1 8.4 0.7 1.6 0.0 0.7 2.3 0.1 0.4 0.0 0.7 0.0 0.0 22.3 16.9 0.4 0.8 12.9 3.8 10.9 0.1 5.2 8.6 8.0 2.7 0.0 0.1 16.0 0.0 0.1 6.0 1.8 7.3 0.0 0.0 22.6 13.3 9.8 9.9 9.5 6.4 4.3 15.8 0.0 22.1 0.0 7.6 5.1 4.6 0.0 2.5 0.2 1.0 68.9 0.0 0.0 8.2 0.0 0.0 0.2 0.0 14.0 0.0 29.9 2.0 3.7 14.7 16.4 21.5 1.9 26.1 9.9 19.4 19.3 9.7 6.5 11.5 15.5 13.7 16.4 0.6 11.4 23.4 16.1 1.7 2.0 1.1 2.9 2.2 4.7 3.8 1.4 4.5 1.8 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell line enhanced" "Detected in many" "HEL: 39.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavourable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favourable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavourable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.3 1.7 18.3 8.6 1.5 0.2 6.1 1.8 2.8 2.3 2.9 4.9 8.8 13.6 4.9 2.5 3.3 22.8 1.7 2.5 24.5 7.0 39.0 5.5 7.9 2.8 13.2 26.0 0.5 5.4 2.2 3.9 4.0 36.7 10.8 0.0 2.5 21.4 8.6 19.2 2.8 32.9 8.0 19.5 2.2 9.3 24.7 18.3 5.7 5.4 12.4 4.1 5.1 0.3 0.1 3.8 3.6 3.8 16.3 21.1 24.3 3.5 13.6 2.0 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 ERLEC1 "C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB" ENSG00000068912 "Endoplasmic reticulum lectin 1" Q96DZ1 2 53787044-53818819 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031501, HPA031502, HPA031503" Enhanced "Intracellular and membrane" "HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425" "unprognostic (1.27e-2)" "unprognostic (3.36e-3)" "unprognostic (3.17e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-2)" "unprognostic (1.86e-1)" "unprognostic (3.27e-3)" "unprognostic (3.79e-1)" "unprognostic (1.29e-1)" "unprognostic (2.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.92e-1)" "unprognostic (4.71e-2)" "unprognostic (1.47e-1)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (3.92e-2)" 21.4 30.0 20.8 15.3 27.7 14.9 26.2 16.7 40.0 38.2 23.6 18.2 48.2 19.4 26.0 52.2 16.9 21.5 21.9 28.9 22.9 30.7 20.7 40.0 24.7 22.2 23.4 26.9 23.2 69.0 26.3 48.8 42.9 29.3 40.5 27.1 19.3 31.0 53.8 20.2 14.4 19.3 20.5 24.3 21.8 28.3 21.0 15.5 17.9 39.0 13.2 20.7 26.5 19.8 21.1 22.5 32.0 17.3 24.3 27.1 21.0 12.1 13.6 13.5 8.2 38.4 35.0 19.7 29.9 32.8 15.0 15.8 8.9 16.6 8.5 28.6 31.5 8.8 8.8 12.6 19.2 19.0 11.0 10.5 9.3 27.2 26.4 17.4 19.4 21.9 21.1 15.7 25.7 17.5 11.1 35.0 22.2 10.0 7.9 13.8 10.3 8.7 7.2 16.1 23.7 17.7 11.6 8.0 14.0 10.8 24.0 18.4 11.4 13.4 18.7 16.5 14.5 13.3 17.6 51.6 33.7 4.8 27.1 10.5 19.3 32.0 14.3 16.6 24.9 15.0 27.1 21.1 21.9 23.5 15.5 16.0 20.8 23.8 5.6 24.3 17.3 22.5 19.9 21.0 20.8 27.7 16.7 40.0 22.9 30.7 23.4 26.9 29.3 15.5 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell line enhanced" "Detected in many" "Daudi: 92.9;MOLT-4: 90.8" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: " "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavourable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.7 16.5 10.1 0.0 48.4 4.5 0.0 11.8 0.6 9.2 11.7 0.1 7.9 92.9 6.8 2.9 5.4 24.6 18.9 7.9 47.2 53.4 33.5 11.8 25.0 4.3 32.0 8.7 3.5 38.9 11.4 23.5 53.0 9.6 10.1 5.5 5.6 90.8 16.4 13.4 64.3 40.5 0.0 9.8 14.8 71.8 42.0 15.9 5.7 1.9 4.4 0.0 16.5 7.5 0.0 26.3 0.1 0.1 12.5 4.9 66.2 4.2 30.7 14.8 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 FGFR1 "BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM" ENSG00000077782 "Fibroblast growth factor receptor 1" P11362 8 38411138-38468834 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Transcription, Transcription regulation" "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 109.2;BJ hTERT+: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033614, HPA056402" Approved 120000000 "CAB033614: AB_783377, HPA056402: " "unprognostic (9.53e-2)" "unprognostic (7.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.35e-2)" "unprognostic (4.23e-3)" "unprognostic (7.02e-2)" "unprognostic (6.59e-2)" "unprognostic (2.77e-1)" "unprognostic (1.81e-1)" "unprognostic (3.99e-2)" "unprognostic (7.97e-3)" "unprognostic (4.59e-2)" "unprognostic (7.69e-2)" "unprognostic (6.87e-3)" "unprognostic (5.60e-2)" "unprognostic (4.59e-3)" "unprognostic (1.05e-3)" 41.1 8.6 12.5 14.5 12.2 7.2 39.5 45.0 10.5 36.0 31.5 10.1 11.6 5.5 29.3 20.6 22.9 29.4 32.4 31.7 12.8 10.1 11.8 5.4 18.6 9.7 11.4 14.3 42.0 51.2 11.5 22.3 28.4 20.0 28.2 10.8 35.8 14.0 31.6 12.0 12.9 14.4 52.4 15.6 4.5 16.4 16.4 8.5 11.3 12.6 13.0 9.8 39.6 41.2 1.6 0.7 1.8 1.1 0.8 5.7 0.7 2.4 9.3 40.3 109.2 25.1 17.9 26.6 24.8 49.8 17.3 18.0 6.0 1.4 0.3 6.9 23.8 0.0 19.1 1.2 20.0 6.5 4.2 0.0 1.5 5.9 14.1 5.8 0.1 16.2 0.1 14.0 2.8 16.6 2.2 0.1 8.1 2.8 17.0 1.9 28.4 3.9 15.7 4.2 0.0 8.4 0.0 1.6 3.6 4.4 0.2 1.0 2.2 1.1 10.4 11.3 6.2 31.2 5.9 0.4 0.7 0.0 13.4 0.3 5.9 1.4 1.1 0.4 5.7 0.3 3.9 0.7 2.7 3.7 0.1 1.6 1.5 4.1 1.8 0.8 0.5 0.7 2.2 0.7 12.5 12.2 45.0 10.5 12.8 10.1 11.4 14.3 20.0 8.5 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086886-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.6;kidney: 37.7;liver: 45.3" "Group enriched" "Detected in many" 4 "CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" 4300000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.5 5.7 0.7 14.3 0.6 0.1 1.6 2.6 0.5 2.8 10.4 0.9 0.7 13.5 0.9 4.8 1.6 1.7 33.6 0.7 0.8 0.3 37.7 45.3 25.3 2.5 0.7 1.0 13.6 26.0 0.0 0.7 1.3 0.8 4.0 3.7 2.0 1.6 0.3 4.3 0.5 17.3 1.6 0.8 11.2 5.4 2.9 0.4 0.3 0.8 2.3 0.7 1.9 3.6 1.1 0.9 3.0 1.1 0.4 0.4 0.0 0.7 11.8 0.2 2.9 0.0 0.0 5.8 0.0 0.0 0.0 0.0 42.0 1.6 1.2 5.5 0.0 0.6 2.3 0.4 0.0 0.7 2.8 0.1 0.6 42.0 1.3 0.1 1.0 0.2 0.0 2.1 0.0 0.0 3.9 0.1 0.9 9.6 0.0 0.8 7.1 1.0 1.9 67.6 7.1 5.7 0.1 0.4 0.7 0.4 3.0 1.4 2.9 0.6 0.2 0.0 5.7 0.0 0.1 0.4 0.4 0.7 0.0 0.2 0.5 1.5 1.1 0.4 0.4 0.3 0.3 1.1 0.4 0.0 0.1 0.6 0.4 0.4 3.0 0.4 0.3 0.9 0.2 0.0 0.7 0.6 2.6 0.5 0.8 0.3 0.7 1.0 0.8 0.4 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026019, HPA068828" Approved Supported Vesicles Vesicles "CAB026019: , HPA068828: " "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.8 3.2 8.4 17.7 0.9 19.8 23.1 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 4.6 9.3 3.3 2.9 11.1 5.7 13.5 5.3 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.0 0.3 5.6 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 FKBP1A "FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE" ENSG00000088832 "FK506 binding protein 1A" P62942 20 1368978-1393172 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 149.0;TIME: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3" "CAB004639, HPA051798" Uncertain 16000000 "CAB004639: AB_425434, HPA051798: " "unprognostic (4.09e-2)" "unprognostic (2.29e-1)" "unprognostic (5.22e-3)" "unprognostic (1.28e-2)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "prognostic unfavourable (3.44e-7)" "unprognostic (7.05e-3)" "unprognostic (2.76e-1)" "unprognostic (8.81e-2)" "unprognostic (5.12e-3)" "unprognostic (6.65e-2)" "prognostic unfavourable (6.69e-5)" "unprognostic (1.97e-2)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" 106.0 42.4 67.3 55.0 114.8 44.4 63.5 15.8 55.8 33.2 39.7 22.1 33.8 32.7 45.5 45.9 42.7 33.8 32.0 36.4 51.7 30.6 41.9 41.7 59.2 84.1 26.0 36.5 41.7 57.7 20.6 21.7 65.0 22.5 34.4 49.4 21.4 30.8 40.6 38.9 31.5 37.1 56.0 23.3 68.0 33.0 21.1 28.4 47.4 62.2 39.7 48.3 48.1 37.0 13.3 63.6 88.4 94.3 14.5 18.6 84.3 69.9 19.4 15.5 22.4 52.4 65.7 20.4 44.5 30.2 35.7 33.1 19.3 27.2 28.6 14.3 41.4 32.2 19.9 81.3 46.9 8.2 21.7 29.4 9.1 36.8 32.2 34.1 16.3 38.2 26.0 32.9 34.0 149.0 26.9 14.7 41.9 8.7 33.3 47.0 33.2 38.0 28.6 27.0 34.7 46.0 17.7 25.8 19.5 22.0 44.3 73.6 17.4 29.1 172.6 132.5 22.2 28.2 32.8 7.4 15.9 30.0 22.8 34.6 29.3 23.9 79.4 88.4 11.5 94.3 10.2 12.8 13.9 13.2 63.6 13.3 14.8 14.2 77.9 14.5 90.3 31.6 18.6 84.3 67.3 114.8 15.8 55.8 51.7 30.6 26.0 36.5 22.5 28.4 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374638 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 396.7;urinary bladder: 276.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" 2900000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavourable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (3.88e-4)" 42.8 8.8 2.9 46.4 3.9 22.9 30.7 2.0 5.2 106.5 204.2 6.3 86.0 13.1 158.9 54.4 140.2 79.9 121.0 18.8 3.2 2.2 17.2 5.5 29.1 21.1 3.4 5.9 77.4 7.3 1.6 4.8 20.0 9.4 129.3 13.4 19.0 12.6 98.8 13.7 15.0 50.2 396.7 3.6 25.5 82.7 29.9 2.9 12.1 11.7 16.3 15.1 276.1 64.5 6.3 13.1 7.1 19.7 5.9 22.6 24.1 87.2 67.8 23.9 30.8 20.9 27.7 39.4 58.4 65.1 53.6 47.7 43.9 16.2 7.5 151.6 90.7 50.1 21.5 51.2 15.1 30.8 7.5 24.2 88.7 15.2 38.5 28.6 31.8 26.5 12.4 79.8 31.9 39.8 6.8 52.3 38.3 20.0 13.6 9.9 25.2 45.1 13.7 21.7 6.7 20.8 18.2 5.3 12.1 48.8 7.9 39.3 7.6 9.0 95.2 61.2 59.0 62.0 107.6 32.8 19.2 15.2 56.9 19.2 61.2 4.1 11.5 7.1 22.6 15.2 14.3 6.3 10.5 18.7 13.1 3.0 4.0 9.1 2.6 5.9 19.7 1.7 12.8 24.1 2.9 3.9 2.0 5.2 3.2 2.2 3.4 5.9 9.4 2.9 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 70.2;TIME: 79.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" 37000000 "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavourable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favourable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 24.7 17.8 7.8 25.3 10.6 2.2 30.0 12.6 7.4 21.3 33.5 17.2 49.6 19.4 36.1 47.4 18.6 17.3 16.0 7.7 10.6 8.5 20.6 29.2 14.1 9.4 16.1 5.3 22.9 22.4 25.6 7.8 36.0 13.2 35.8 28.5 20.1 25.5 44.0 7.7 28.9 50.2 39.7 24.3 12.1 21.2 11.7 13.5 49.3 28.2 12.0 13.0 32.8 34.7 3.8 15.9 7.4 1.2 5.9 4.9 1.2 19.8 34.0 3.4 5.0 2.3 4.0 59.9 7.4 6.0 16.5 16.9 34.0 34.0 3.2 2.8 26.0 32.7 6.4 47.2 16.1 17.9 3.1 2.7 28.9 16.5 17.1 2.3 9.8 6.3 20.5 22.9 70.2 55.8 4.5 1.0 10.2 4.3 7.2 5.7 5.3 29.4 3.2 0.9 2.8 22.1 33.9 3.8 3.6 37.5 20.6 4.1 17.0 6.6 79.1 4.3 13.5 51.5 26.3 0.7 0.2 2.6 16.0 4.3 4.5 7.4 0.3 4.2 0.5 0.8 2.6 3.8 1.6 0.7 1.2 1.6 4.9 3.5 0.1 5.9 1.2 15.9 1.7 1.2 7.8 10.6 12.6 7.4 10.6 8.5 16.1 5.3 13.2 13.5 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell line enhanced" "Detected in many" "BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006135 Enhanced Supported "Plasma membrane,Cytosol" 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavourable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.1 8.6 0.8 78.6 14.9 22.4 10.8 24.4 0.2 0.0 13.3 35.8 0.0 4.8 0.1 13.3 0.0 2.6 0.0 4.0 0.0 9.0 0.0 0.0 16.3 0.0 38.9 0.0 13.9 9.4 0.0 15.2 0.0 0.0 0.3 13.1 4.5 0.0 26.0 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 0.1 0.3 28.8 7.8 33.6 2.0 0.0 0.0 0.0 0.0 26.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favourable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.6 32.5 54.8 25.5 93.1 42.6 49.2 55.8 51.0 63.9 45.8 94.7 50.1 31.7 86.9 72.5 41.8 50.2 74.3 43.3 20.9 30.2 35.2 49.4 62.0 43.1 20.4 22.2 50.7 37.8 31.0 41.7 48.3 30.9 43.3 42.0 132.2 104.3 50.1 17.4 34.4 64.2 48.0 55.9 51.2 38.2 68.0 155.7 77.6 77.0 62.2 58.9 56.1 53.1 84.8 76.2 30.5 52.5 75.9 49.0 66.9 37.2 10.0 43.2 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" 60000000 "Plasma membrane" "Golgi apparatus" "HPA040736: " "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavourable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 55.2 42.1 84.7 55.1 82.3 41.7 37.8 78.8 112.5 44.0 52.1 46.4 26.0 55.4 44.3 31.2 41.7 38.8 36.6 39.6 74.7 65.7 43.9 38.7 47.1 47.1 68.5 52.1 45.0 33.9 48.9 36.9 45.3 56.6 40.1 41.0 70.7 37.6 41.7 19.7 35.5 65.3 51.2 61.0 51.0 40.8 31.4 39.2 44.5 37.6 19.5 45.6 42.2 54.1 7.7 18.8 18.4 13.2 10.6 9.9 6.0 54.0 51.2 60.8 42.4 34.8 38.3 23.5 76.8 51.3 69.8 54.8 41.7 54.2 56.5 56.6 77.4 28.6 60.9 55.7 63.8 86.6 30.0 54.8 48.5 47.4 43.8 32.9 60.2 33.8 39.3 66.6 62.0 56.6 33.9 51.1 66.5 33.7 72.1 25.9 35.0 41.5 70.4 47.0 44.6 47.8 33.7 74.8 85.3 71.2 46.4 62.3 32.4 45.2 86.2 61.5 41.3 47.8 55.7 34.7 60.4 129.3 52.6 69.5 34.6 7.4 11.1 17.1 8.7 13.2 8.0 7.4 8.7 9.7 10.9 7.7 5.9 6.5 18.4 10.6 13.2 18.8 9.9 6.0 84.7 82.3 78.8 112.5 74.7 65.7 68.5 52.1 56.6 39.2 GNGT2 GNG9 ENSG00000167083 "G protein subunit gamma transducin 2" O14610 17 49202791-49210574 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "blood: 29.1;lymphoid tissue: 21.1;retina: 46.7" "Cell line enhanced" "Detected in some" "Daudi: 35.6;HDLM-2: 30.6;HUVEC TERT2: 9.2;RH-30: 11.3;TIME: 8.9;U-698: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 29.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043381 Enhanced "HPA043381: " "unprognostic (9.11e-2)" "unprognostic (4.09e-3)" "unprognostic (1.99e-2)" "unprognostic (4.62e-5)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (1.75e-1)" "unprognostic (7.37e-2)" "unprognostic (1.30e-2)" "unprognostic (2.11e-2)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (3.11e-4)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (1.23e-1)" 2.7 2.1 2.7 9.4 3.7 1.3 1.8 0.7 2.2 2.1 2.3 2.0 0.4 2.6 1.6 1.2 1.8 1.7 3.3 2.4 2.5 1.9 3.0 2.6 6.2 12.2 3.2 0.4 1.7 1.2 0.1 1.4 1.9 2.2 2.2 3.3 46.7 1.6 1.1 0.6 0.6 4.9 2.9 4.5 21.1 1.7 0.8 2.5 6.0 2.5 1.4 16.6 3.6 5.1 2.0 9.7 0.9 29.1 10.6 14.4 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.6 0.5 0.0 0.0 35.6 0.3 0.1 0.0 0.0 0.0 2.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 9.2 0.0 0.2 0.8 0.0 2.7 2.1 0.3 0.0 6.9 11.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.0 5.7 0.0 0.0 0.1 1.6 10.9 0.1 0.1 0.0 0.0 4.3 0.4 14.4 21.5 12.6 1.9 2.4 10.2 9.7 2.0 1.5 5.9 0.9 10.6 29.1 0.8 1.8 5.4 2.7 3.7 0.7 2.2 2.5 1.9 3.2 0.4 2.2 2.5 GSG1 MGC3146 ENSG00000111305 "Germ cell associated 1" Q2KHT4 12 13083560-13103683 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 156.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.3;LHCN-M2: 10.7;RPTEC TERT1: 13.4;U-2 OS: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (1.50e-1)" "unprognostic (2.21e-2)" "unprognostic (6.33e-2)" "unprognostic (2.36e-2)" "unprognostic (1.34e-1)" "unprognostic (8.01e-2)" "unprognostic (1.04e-1)" "unprognostic (4.52e-1)" "unprognostic (6.85e-2)" "unprognostic (8.23e-2)" "unprognostic (5.91e-2)" "unprognostic (3.20e-3)" "unprognostic (1.48e-1)" "unprognostic (3.65e-2)" "unprognostic (1.79e-1)" "unprognostic (6.32e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 156.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 2.6 0.7 0.5 1.2 0.1 0.1 0.5 0.3 0.1 2.3 1.3 0.5 0.2 0.4 0.4 0.5 0.2 0.1 0.2 0.2 9.3 0.1 0.1 0.0 0.9 0.2 0.0 0.2 0.6 0.3 0.0 0.2 0.1 0.9 0.0 1.8 0.1 0.0 0.1 1.8 10.7 0.3 0.1 1.1 2.3 0.2 0.1 3.9 0.2 13.4 0.2 0.6 0.3 0.2 0.0 0.1 0.1 1.5 0.1 0.6 6.8 0.3 0.3 0.6 0.3 0.1 2.9 0.3 0.2 1.3 0.5 0.9 1.2 0.4 0.6 0.8 0.6 1.0 0.4 1.3 0.8 0.9 2.6 0.5 0.7 0.7 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.0 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787535-28063509 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;heart muscle: 19.3" "Group enriched" "Detected in some" 7 "HMC-1: 13.3;THP-1: 4.9" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014479 Enhanced "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.7 0.8 8.7 0.6 14.6 0.7 0.6 1.8 13.3 0.8 1.1 2.7 0.0 1.1 1.1 1.0 0.6 3.4 0.5 19.3 6.0 6.8 1.1 1.1 0.9 0.6 10.0 3.3 0.4 0.7 0.4 0.2 2.0 6.5 0.8 0.7 1.2 0.8 0.6 1.0 1.8 1.2 0.5 3.5 0.9 2.5 2.2 3.3 0.0 1.0 0.0 0.5 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.0 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.5 0.8 0.1 0.3 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.6 0.1 4.9 1.2 0.0 0.8 0.0 0.2 1.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 8.7 14.6 1.8 10.7 6.0 6.8 10.0 3.3 6.5 3.3 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.1 0.0 0.0 0.0 3.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.5 4.2 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 GUCY2D "CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1" ENSG00000132518 "Guanylate cyclase 2D, retinal" Q02846 17 8002594-8020339 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 10.6;retina: 33.3" "Cell line enriched" "Detected in single" 7 "HMC-1: 5.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 31 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 53 "dendritic cells: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.57e-4)" "unprognostic (5.05e-1)" "unprognostic (1.49e-1)" "unprognostic (9.75e-5)" "unprognostic (5.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.44e-2)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" "unprognostic (4.44e-1)" "unprognostic (7.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.46e-1)" "unprognostic (3.08e-1)" "unprognostic (1.07e-1)" 0.1 0.0 0.1 0.3 0.1 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 1.3 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 33.3 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.6 0.1 5.0 0.1 0.2 0.1 0.1 0.9 0.1 0.2 0.0 10.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 5.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.1 HAMP "HEPC, HFE2B, LEAP-1, LEAP1" ENSG00000105697 "Hepcidin antimicrobial peptide" P81172 19 35280716-35285143 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hormone" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 716.5" "Cell line enriched" "Detected in single" 229 "Hep G2: 68.3" "Group enriched" "Detected in many" 12 "glioma: 6.5;liver cancer: 16.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "myeloid DC: 2.5;plasmacytoid DC: 7.6" "Lineage enriched" "Detected in single" 13 "dendritic cells: 7.6" "Not detected" "Not detected" "Secreted to blood" 1900000 3900000 "unprognostic (5.53e-2)" "unprognostic (5.02e-4)" "unprognostic (2.10e-3)" "unprognostic (4.69e-3)" "unprognostic (5.35e-2)" "unprognostic (2.24e-1)" "unprognostic (3.92e-2)" "unprognostic (9.36e-2)" "unprognostic (2.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.61e-1)" "unprognostic (1.86e-1)" "unprognostic (3.68e-7)" "unprognostic (4.11e-2)" "unprognostic (3.93e-2)" "unprognostic (4.08e-2)" "unprognostic (7.77e-2)" 0.4 0.5 1.8 0.6 10.8 1.2 0.7 0.2 4.4 0.6 0.3 0.2 0.0 0.5 0.4 0.4 0.4 0.9 0.4 45.1 10.0 1.8 0.3 716.5 0.4 1.0 4.2 0.0 1.1 8.7 0.4 0.5 0.7 6.7 0.6 0.3 0.0 0.4 0.6 0.5 0.4 0.3 0.4 13.9 0.3 0.4 0.5 4.0 0.0 0.3 0.0 1.0 0.4 0.0 0.5 7.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 68.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.5 0.0 7.6 0.0 0.0 1.8 10.8 0.2 4.4 10.0 1.8 4.2 0.0 6.7 4.0 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.3" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 IFITM1 "9-27, CD225, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 313506-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 120.0;BJ hTERT+ SV40 Large T+ RasG12V: 215.2;HMC-1: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4" "Group enriched" "Detected in all" 7 "granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1" "HPA004810, CAB017615" Enhanced Supported Cytosol Cytosol "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavourable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 81.1 14.2 17.4 36.7 24.5 41.2 57.0 11.9 23.1 71.0 28.2 12.9 20.6 17.2 48.3 152.4 44.4 67.2 31.2 62.6 19.8 13.9 59.8 34.5 44.1 159.7 34.8 14.7 100.2 16.3 22.3 23.3 36.3 27.3 38.7 22.1 49.5 27.4 41.6 38.7 23.6 33.0 46.0 37.9 112.9 20.5 29.4 20.1 42.7 48.3 28.0 50.3 39.3 52.8 13.0 4.3 106.8 18.6 164.4 128.1 147.7 6.2 0.1 52.2 4.2 3.8 13.4 0.3 11.1 51.9 120.0 215.2 0.1 43.5 0.1 8.3 11.6 14.8 1.6 1.1 2.4 13.2 2.7 6.4 4.0 0.4 34.6 9.3 66.4 25.1 0.0 1.3 0.1 0.2 22.7 52.7 0.0 0.9 4.6 17.9 14.8 1.6 1.2 0.1 1.2 32.1 0.0 0.0 0.0 5.8 0.6 10.6 2.1 0.8 0.3 0.1 0.1 0.0 0.0 3.7 2.0 0.3 0.1 14.0 0.1 15.6 2.3 56.6 120.0 10.9 80.7 13.0 128.1 121.4 4.3 11.3 123.5 123.4 106.8 164.4 18.6 1.2 70.4 147.7 17.4 24.5 11.9 23.1 19.8 13.9 34.8 14.7 27.3 20.1 IFITM2 1-8D ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 307631-315272 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 875.3" "Cell line enhanced" "Detected in many" "HHSteC: 98.0;HMC-1: 111.9;HSkMC: 121.1;U-937: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 875.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 875.3" HPA004337 Uncertain "HPA004337: AB_1851427" "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavourable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 101.0 25.2 14.3 95.5 20.9 56.3 143.6 8.2 16.6 70.8 40.2 10.9 14.3 9.5 63.6 46.1 56.0 70.8 28.5 91.1 13.3 10.8 83.0 326.2 141.9 255.5 29.3 3.3 106.5 31.1 68.6 18.9 48.0 21.1 54.3 17.7 39.1 20.1 37.7 72.7 20.1 24.0 63.2 21.7 233.4 28.4 38.5 15.6 12.5 83.4 26.2 35.4 98.0 119.7 27.5 21.6 875.3 74.9 52.8 33.3 47.1 4.1 12.8 35.3 0.2 23.0 66.8 0.1 13.0 25.1 7.4 17.2 0.4 38.1 0.0 31.6 66.2 8.5 0.1 2.2 3.1 0.0 5.3 12.7 14.5 14.1 98.0 20.4 111.9 121.1 0.4 2.1 1.1 24.3 0.5 42.0 5.3 28.4 0.1 74.8 4.3 29.9 14.0 3.7 0.2 68.6 0.0 0.1 0.8 9.6 11.1 3.9 16.1 7.3 63.7 1.1 4.0 5.8 0.2 0.1 0.6 0.6 2.1 86.9 3.9 77.9 19.8 138.8 33.3 53.2 24.6 27.5 30.0 29.4 21.6 24.5 26.0 28.1 875.3 52.8 74.9 9.1 15.8 47.1 14.3 20.9 8.2 16.6 13.3 10.8 29.3 3.3 21.1 15.6 IFITM3 1-8U ENSG00000142089 "Interferon induced transmembrane protein 3" Q01628 11 319669-327537 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 141.4;BJ hTERT+ SV40 Large T+ RasG12V: 180.3;HHSteC: 165.2;HSkMC: 157.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 148.9;non-classical monocyte: 150.9" "Group enriched" "Detected in all" 6 "granulocytes: 148.9;monocytes: 150.9;NK-cells: 44.7" HPA004337 Uncertain "HPA004337: AB_1851427" "unprognostic (4.17e-2)" "unprognostic (4.19e-1)" "unprognostic (1.67e-1)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (6.00e-2)" "unprognostic (3.36e-2)" "unprognostic (6.44e-2)" "unprognostic (8.90e-2)" "unprognostic (9.42e-2)" "unprognostic (7.45e-2)" "unprognostic (1.95e-2)" "prognostic unfavourable (5.78e-7)" "unprognostic (7.81e-2)" "unprognostic (3.34e-2)" "unprognostic (8.28e-2)" "unprognostic (1.19e-1)" 109.8 46.1 34.2 64.5 39.8 21.2 197.5 15.1 36.3 135.2 70.4 28.3 45.8 25.3 98.7 143.6 50.9 118.2 68.7 162.1 31.6 24.8 94.3 157.0 161.7 135.3 36.2 15.3 148.4 47.5 99.8 33.7 92.5 39.6 78.2 25.4 81.0 52.8 70.8 62.0 31.1 50.0 111.5 43.8 153.4 51.3 54.3 30.4 6.8 115.9 60.7 27.8 89.2 75.9 3.0 20.1 148.9 150.9 44.7 4.9 34.0 24.3 2.1 93.0 24.2 42.7 69.2 2.0 37.9 70.7 141.4 180.3 2.9 82.2 0.0 40.5 54.9 39.8 0.0 26.8 8.8 0.8 2.7 0.3 33.2 30.3 165.2 0.2 0.3 157.1 6.0 11.4 26.1 25.9 0.1 0.3 13.0 51.4 0.1 1.0 11.1 18.8 3.3 8.6 0.3 81.8 2.7 0.0 0.1 45.4 7.7 38.5 1.8 2.1 50.5 9.3 6.3 8.3 1.5 0.1 0.1 0.3 4.2 0.4 14.2 21.0 33.1 21.2 4.9 132.0 2.8 3.0 2.9 4.5 20.1 2.4 3.0 4.3 148.9 44.7 150.9 1.5 1.6 34.0 34.2 39.8 15.1 36.3 31.6 24.8 36.2 15.3 39.6 30.4 IFNAR1 "IFNAR, IFRC" ENSG00000142166 "Interferon alpha and beta receptor subunit 1" P17181 21 33324477-33359862 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018015, HPA029226" Uncertain 100000 "HPA018015: AB_1851433, HPA029226: " "unprognostic (2.42e-3)" "unprognostic (2.95e-1)" "unprognostic (3.01e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (3.02e-1)" "unprognostic (4.69e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.38e-1)" "unprognostic (9.38e-3)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (8.45e-2)" "unprognostic (3.06e-2)" 27.2 16.4 18.5 16.8 18.7 14.8 15.9 18.1 22.9 14.2 16.8 15.1 10.0 12.3 15.7 10.9 15.8 13.5 16.2 14.5 16.9 15.8 17.5 56.4 16.6 15.0 19.7 13.8 16.6 18.3 30.6 17.9 23.2 18.3 14.7 12.2 12.1 17.6 12.6 17.3 10.6 15.8 13.7 22.2 29.8 18.8 10.3 16.7 26.9 21.4 9.1 13.1 18.7 18.1 20.5 17.8 64.5 23.1 7.3 12.1 10.7 13.1 12.0 5.1 5.8 16.9 17.3 5.9 14.2 15.2 6.5 6.7 12.9 15.1 10.2 11.5 9.7 7.9 4.8 8.3 7.0 11.5 9.6 15.1 11.6 7.6 7.2 11.1 10.8 14.3 7.4 10.8 6.5 12.5 17.3 49.9 10.7 10.9 8.2 4.5 5.5 7.7 8.1 18.0 17.3 7.2 17.3 6.1 5.5 14.2 10.2 9.0 15.6 8.2 19.8 13.2 7.2 17.3 7.9 33.4 45.8 11.7 17.7 15.7 14.1 18.9 16.8 9.7 8.0 19.7 7.5 18.5 10.6 9.0 11.3 20.5 12.1 9.4 64.5 7.3 23.1 17.8 12.0 10.7 18.5 18.7 18.1 22.9 16.9 15.8 19.7 13.8 18.3 16.7 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: " "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 93.4 41.7 0.6 3.9 17.7 2.8 4.2 0.8 0.4 0.0 2.9 7.8 0.7 0.0 0.3 2.3 7.7 0.0 0.1 0.4 4.3 29.3 0.0 0.0 115.0 0.3 3.1 0.7 1.2 0.4 0.1 4.0 0.7 0.0 0.1 0.1 0.1 0.0 0.2 0.0 2.6 1.9 0.0 0.0 1.7 1.1 0.0 1.6 0.1 0.0 8.0 0.5 13.4 0.3 0.0 0.0 0.0 3.1 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 ITGA1 "CD49a, VLA1" ENSG00000213949 "Integrin subunit alpha 1" P56199 5 52787896-52959210 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.0;HHSteC: 25.8;WM-115: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.8" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042555 Uncertain 2300000 "HPA042555: AB_10794281" "unprognostic (1.48e-1)" "unprognostic (1.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (1.38e-1)" "unprognostic (9.89e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (1.79e-3)" "unprognostic (1.50e-2)" "unprognostic (2.62e-1)" "unprognostic (9.86e-2)" "prognostic unfavourable (2.24e-4)" "unprognostic (3.13e-3)" "unprognostic (2.06e-2)" "unprognostic (1.07e-2)" "unprognostic (1.62e-2)" 22.6 20.2 2.3 12.7 2.7 0.0 12.4 1.2 2.9 10.9 28.2 1.5 13.6 5.3 15.9 12.5 22.3 9.2 13.9 11.1 2.5 2.2 17.9 40.4 28.8 10.2 3.1 1.4 9.6 3.3 11.5 3.0 24.8 3.3 26.1 8.2 5.9 2.9 18.2 9.7 2.4 13.5 52.8 2.7 66.0 16.8 4.1 1.6 0.6 10.7 3.5 2.2 42.7 17.8 0.0 0.1 1.2 0.3 0.0 1.8 0.1 0.0 0.0 2.0 0.0 5.8 1.7 1.2 2.7 7.2 1.6 4.8 3.7 0.3 0.0 0.9 21.0 1.4 0.4 2.3 1.5 0.0 1.5 0.0 3.4 2.7 25.8 0.0 0.0 3.9 0.2 1.9 0.7 0.3 0.0 0.0 2.4 0.0 0.8 0.0 1.1 0.7 0.0 1.9 0.0 3.1 0.0 0.1 9.1 2.7 0.6 0.6 0.0 0.0 2.1 4.4 0.4 0.1 1.4 0.0 0.0 0.0 2.8 0.0 19.1 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.6 1.8 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.1 2.3 2.7 1.2 2.9 2.5 2.2 3.1 1.4 3.3 1.6 ITGA6 CD49f ENSG00000091409 "Integrin subunit alpha 6" P23229 2 172427354-172506282 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 50.1;HaCaT: 55.2;HBEC3-KT: 108.5;hTCEpi: 47.3;hTERT-HME1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.2" "Group enriched" "Detected in many" 34 "granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009009, HPA012696, HPA027582" Enhanced 45000000 "CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (2.59e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.19e-1)" "unprognostic (1.61e-3)" "unprognostic (9.34e-2)" "unprognostic (6.01e-2)" "unprognostic (1.85e-3)" "unprognostic (1.84e-1)" "prognostic favourable (2.35e-11)" "unprognostic (3.35e-2)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (1.21e-3)" 28.0 3.1 9.8 19.1 10.5 1.6 30.1 3.0 8.4 27.0 34.9 9.4 42.3 28.5 28.2 11.3 17.0 11.1 23.8 21.7 9.7 8.2 22.0 4.9 29.0 14.9 9.8 5.1 7.6 31.3 7.4 4.9 38.7 12.6 14.3 25.2 17.6 37.1 32.4 13.5 17.5 44.2 15.2 9.6 14.9 25.0 12.4 6.9 15.1 11.5 35.2 13.2 24.1 17.3 0.3 0.1 16.2 0.2 5.5 10.0 3.3 11.4 9.8 4.3 7.7 0.2 0.1 23.6 50.1 5.4 5.1 3.2 5.5 22.0 0.1 14.1 13.3 55.2 2.8 108.5 9.3 0.1 2.6 0.2 10.5 9.1 0.7 3.1 0.3 1.0 47.3 0.3 48.1 32.8 0.0 0.8 6.4 0.5 0.8 2.7 7.8 8.4 0.1 12.8 0.2 7.8 16.1 0.1 0.5 9.2 0.0 10.7 2.0 0.2 14.7 7.2 6.5 13.2 8.6 0.7 0.5 0.3 0.2 1.1 28.9 2.6 0.2 16.2 4.2 0.0 8.5 0.2 5.4 5.0 0.1 0.3 10.0 4.6 0.5 5.5 0.0 0.0 5.7 3.3 9.8 10.5 3.0 8.4 9.7 8.2 9.8 5.1 12.6 6.9 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavourable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.7 11.7 7.8 24.9 28.7 19.4 29.7 19.2 15.5 6.8 6.8 10.2 33.8 0.0 37.9 21.6 12.3 3.9 18.1 9.8 1.9 3.5 2.3 15.4 14.0 11.3 1.6 1.4 14.1 8.6 15.2 12.9 16.2 2.2 4.9 18.1 3.8 0.9 1.3 5.9 5.9 0.0 15.9 1.3 17.6 75.3 1.6 4.8 22.2 6.9 8.1 5.4 4.5 49.1 42.2 13.2 8.6 16.2 1.2 2.0 1.1 17.0 0.6 20.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 17.2" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;CAPAN-2: 2.6;HaCaT: 1.8;hTCEpi: 4.3;K-562: 2.0;RT4: 2.7;U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038104 Enhanced "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 2.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 IZUMO3 "bA20A20.1, C9orf134" ENSG00000205442 "IZUMO family member 3" Q5VZ72 9 24542952-24545946 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 169 "testis: 16.9" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IZUMO4 C19orf36 ENSG00000099840 "IZUMO family member 4" Q1ZYL8 19 2096429-2099593 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 108.2" "Cell line enhanced" "Detected in many" "Karpas-707: 10.8;RPMI-8226: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048496 Enhanced "Secreted in male reproductive system" "HPA048496: " "unprognostic (2.75e-3)" "unprognostic (1.10e-2)" "unprognostic (3.65e-2)" "prognostic favourable (7.08e-4)" "unprognostic (1.40e-1)" "unprognostic (2.18e-5)" "unprognostic (2.67e-2)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (2.48e-1)" "prognostic favourable (1.69e-4)" "unprognostic (2.12e-1)" "unprognostic (6.58e-5)" "unprognostic (6.38e-2)" "unprognostic (2.17e-1)" "unprognostic (5.68e-1)" "unprognostic (7.51e-3)" 1.6 1.1 4.4 0.9 5.6 0.6 0.9 1.3 4.4 1.0 0.8 2.9 1.2 0.6 0.9 1.6 1.0 1.4 1.3 1.6 4.4 2.1 1.1 2.0 0.9 1.1 10.5 3.3 3.0 8.3 0.8 2.7 0.6 4.2 1.9 0.8 0.6 1.4 1.6 0.9 1.4 0.7 0.7 3.6 0.8 1.0 108.2 6.6 0.4 1.3 0.8 1.4 0.9 0.6 5.3 2.8 3.4 3.1 1.0 5.1 2.6 0.7 0.7 0.4 3.3 1.5 1.6 0.4 0.5 0.8 0.6 0.1 0.3 0.7 0.6 0.8 0.8 0.7 0.1 3.7 0.2 1.5 0.2 0.0 1.3 1.0 4.2 0.0 0.6 0.6 1.4 1.0 1.1 0.0 0.0 10.8 1.4 0.2 1.0 0.3 0.3 0.9 0.8 0.0 13.1 1.7 0.4 0.6 0.9 0.5 1.2 0.5 0.6 1.2 0.5 0.5 0.2 0.1 0.3 1.2 1.4 1.0 1.8 1.1 0.3 0.0 1.6 1.4 1.6 2.2 3.5 5.3 5.1 3.7 2.2 1.8 4.1 1.7 3.4 1.0 3.1 2.8 4.7 2.6 4.4 5.6 1.3 4.4 4.4 2.1 10.5 3.3 4.2 6.6 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Cell line enhanced" "Detected in many" "HEL: 5.8;hTEC/SVTERT24-B: 9.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.8 0.8 1.2 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.6 1.7 5.8 1.0 2.6 0.0 1.6 0.5 0.0 0.0 9.1 0.0 3.6 0.2 0.5 0.4 0.2 0.5 1.0 1.8 0.4 0.9 1.2 4.6 0.0 0.4 1.3 1.4 0.5 1.1 1.1 1.4 0.9 3.7 1.5 0.9 2.4 1.9 3.2 0.7 0.7 4.5 1.9 1.6 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;epididymis: 27.8" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 35.9" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 1.1 5.9 20.6 1.2 27.9 0.6 1.9 6.4 31.2 4.0 1.0 6.0 5.2 0.9 2.7 27.8 1.0 2.8 2.9 1.2 11.7 20.5 4.9 0.8 1.9 1.2 12.9 7.3 0.9 2.4 5.1 0.7 2.1 11.1 2.3 1.3 0.8 1.3 7.9 0.8 0.7 1.1 2.1 6.9 2.2 1.1 5.2 5.3 0.0 1.2 0.0 1.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 35.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 27.9 6.4 14.6 11.7 20.5 12.9 7.3 11.1 5.3 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8" "Cell line enhanced" "Detected in many" "HEL: 19.7;HMC-1: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6" "Group enriched" "Detected in many" 5 "B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2" "Group enriched" "Detected in many" 5 "amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 86.5 3.5 15.5 2.0 54.5 0.9 10.4 8.3 26.1 1.8 2.4 2.6 0.0 1.4 2.3 2.4 1.2 2.2 1.9 74.8 19.6 5.0 1.0 1.0 1.4 3.7 4.2 11.3 5.7 1.6 1.2 3.3 1.8 4.3 1.6 2.7 1.7 4.6 2.1 3.8 3.0 1.6 1.8 2.1 2.8 1.6 4.1 9.8 0.0 1.3 0.8 3.9 1.6 0.7 4.6 0.5 1.9 1.2 0.0 0.4 0.4 1.6 2.4 2.5 3.1 1.0 1.1 0.6 1.1 1.0 0.6 0.9 3.6 3.2 1.6 0.9 0.7 1.7 0.8 0.4 0.6 2.2 1.9 19.7 2.4 1.8 0.9 1.3 12.2 2.6 1.7 1.0 1.3 1.0 5.7 1.7 0.9 1.1 0.7 3.8 0.7 0.6 0.9 0.2 1.2 0.9 1.0 7.2 1.1 0.8 0.5 2.3 2.0 0.8 2.1 1.3 2.1 0.5 1.1 1.7 1.7 1.6 1.4 5.0 0.2 0.0 0.1 1.9 0.1 1.2 0.4 2.9 0.3 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.5 0.5 0.3 0.4 15.5 54.5 8.3 26.1 19.6 5.0 4.2 11.3 4.3 9.8 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Cell line enhanced" "Detected in many" "A-431: 9.1;BJ hTERT+: 12.4;RPTEC TERT1: 24.4;U-138 MG: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA066717: , HPA069797: " "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavourable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.1 0.0 0.6 4.2 3.7 3.0 0.0 4.3 12.4 7.0 6.5 0.0 0.0 0.0 0.4 5.6 0.1 2.7 0.7 3.0 0.0 1.0 0.0 1.1 0.0 1.5 0.0 0.0 2.1 2.5 1.5 7.0 0.0 0.0 0.0 0.6 5.3 0.0 0.0 0.1 2.5 0.0 0.0 0.0 24.4 0.0 0.5 0.1 0.2 0.2 4.7 0.2 0.0 0.2 11.4 2.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.9;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.1 2.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.6 3.3 1.4 0.5 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.1 0.0 3.2 0.5 0.0 0.7 0.0 1.4 0.6 2.0 1.1 0.0 0.6 2.7 1.9 2.8 1.4 0.8 4.1 1.3 9.9 0.9 7.7 4.6 1.4 1.7 2.1 0.9 1.2 2.1 1.1 1.5 2.3 3.1 1.0 0.1 1.2 3.6 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 KCNMB1 hslo-beta ENSG00000145936 "Potassium calcium-activated channel subfamily M regulatory beta subunit 1" Q16558 5 170374671-170389677 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 55.5" "Cell line enhanced" "Detected in some" "REH: 12.7;SK-BR-3: 3.2;U-937: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 7.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "unprognostic (2.06e-2)" "unprognostic (2.70e-4)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (8.88e-2)" "unprognostic (1.61e-2)" "unprognostic (3.46e-1)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (5.37e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (4.13e-6)" "unprognostic (1.08e-1)" "unprognostic (2.49e-1)" "unprognostic (4.31e-2)" "unprognostic (1.04e-2)" 3.2 1.0 0.6 7.7 0.5 0.7 4.2 0.4 0.6 26.8 34.7 0.8 12.6 2.2 31.3 10.6 29.8 10.9 32.4 2.6 0.6 0.7 1.9 0.4 2.2 1.3 1.1 0.9 8.7 0.5 0.1 0.5 0.9 2.2 29.4 5.0 5.6 5.3 29.3 0.9 1.6 11.4 55.5 1.5 1.1 13.4 8.0 0.6 0.3 1.0 1.5 1.6 43.4 6.4 0.5 7.0 1.4 7.1 0.6 0.3 1.0 0.1 0.2 2.3 0.5 0.2 0.0 0.4 0.3 0.1 0.1 0.0 0.5 0.4 0.2 1.6 0.1 0.2 0.1 0.1 0.1 0.5 0.1 1.5 0.8 0.3 0.0 0.6 0.4 0.3 0.0 0.2 0.4 0.2 0.5 1.0 0.1 0.9 0.0 1.3 0.4 0.2 12.7 0.1 0.3 0.1 0.4 0.5 0.3 0.1 3.2 0.0 0.2 1.3 0.8 0.3 0.5 0.5 0.1 0.8 0.3 0.2 0.2 5.3 0.2 1.3 4.3 0.4 0.2 7.1 0.1 0.2 0.3 0.2 7.0 0.5 0.2 0.2 1.4 0.6 6.0 2.6 0.2 1.0 0.6 0.5 0.4 0.5 0.6 0.7 1.1 0.9 2.2 0.6 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.3;fHDF/TERT166: 2.5;SCLC-21H: 8.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" CAB022649 Uncertain "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.7 6.3 7.8 0.5 6.2 0.4 1.3 1.8 11.2 2.5 1.9 2.2 4.4 1.0 7.2 36.8 0.9 14.3 0.9 7.4 13.2 4.5 4.1 0.6 1.6 0.4 4.7 4.9 16.3 4.5 0.4 10.2 0.5 6.2 1.1 0.9 0.5 0.6 1.9 0.6 0.7 0.9 3.0 3.2 1.9 3.6 0.6 3.2 0.0 1.1 0.0 0.4 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.4 0.0 0.0 1.4 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 1.0 8.3 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.2 1.8 11.2 13.2 4.5 4.7 4.9 6.2 3.2 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.9;NB-4: 7.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.4 2.6 0.1 3.0 0.6 1.1 0.0 0.2 1.5 3.7 0.4 10.9 2.9 2.5 1.2 0.2 3.6 1.9 0.6 0.9 0.0 1.1 0.4 0.1 1.5 1.8 0.1 7.4 0.0 2.3 3.2 0.0 0.1 1.0 2.0 1.5 0.4 0.9 1.2 0.7 3.0 6.0 0.7 0.6 1.0 0.3 0.9 1.0 0.4 3.5 0.6 4.2 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 KL ENSG00000133116 Klotho Q9UEF7 13 33016433-33066145 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5" "Group enriched" "Detected in some" 5 "HMC-1: 5.0;SK-BR-3: 9.4" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Region enhanced" "Detected in some" "pons and medulla: 11.6" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Secreted to blood" 510400 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favourable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favourable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 4.8 0.6 0.8 0.9 4.3 0.1 7.4 0.0 0.8 0.7 2.1 3.3 0.2 1.0 1.0 3.2 0.8 0.7 0.9 0.9 2.4 0.8 64.3 0.2 10.4 0.9 0.5 0.3 0.4 1.6 76.9 0.3 25.5 11.6 3.3 0.4 0.3 0.7 1.0 0.9 0.4 3.2 0.7 0.4 3.1 1.9 0.6 0.3 0.0 1.4 1.3 0.3 1.5 1.1 0.0 0.0 0.0 1.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 4.3 0.0 0.8 2.4 0.8 0.5 0.3 11.6 0.3 KLB ENSG00000134962 "Klotho beta" Q86Z14 4 39406853-39451536 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adipose tissue: 17.3;liver: 49.2;pancreas: 21.4" "Group enriched" "Detected in some" 23 "ASC diff: 6.4;Hep G2: 22.9" "Cancer enriched" "Detected in some" 16 "liver cancer: 11.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021136 Uncertain 290000 "HPA021136: AB_1852616" "unprognostic (1.03e-2)" "unprognostic (1.61e-2)" "unprognostic (4.67e-2)" "unprognostic (2.69e-1)" "unprognostic (4.30e-2)" "unprognostic (7.02e-3)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (6.99e-3)" "unprognostic (4.51e-3)" "unprognostic (3.02e-3)" "unprognostic (8.90e-3)" "unprognostic (1.73e-1)" "unprognostic (5.03e-2)" "unprognostic (4.53e-2)" "unprognostic (3.87e-2)" "unprognostic (3.09e-2)" 17.3 0.0 0.2 1.9 1.0 0.2 3.9 0.4 0.2 0.0 1.6 0.0 0.0 0.2 0.1 0.5 0.3 0.1 1.3 0.5 1.0 0.2 0.1 49.2 1.4 0.5 0.1 0.0 0.2 21.4 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.4 0.5 0.6 0.3 0.0 0.0 1.5 2.5 0.2 0.0 0.1 0.4 0.0 0.3 0.2 0.5 2.5 2.3 0.7 0.4 0.4 0.2 0.0 0.2 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 22.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.7 0.2 0.3 0.4 0.2 0.4 0.2 0.2 0.1 0.5 0.2 0.4 2.3 0.4 0.5 2.5 0.1 0.2 0.2 1.0 0.4 0.2 1.0 0.2 0.1 0.0 0.4 0.2 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 9.2;lymphoid tissue: 24.4" "Cell line enriched" "Detected in some" 4 "AF22: 20.5" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Low region specificity" "Detected in many" HPA014053 Uncertain "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.8 1.0 2.2 3.4 2.3 0.0 0.1 0.8 9.2 0.1 0.9 0.4 0.1 0.6 3.1 0.1 1.2 0.7 0.6 0.5 2.7 7.3 0.6 2.5 1.5 24.4 6.9 0.5 0.6 0.4 0.0 0.1 2.9 1.7 0.1 1.0 0.1 3.4 0.1 0.6 0.1 0.9 2.2 7.3 2.6 0.1 0.2 0.1 2.2 0.2 2.1 1.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.8 3.7 2.7 7.3 6.9 0.5 1.7 0.1 LYPD6B "CT116, LYPD7" ENSG00000150556 "LY6/PLAUR domain containing 6B" Q8NI32 2 149038107-149215262 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 25.4;LHCN-M2: 40.8;NB-4: 13.3;RT4: 21.5;SK-BR-3: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049239 Uncertain "Intracellular and membrane" "HPA049239: " "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (3.12e-3)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (2.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.64e-2)" "unprognostic (7.95e-3)" "unprognostic (2.59e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (1.32e-3)" 0.2 0.2 1.4 0.1 1.5 0.0 8.9 0.7 2.4 1.4 2.3 0.6 21.8 1.1 1.1 0.5 2.1 12.2 27.3 0.1 5.0 2.4 4.0 0.4 2.7 2.4 0.7 0.6 1.7 13.2 9.8 0.6 0.6 0.9 5.0 1.5 2.5 11.9 26.6 0.1 38.9 2.9 1.8 0.6 1.3 20.3 16.9 0.7 0.2 0.2 0.6 2.3 9.1 3.7 2.8 0.0 14.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.6 2.6 1.0 0.3 0.0 0.0 0.0 25.4 5.5 0.6 0.6 8.4 0.0 2.9 0.0 0.8 0.0 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.0 0.0 40.8 9.2 0.0 13.3 0.8 0.1 0.0 0.1 1.6 1.3 21.5 1.5 0.0 0.1 12.9 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.5 0.7 2.4 5.0 2.4 0.7 0.6 0.9 0.7 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favourable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 9.8 16.5 12.1 6.9 11.3 26.5 8.9 27.8 13.2 9.2 8.9 11.3 12.7 9.5 9.7 11.9 17.2 7.9 8.8 8.8 8.7 9.4 11.9 33.0 9.4 7.8 12.9 11.5 17.2 28.1 11.4 12.8 8.1 11.3 12.9 9.2 10.4 20.7 13.5 31.2 10.7 9.7 8.5 10.1 9.6 11.5 15.6 13.8 17.9 13.2 12.5 11.1 10.5 10.2 2.6 4.0 6.8 2.5 1.5 3.0 0.7 10.0 3.4 10.3 18.6 12.5 9.6 5.5 10.8 11.3 9.7 10.8 3.1 13.5 20.3 12.6 11.9 10.4 8.8 10.3 10.3 10.5 8.6 25.3 5.7 8.3 8.9 9.0 18.6 9.4 12.6 14.3 9.5 11.1 16.7 7.4 9.5 6.1 21.7 11.6 12.2 5.5 13.2 10.9 16.0 10.8 5.1 17.5 19.0 8.2 20.8 13.0 7.6 11.0 12.9 11.7 7.5 14.5 7.0 13.2 8.5 11.8 12.7 12.4 9.0 6.8 1.1 6.2 2.1 0.9 3.0 1.6 2.4 2.7 1.4 2.6 2.5 3.0 0.5 1.5 2.5 4.0 1.4 0.7 12.1 11.3 27.8 13.2 8.7 9.4 12.9 11.5 11.3 13.8 MAGI2 "ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2" ENSG00000187391 "Membrane associated guanylate kinase, WW and PDZ domain containing 2" Q86UL8 7 78017057-79453574 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.7;parathyroid gland: 31.8" "Cell line enriched" "Detected in some" 4 "Karpas-707: 42.0" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013650 Approved "HPA013650: AB_1853501" "unprognostic (4.32e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-4)" "unprognostic (5.04e-2)" "unprognostic (3.33e-1)" "unprognostic (6.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.17e-1)" "unprognostic (8.80e-3)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "prognostic favourable (1.08e-4)" "unprognostic (4.34e-4)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" 5.4 8.3 21.0 2.2 20.5 1.8 3.9 43.7 36.8 5.5 3.2 17.7 2.5 3.1 5.6 5.6 3.6 4.8 4.6 3.9 21.8 12.7 7.6 2.5 4.4 1.6 13.6 19.5 11.5 5.1 31.8 7.7 2.3 16.5 11.9 3.0 3.5 2.8 11.6 2.9 2.3 3.2 4.1 15.1 3.1 2.9 5.1 24.4 0.0 9.0 0.0 1.4 4.1 2.9 2.0 1.4 3.8 0.9 1.0 0.9 0.2 0.0 0.3 10.1 0.2 2.1 3.3 0.1 1.8 3.3 0.4 0.5 0.0 0.1 0.0 0.0 1.1 0.1 0.6 0.0 0.5 0.5 0.4 0.1 0.2 0.5 3.1 0.2 0.5 2.5 0.1 0.2 0.1 0.4 0.3 42.0 0.9 0.4 0.1 0.2 2.2 0.1 0.1 0.1 0.7 0.1 0.1 1.5 2.6 0.4 0.1 0.9 0.2 0.3 0.5 1.5 0.5 4.1 0.2 0.2 0.0 0.1 0.9 0.1 0.6 2.7 0.7 0.8 0.9 0.6 0.6 1.1 0.6 0.5 0.4 2.0 0.6 0.8 3.8 1.0 0.9 1.4 0.6 0.2 21.0 20.5 43.7 34.5 21.8 12.7 13.6 19.5 16.5 24.4 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "intestine: 241.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 10.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 3.0;stomach cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029119 Enhanced "Secreted to digestive system" 120000 "HPA029119: " "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 0.1 78.8 0.0 0.0 54.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 241.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.4 0.3 0.3 0.0 1.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 2.0 1.0 0.3 0.2 0.1 0.5 1.4 1.7 0.5 0.0 0.2 0.0 0.0 0.0 0.7 0.9 1.1 0.7 0.6 0.4 1.3 0.3 0.0 0.7 0.0 0.1 0.4 1.1 0.2 0.0 1.9 1.3 4.0 1.3 0.0 1.8 1.7 2.9 0.0 0.7 10.3 2.3 0.8 0.2 0.3 0.4 3.0 0.9 1.3 0.8 3.4 0.0 0.5 2.2 0.5 2.6 0.0 0.5 0.0 0.3 0.3 1.0 0.1 1.3 1.1 0.7 1.4 0.4 0.1 1.2 0.3 0.2 0.0 0.1 0.2 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Uncertain Supported Mitochondria Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favourable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 16.8 36.4 22.9 14.4 25.3 17.0 15.4 56.3 30.7 18.2 16.9 18.9 11.6 20.9 29.7 14.3 13.3 20.5 18.6 24.0 23.3 21.7 58.9 64.7 16.7 11.2 20.9 22.7 25.0 11.6 21.1 23.4 16.3 25.2 14.9 19.2 15.1 15.5 13.8 36.9 16.3 21.5 22.2 17.5 18.1 24.1 11.8 15.0 15.1 13.8 14.6 11.9 20.0 15.2 6.5 9.5 39.0 21.7 5.6 6.5 11.5 15.8 28.0 17.9 20.9 28.9 27.2 8.1 17.5 39.8 26.2 36.2 16.4 30.1 21.5 14.9 24.5 19.0 22.4 15.8 31.0 19.1 18.3 14.5 15.7 23.7 22.9 19.9 16.0 27.1 14.3 28.7 26.8 22.5 22.3 25.4 30.4 14.4 17.4 18.9 7.5 6.8 19.1 24.1 14.1 32.1 11.8 13.8 19.8 20.7 25.9 16.1 15.4 19.3 13.8 13.0 20.2 25.7 14.5 13.5 22.4 15.1 26.0 26.6 8.8 7.3 21.7 39.0 6.5 18.3 5.7 5.8 5.8 6.0 9.5 6.5 5.7 4.8 18.3 5.6 18.4 6.1 5.5 11.5 22.9 25.3 56.3 30.7 23.3 21.7 20.9 22.7 25.2 15.0 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: " "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 12.0 6.9 16.6 10.5 14.8 19.9 14.3 20.6 16.8 22.0 15.3 10.1 19.6 18.9 13.3 19.6 16.2 16.3 17.2 30.3 19.1 16.9 32.6 7.6 11.6 17.9 24.4 19.0 17.2 17.1 12.3 8.7 14.6 11.5 8.5 35.8 10.5 16.2 23.3 11.3 11.0 17.9 42.3 12.6 43.2 9.9 13.4 10.3 14.0 16.5 13.3 16.1 23.1 18.0 9.6 8.6 19.5 16.9 6.4 8.3 13.8 9.4 20.5 23.7 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase" P46934 15 55826922-55993746 "Enzymes, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavourable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavourable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 14.1 4.1 2.5 3.1 3.3 4.5 8.7 1.5 2.7 9.9 9.4 2.8 3.4 3.4 10.1 4.1 8.2 3.8 4.5 4.1 2.9 2.4 8.6 21.5 7.2 2.1 3.5 1.3 6.6 2.8 6.5 6.7 20.1 3.5 8.4 3.4 5.4 4.0 6.4 57.7 7.1 15.2 10.9 6.0 5.9 4.4 2.6 3.1 9.4 5.7 9.0 3.3 11.9 8.9 0.1 1.6 1.2 2.8 1.2 2.9 0.9 7.3 11.4 3.1 3.0 4.1 6.8 5.1 14.1 22.3 10.4 10.5 5.1 2.2 1.8 3.7 5.3 12.2 3.4 9.3 17.1 4.1 2.1 9.1 2.7 2.6 21.9 4.0 0.9 11.5 23.0 12.5 21.1 8.5 3.9 0.0 30.5 3.8 5.3 0.0 0.8 1.7 3.9 24.7 1.0 4.3 14.6 0.3 2.0 6.3 4.5 5.6 5.6 3.0 29.6 23.2 7.7 4.9 22.9 1.2 2.6 4.8 15.7 8.5 5.5 0.6 1.0 0.0 1.3 2.8 2.9 0.1 1.5 1.2 0.8 0.0 1.4 1.6 1.2 1.2 1.9 1.6 1.3 0.9 2.5 3.3 1.5 2.7 2.9 2.4 3.5 1.3 3.5 3.1 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell line enhanced" "Detected in some" "MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA064630: " "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 0.0 6.7 0.0 14.5 0.0 23.2 3.6 15.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143997 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6;lymphoid tissue: 23.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavourable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 3.3 6.7 6.9 6.9 23.6 2.4 3.4 11.8 15.8 1.8 9.5 2.1 0.6 1.9 2.8 0.9 5.6 1.1 5.5 2.4 8.3 5.9 2.5 0.9 5.3 6.6 4.9 7.1 2.0 9.8 11.6 1.4 3.8 13.5 1.4 2.8 10.1 2.6 1.6 4.5 1.7 2.7 1.9 2.5 23.8 1.9 8.6 4.7 1.9 10.0 3.1 6.8 4.2 2.5 1.0 2.1 0.9 3.3 0.3 2.2 0.7 24.7 27.6 40.0 0.1 5.9 34.5 6.6 24.6 3.9 21.9 11.9 5.7 15.9 6.1 15.2 5.2 11.1 25.5 24.5 27.0 0.0 16.4 4.9 9.8 6.1 7.3 15.8 13.1 20.7 16.4 8.8 12.4 14.5 7.3 7.6 14.0 6.7 9.0 8.6 19.2 20.3 0.0 7.8 12.4 15.4 5.3 26.3 19.1 32.5 2.5 3.6 0.5 11.6 7.0 0.0 0.0 0.0 0.1 8.2 6.7 13.6 17.8 11.2 17.6 0.9 3.3 0.1 0.1 1.6 1.3 1.0 1.3 0.1 2.1 0.4 0.0 0.1 0.9 0.3 1.5 0.2 2.2 0.7 6.9 23.6 11.8 15.8 8.3 5.9 4.9 7.1 13.5 4.7 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239554 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2" "Cell line enhanced" "Detected in some" "AF22: 10.2;AN3-CA: 16.8;NTERA-2: 43.3;SCLC-21H: 12.9;SH-SY5Y: 20.6" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.7 15.5 4.2 0.8 13.3 0.5 1.2 23.2 11.8 0.6 0.7 10.7 0.0 0.7 1.5 5.8 1.4 0.8 0.6 0.6 6.3 4.3 0.6 0.5 0.5 0.5 4.7 7.2 0.6 0.7 0.7 0.3 0.9 18.2 2.2 0.7 0.0 0.7 1.1 26.2 1.9 0.7 0.8 3.3 0.5 0.6 0.9 9.0 0.0 0.5 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.2 16.8 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 43.3 0.4 0.0 0.1 0.0 0.0 1.5 12.9 20.6 0.4 0.1 1.1 4.5 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.3 23.2 9.5 6.3 4.3 4.7 7.2 18.2 9.0 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.0 0.0 0.0 0.5 0.0 0.0 1.6 0.2 0.0 0.5 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HeLa: 1.9;PC-3: 2.5;REH: 2.5;RT4: 1.6;SCLC-21H: 4.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced "HPA018833: " "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 2.5 0.0 0.0 0.0 1.6 4.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 NOV "CCN3, IGFBP9" ENSG00000136999 "Nephroblastoma overexpressed" P48745 8 119416306-119424353 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 236.7" "Group enriched" "Detected in many" 5 "BJ hTERT+: 43.0;U-2197: 44.5" "Cancer enhanced" "Detected in all" "melanoma: 62.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 113 "eosinophil: 28.1;neutrophil: 14.0" "Lineage enriched" "Detected in single" 151 "granulocytes: 28.1" "Group enriched" "Detected in many" 7 "amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1" "Low region specificity" "Detected in many" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" 269030000 2900000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 6.3 236.7 2.2 1.4 7.9 1.0 5.6 3.1 12.3 5.0 2.0 3.6 3.6 1.5 5.8 2.9 1.9 3.0 2.0 5.7 3.5 1.9 4.9 0.9 2.9 1.1 2.1 15.1 1.8 2.7 2.1 13.4 0.8 7.4 5.6 2.2 1.2 1.2 5.0 1.6 3.6 1.5 2.5 2.5 1.0 1.6 2.6 0.0 0.0 6.9 4.8 1.1 3.3 2.5 0.0 0.1 28.1 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 3.9 1.0 0.0 5.7 43.0 5.2 3.0 0.0 0.1 0.0 4.5 7.2 3.6 0.2 0.0 1.7 0.0 0.1 0.0 3.3 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.6 0.0 0.0 0.0 5.5 0.0 1.3 0.0 2.1 0.0 8.0 0.0 0.0 0.0 3.7 5.7 44.5 1.1 0.0 0.0 0.0 5.9 1.8 4.3 0.0 0.1 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.2 7.9 3.1 12.3 3.5 1.9 2.1 15.1 7.4 0.0 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB037267, HPA049486" Enhanced "CAB037267: AB_261982, HPA049486: " "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPR2 "AMDM, ANPb, ANPRB, GUCY2B, NPRB" ENSG00000159899 "Natriuretic peptide receptor 2" P20594 9 35792154-35809732 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Osteogenesis" "Lyase, Receptor" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7" "Cell line enhanced" "Detected in many" "ASC diff: 27.2;ASC TERT1: 20.3;BJ hTERT+: 16.6;HSkMC: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.1;T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.93e-2)" "unprognostic (8.22e-3)" "unprognostic (9.25e-3)" "unprognostic (3.59e-2)" "unprognostic (6.13e-2)" "unprognostic (2.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.40e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-1)" "unprognostic (3.99e-2)" "unprognostic (6.99e-3)" "unprognostic (7.10e-2)" "unprognostic (3.24e-1)" "unprognostic (7.86e-2)" 9.0 4.8 3.8 1.9 6.4 0.0 7.2 32.7 11.2 29.2 7.8 1.8 4.4 1.8 22.6 9.8 5.3 7.6 5.7 7.6 3.7 4.2 3.7 8.4 4.7 2.3 2.5 5.1 8.0 1.3 2.7 7.9 7.1 11.8 8.3 4.0 8.3 3.3 9.5 7.7 6.2 3.7 17.1 3.9 2.6 4.5 5.5 4.0 0.9 3.2 2.4 2.0 6.2 8.9 0.4 3.1 0.0 0.0 0.1 2.1 0.1 0.0 1.6 1.9 0.0 27.2 20.3 1.2 7.5 16.6 6.1 6.6 4.0 2.7 1.1 2.0 14.7 0.7 2.3 0.2 5.5 1.2 0.7 1.0 1.7 1.9 14.8 0.1 0.0 20.1 1.1 6.8 0.5 10.0 0.5 0.1 11.4 0.5 0.3 0.4 2.5 2.8 1.3 0.1 0.5 0.9 0.8 0.5 0.6 0.2 0.0 0.3 0.1 0.0 6.4 6.5 5.0 2.1 0.7 0.2 0.3 2.9 8.3 0.3 3.6 0.0 0.0 0.0 1.1 0.0 0.0 0.4 1.2 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.0 3.1 2.1 0.1 3.8 6.4 32.7 11.2 3.7 4.2 2.5 5.1 11.8 4.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Cytokinetic bridge,Mitochondria" 21000 Mitochondria "Cytokinetic bridge" "HPA051497: , HPA072453: " "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.7 32.0 18.4 13.5 37.7 34.1 25.8 41.0 67.3 47.4 42.2 21.7 57.1 10.3 24.5 58.9 73.9 29.6 34.2 27.3 18.4 19.6 8.2 16.3 19.2 26.8 12.5 22.9 27.8 30.2 30.6 18.6 25.1 4.6 11.8 33.8 14.2 5.5 7.7 17.0 11.4 9.1 21.1 8.7 64.5 26.3 11.3 3.5 39.7 22.2 26.3 20.0 17.2 28.3 36.9 24.8 21.1 23.8 10.3 19.2 8.9 34.2 19.6 25.2 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 28.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" 620000 "Plasma membrane" "HPA071400: " "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 28.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 OS9 "ERLEC2, OS-9" ENSG00000135506 "OS9, endoplasmic reticulum lectin" Q13438 12 57693955-57721557 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 8 "RH-30: 285.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011518, HPA013694" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "CAB011518: AB_776918, HPA013694: AB_1854812" "unprognostic (1.67e-2)" "unprognostic (4.20e-1)" "unprognostic (3.93e-2)" "unprognostic (1.50e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-3)" "unprognostic (4.78e-2)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (1.64e-1)" "unprognostic (5.67e-3)" "unprognostic (2.23e-1)" "unprognostic (1.83e-2)" "unprognostic (2.78e-1)" "unprognostic (1.67e-2)" "unprognostic (4.81e-2)" "unprognostic (2.21e-2)" 39.3 32.9 24.4 28.1 27.6 32.2 38.0 27.0 34.9 37.4 39.1 27.6 34.5 37.2 36.2 37.7 35.2 32.0 33.0 39.2 23.2 23.1 42.9 94.4 40.2 34.2 27.7 22.0 44.2 110.7 49.5 29.2 47.0 28.2 34.7 34.1 42.0 53.2 28.5 19.0 36.9 47.4 28.1 18.6 37.5 35.7 21.4 24.0 23.8 47.6 23.2 34.4 33.3 35.1 11.5 35.8 54.1 48.7 11.4 16.1 36.7 6.6 13.5 6.9 17.0 35.9 24.4 15.3 16.7 21.3 12.3 12.5 14.0 21.7 8.5 27.8 19.9 12.0 6.4 10.7 9.8 10.9 7.7 9.6 9.6 12.6 23.5 15.0 24.7 22.4 17.4 12.1 12.3 20.5 7.2 34.0 12.8 11.4 4.0 18.2 7.8 9.6 5.3 285.5 21.3 9.3 16.5 7.1 9.4 23.7 16.3 13.4 19.5 29.6 18.7 16.7 10.0 11.2 10.5 20.2 17.4 8.8 14.1 11.0 22.9 30.6 48.7 54.1 16.1 44.4 15.2 10.9 13.7 14.2 35.8 11.5 10.7 12.3 52.0 11.4 35.0 31.1 15.0 36.7 24.4 27.6 27.0 34.9 23.2 23.1 27.7 22.0 28.2 24.0 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7" "Cell line enriched" "Detected in some" 13 "Hep G2: 73.2" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 7 "monocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 3.0 249.6 41.7 0.1 0.0 3.3 0.3 16.8 0.1 0.1 0.1 0.1 0.3 139.4 0.0 0.1 0.0 0.1 798.6 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.1 35.9 0.1 0.1 0.1 0.0 0.1 0.1 963.7 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.7 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain Uncertain "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 59.9;LHCN-M2: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles Vesicles "HPA049215: , HPA058413: " "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.6 31.4 9.1 4.4 14.1 3.6 4.4 20.0 15.4 12.6 4.6 7.2 12.2 3.4 10.1 3.2 13.9 7.0 6.2 13.4 10.9 9.2 3.3 1.7 5.0 6.6 7.1 8.8 4.9 4.6 6.9 4.1 4.0 8.4 5.0 2.5 7.6 5.8 16.4 5.9 6.8 2.9 6.3 5.5 4.8 5.4 5.4 5.9 2.6 8.5 4.7 5.9 6.5 5.4 4.1 7.2 13.7 5.8 7.8 12.0 4.7 4.3 5.2 1.3 9.1 5.6 3.3 0.5 1.2 2.6 2.0 1.3 0.6 6.7 0.3 5.5 2.8 5.9 1.8 59.9 0.6 2.7 0.6 0.7 3.2 1.2 8.3 0.7 7.8 4.3 7.1 5.8 12.6 1.8 0.3 4.1 20.8 1.2 0.6 0.9 1.6 3.5 1.3 1.6 6.7 3.3 1.7 1.5 2.2 10.4 2.0 2.0 2.3 0.3 1.0 5.2 2.7 12.5 2.2 3.6 2.0 0.5 15.0 1.6 2.9 13.7 5.8 7.1 12.0 5.2 9.4 3.7 8.0 10.0 7.2 4.1 5.4 8.1 1.2 7.8 4.2 3.9 5.2 4.7 9.1 14.1 20.0 14.4 10.9 9.2 7.1 8.8 8.4 5.9 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645322-56715335 "Enzymes, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;skeletal muscle: 40.2" "Cell line enhanced" "Detected in many" "HEK 293: 8.5;RPTEC TERT1: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA044540: " "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavourable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavourable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favourable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 2.4 2.1 3.7 1.2 6.3 0.7 4.1 7.2 8.1 2.2 5.5 1.2 2.4 1.2 3.0 3.2 6.3 3.5 2.6 39.1 4.2 2.9 14.5 1.4 2.0 0.8 2.4 6.2 2.5 2.6 10.4 2.6 1.2 5.0 4.6 2.2 6.0 4.5 3.5 40.2 1.4 2.1 7.2 1.9 1.9 3.2 1.7 0.8 0.0 4.0 12.3 0.8 4.4 2.1 0.2 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.7 2.0 0.0 0.7 0.5 2.3 1.8 1.4 2.5 4.3 3.8 4.7 0.0 0.6 0.6 0.0 7.8 0.0 7.1 0.0 8.5 0.0 6.9 5.2 0.0 0.0 0.1 0.6 0.0 3.5 0.3 0.8 0.0 0.0 1.0 0.1 0.0 0.0 5.5 5.4 0.0 0.0 0.0 14.0 1.2 2.0 5.4 5.7 0.1 0.0 3.2 0.0 0.0 1.5 2.3 2.7 6.3 0.0 0.0 0.0 4.5 0.0 1.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.7 6.3 7.2 8.1 4.2 2.9 2.4 6.2 5.0 0.8 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696600-42722574 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 117.8" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;ASC TERT1: 4.8;fHDF/TERT166: 6.9;HHSteC: 10.8;HSkMC: 8.4;LHCN-M2: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA029458 Enhanced "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 1.0 0.8 1.5 1.0 1.0 0.0 1.0 1.0 4.8 1.7 2.0 1.0 1.0 0.3 2.3 2.3 1.0 0.9 1.2 1.4 1.1 3.0 1.0 1.0 1.2 1.0 1.1 1.0 3.4 2.0 6.9 2.7 1.0 1.0 1.4 0.8 117.8 1.0 1.3 14.4 0.0 1.1 2.3 1.0 1.0 1.0 3.5 1.0 1.0 5.2 1.0 1.0 1.0 1.0 0.6 0.3 3.4 0.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 4.2 4.8 1.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 10.8 0.0 0.0 8.4 0.0 0.0 0.0 1.2 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.4 0.2 0.8 0.2 0.3 0.0 0.3 0.6 0.4 0.2 2.5 0.2 0.6 0.0 0.3 0.0 1.5 1.0 1.0 3.0 1.1 3.0 1.1 1.0 1.0 1.0 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;REH: 15.2;U-138 MG: 13.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "HPA014447, HPA019203" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014447: AB_1855786, HPA019203: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.9 7.4 1.0 3.8 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.5 3.3 2.0 2.7 0.4 0.3 5.3 1.6 1.3 8.9 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 1.0 0.2 1.6 0.6 3.3 0.5 0.6 5.7 1.0 15.2 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 7.4 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 198 "intestine: 333.2" "Cell line enriched" "Detected in some" 7 "CACO-2: 40.9" "Cancer enhanced" "Detected in many" "stomach cancer: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 4.6" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" 96000 "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 130.1 0.0 0.0 221.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 1.6 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 333.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 40.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 2.1 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106093-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 3.7;NTERA-2: 7.0;SCLC-21H: 11.7;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" "HPA065016: " "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 2.1 14.5 14.6 8.2 18.5 2.6 8.6 25.3 20.8 4.7 7.0 8.4 11.3 2.9 11.6 28.0 5.0 8.1 4.9 8.2 9.8 10.5 6.6 2.2 4.7 9.3 9.8 17.0 17.4 12.0 22.7 23.2 1.0 16.4 15.3 3.3 9.8 13.1 14.7 6.7 17.4 5.7 9.3 10.1 6.9 6.2 7.7 9.9 0.4 17.1 1.9 8.8 7.7 4.0 12.8 1.5 2.9 1.5 1.8 6.9 0.8 0.0 1.3 2.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.6 0.0 0.0 0.0 3.7 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 7.0 0.0 0.0 0.0 0.0 0.7 0.0 11.7 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 1.6 0.7 0.0 0.0 0.1 0.0 0.1 2.9 0.6 1.2 2.2 0.8 1.5 11.0 4.6 2.4 0.6 12.8 6.9 5.9 1.8 1.8 1.5 1.5 2.5 0.8 14.6 18.5 25.3 19.1 9.8 10.5 9.8 17.0 16.4 9.9 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 465.5;skeletal muscle: 423.5" "Group enriched" "Detected in some" 5 "Hep G2: 42.7;SK-MEL-30: 146.4" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced 240000 "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavourable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 27.7 3.2 70.0 2.8 67.3 2.2 14.3 4.1 42.5 2.0 2.4 47.3 0.0 3.5 2.6 8.5 14.1 8.8 2.6 465.5 44.9 42.9 20.0 2.6 2.4 2.5 85.0 30.7 2.2 4.5 2.0 4.3 4.5 31.4 6.3 2.1 4.3 99.3 3.7 423.5 4.0 2.9 2.1 87.7 2.4 3.3 2.8 31.8 0.0 29.0 57.6 4.7 2.9 0.1 0.6 0.6 2.1 1.0 0.3 0.5 0.5 0.7 0.3 0.5 4.5 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.9 0.4 0.5 19.1 0.0 1.1 0.0 0.0 0.0 0.4 0.4 1.0 0.6 42.7 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 3.4 0.5 0.0 1.2 0.1 0.5 0.2 0.3 3.0 0.4 1.0 0.8 1.6 0.7 0.2 0.3 1.3 146.4 4.4 2.2 0.3 0.4 0.3 0.3 0.4 0.7 0.7 0.7 0.3 0.7 0.2 2.1 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.0 0.0 0.3 1.0 0.6 0.0 0.5 70.0 67.3 4.1 42.5 44.9 42.9 85.0 30.7 31.4 31.8 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavourable (3.33e-4)" "prognostic unfavourable (1.00e-4)" "prognostic unfavourable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavourable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 70.5 72.4 0.2 15.0 81.9 109.3 54.0 40.0 54.0 35.9 36.4 130.0 98.3 0.0 38.9 69.7 123.3 20.6 155.5 33.5 12.7 5.9 8.6 32.9 30.5 29.4 3.2 7.4 28.4 131.1 39.1 45.0 79.3 0.1 0.2 47.6 61.2 0.6 20.6 9.7 80.5 0.0 14.0 1.4 151.1 21.0 0.6 0.5 65.3 23.4 30.4 51.7 8.3 84.2 17.2 43.1 81.4 27.9 1.9 0.4 12.1 101.1 2.9 60.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 118.0;SK-BR-3: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavourable (3.18e-4)" "prognostic unfavourable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavourable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.5 27.2 1.4 3.2 9.4 35.7 3.7 32.4 29.8 26.6 23.7 25.5 31.6 0.0 52.0 48.4 41.5 0.0 72.6 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 118.0 0.7 0.0 58.5 75.0 0.0 0.1 6.0 73.7 0.0 16.4 0.1 100.3 20.3 0.0 0.1 23.8 143.0 4.7 44.4 0.3 63.3 16.0 25.7 15.4 73.1 0.0 0.2 0.1 47.6 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 81.0;WM-115: 159.2" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 81.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 159.2 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.7 10.1 10.1 31.3 14.0 18.1 15.9 11.8 17.3 9.8 22.3 3.8 24.0 18.9 13.4 17.3 10.4 14.3 22.2 17.5 6.7 13.6 8.7 8.0 7.7 9.0 5.5 6.7 11.9 20.6 11.1 17.7 15.0 3.3 13.6 18.6 15.0 9.5 11.8 8.2 10.4 11.7 16.7 21.6 17.8 15.3 28.8 17.5 10.9 15.5 11.2 21.6 10.1 15.2 10.9 8.0 11.9 9.9 9.5 11.4 11.8 21.2 20.7 9.0 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" 110000 "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 28.8 27.9 15.7 32.2 21.9 22.6 38.7 7.6 16.5 20.9 37.8 27.6 24.6 37.7 22.5 27.9 54.7 24.7 27.0 18.8 14.8 10.1 34.2 37.8 28.8 42.1 24.2 11.6 20.5 32.1 42.7 17.6 47.8 17.4 20.3 37.1 17.5 56.4 31.9 18.5 36.1 47.5 17.1 20.1 39.4 33.2 29.2 20.1 25.8 29.2 28.3 38.4 21.4 25.8 37.8 59.5 46.9 51.3 36.6 47.0 47.4 12.6 16.7 7.2 11.1 21.9 11.4 21.5 13.1 16.7 14.0 15.1 23.9 30.1 10.5 17.3 19.7 46.3 21.3 16.3 5.8 41.4 20.9 26.6 9.7 16.4 16.6 13.6 51.2 14.6 29.1 13.2 9.6 13.5 8.8 19.9 9.8 19.4 6.9 15.7 7.1 10.8 12.1 6.6 36.1 16.1 18.3 7.4 7.5 10.7 19.0 12.0 26.1 21.9 12.6 12.1 7.2 13.0 15.2 13.8 20.2 10.7 11.3 32.2 8.8 46.9 51.3 39.4 46.6 48.3 37.6 37.8 42.7 46.9 37.8 32.5 35.6 38.2 34.6 36.6 50.3 59.5 47.0 47.4 15.7 21.9 7.6 16.5 14.8 10.1 24.2 11.6 17.4 20.1 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles Vesicles "HPA071167: " "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 23.6 41.8 21.0 20.8 25.6 16.8 28.8 22.5 35.5 21.9 19.0 36.1 26.8 24.1 20.7 17.8 27.1 21.9 21.5 37.8 19.8 20.2 33.3 40.8 23.4 25.5 27.1 26.3 22.6 41.5 41.5 20.0 37.0 26.2 23.0 17.3 26.0 33.0 28.1 45.3 30.0 20.9 18.9 30.4 27.0 24.4 14.5 26.4 21.6 27.3 23.6 27.3 23.9 20.8 32.2 32.5 25.6 35.0 29.9 28.7 30.0 13.8 29.7 9.0 17.9 21.9 17.3 9.2 16.6 19.7 18.8 17.7 16.2 19.7 12.8 24.8 19.3 21.6 12.9 12.6 6.9 17.5 23.7 9.0 19.4 13.2 21.9 17.0 15.4 15.1 16.1 23.5 10.8 15.7 16.0 31.1 20.3 27.6 15.6 15.7 17.3 32.6 13.5 7.3 39.4 11.1 12.4 11.7 23.6 11.6 27.2 19.2 29.3 26.5 12.8 21.1 11.9 21.8 24.6 41.3 38.4 15.9 20.8 18.2 24.3 25.6 29.0 23.2 28.7 31.1 25.6 32.2 26.6 26.8 31.6 30.5 24.6 26.3 2.6 29.9 35.0 32.5 26.6 30.0 21.0 25.6 22.5 35.5 19.8 20.2 27.1 26.3 26.2 26.4 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favourable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavourable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 22.8 22.9 10.4 25.4 21.0 13.1 12.5 14.9 13.9 16.3 19.9 18.6 22.1 9.4 14.5 11.9 27.4 9.9 15.1 6.1 14.8 8.9 6.5 8.1 17.8 27.0 6.5 10.1 20.1 9.6 14.2 8.6 11.1 14.8 10.7 9.4 27.4 8.7 12.7 17.1 7.7 10.9 7.6 14.2 20.1 20.3 14.8 19.5 9.4 22.7 12.4 22.1 17.1 11.8 20.1 13.9 35.9 15.7 26.0 25.6 8.4 26.6 11.0 12.9 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021496 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.4;SH-SY5Y: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 20.0" "Lineage enriched" "Detected in single" 24 "dendritic cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favourable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favourable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 2.1 11.1 29.2 2.5 35.7 1.7 2.1 57.5 87.0 1.5 3.3 7.5 0.0 20.6 3.3 2.4 1.3 3.1 3.3 2.8 32.4 32.1 8.9 2.6 1.9 4.0 23.9 27.8 3.6 16.7 27.0 7.4 3.8 31.1 2.6 3.1 10.7 4.1 1.9 0.8 1.6 14.7 2.1 11.9 3.6 8.2 5.6 5.6 0.0 3.8 0.0 5.3 5.5 0.7 0.2 20.0 0.8 0.1 0.3 0.2 0.2 0.6 8.0 1.7 5.5 0.1 0.1 0.2 0.2 0.2 1.8 0.6 2.1 4.0 11.9 3.8 0.4 0.5 6.8 0.4 0.6 1.8 0.8 1.5 0.8 10.9 1.2 0.3 5.1 0.6 0.9 0.4 0.1 0.7 0.1 9.8 0.4 6.4 0.4 4.3 5.9 3.1 0.2 1.4 2.8 0.4 3.7 39.4 22.0 8.7 6.0 11.9 3.4 14.5 0.5 0.5 3.8 0.8 0.5 0.9 0.9 1.1 1.4 9.2 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.3 0.1 20.0 0.0 0.2 29.2 35.7 57.5 64.8 32.4 32.1 23.9 27.8 31.1 5.6 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118161951-118176673 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7" "Group enriched" "Detected in some" 6 "HBEC3-KT: 1.5;U-2 OS: 2.5;U-2197: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 1.8 3.0 14.7 1.4 31.5 1.0 1.9 31.1 37.0 2.9 2.0 3.1 0.0 1.7 3.2 2.9 3.6 2.9 2.7 17.5 22.5 11.6 1.6 1.0 2.5 1.0 8.7 30.6 2.8 1.1 1.0 0.8 1.0 12.8 2.4 1.9 0.4 1.8 2.7 9.7 1.4 2.5 3.5 13.9 1.1 1.3 1.3 6.9 0.0 1.9 0.7 1.0 1.5 0.6 0.3 0.2 2.1 0.3 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 2.5 5.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.1 0.3 0.9 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 1.3 0.2 0.0 0.2 0.1 0.0 14.7 31.5 31.1 37.0 22.5 11.6 8.7 30.6 12.8 6.9 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "AN3-CA: 3.8;HBEC3-KT: 2.9;NTERA-2: 4.3;SH-SY5Y: 1.7;U-2 OS: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 731.2" "Region enhanced" "Detected in many" "basal ganglia: 122.8" HPA017293 Approved "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 20.5 5.4 1.9 1.2 36.4 0.1 6.1 11.7 21.7 2.4 2.6 2.0 0.5 2.4 3.7 1.8 5.4 5.5 3.2 11.0 3.1 2.9 1.4 0.6 8.7 2.0 5.3 2.1 0.7 5.0 6.4 2.4 1.9 28.7 2.1 2.2 4.3 2.8 2.6 25.6 3.8 4.6 7.0 5.5 0.5 3.0 0.8 8.7 1.5 10.4 9.5 1.1 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 36.4 11.7 21.7 3.1 2.9 5.3 2.1 28.7 8.7 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 99.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.4 22.4 23.9 12.4 89.4 77.1 10.5 14.9 53.2 21.6 28.5 8.9 30.3 0.0 24.0 19.9 6.0 12.9 17.1 26.8 2.6 11.0 21.7 19.9 7.1 99.4 5.5 35.4 52.6 23.2 21.7 65.3 51.8 10.7 12.7 49.0 3.8 12.2 6.5 14.9 6.4 5.9 7.3 2.8 34.4 15.2 10.4 18.9 15.9 6.8 73.0 6.2 15.2 44.5 20.9 9.0 24.6 9.5 3.8 5.1 8.7 53.2 0.0 18.7 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 SDF4 Cab45 ENSG00000078808 "Stromal cell derived factor 4" Q9BRK5 1 1216908-1232031 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011249, HPA011895, CAB015227" Supported Supported Supported "Golgi apparatus" "Intracellular and membrane" 720000 "Golgi apparatus" "CAB015227: , HPA011249: , HPA011895: " "unprognostic (1.98e-1)" "prognostic unfavourable (5.89e-4)" "unprognostic (3.63e-1)" "unprognostic (2.38e-3)" "unprognostic (5.88e-2)" "unprognostic (7.95e-3)" "unprognostic (3.73e-3)" "unprognostic (1.06e-1)" "unprognostic (2.01e-1)" "unprognostic (8.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.04e-2)" 34.7 36.0 17.9 37.3 22.7 19.7 56.3 20.6 33.2 30.3 49.9 21.3 46.6 48.5 35.5 53.4 26.2 26.9 57.5 50.8 18.7 18.5 36.3 73.8 55.8 46.2 19.7 21.3 33.1 56.4 25.9 31.1 47.9 18.2 30.3 25.6 26.5 46.7 52.1 30.7 25.5 56.2 27.6 18.0 33.8 32.9 30.0 18.1 20.5 35.1 28.5 19.6 28.5 44.8 11.5 16.0 20.6 15.9 19.6 22.0 7.0 28.3 25.8 14.3 45.2 69.9 35.3 17.1 55.7 51.1 41.0 34.4 30.4 49.6 18.0 43.2 53.6 29.2 16.3 24.4 12.6 30.1 27.6 31.5 39.8 42.4 32.2 31.7 42.7 43.4 12.6 30.8 17.5 32.7 25.9 47.8 20.1 20.5 15.6 32.0 13.0 34.7 17.5 18.5 47.6 27.2 13.8 51.9 18.4 37.0 44.1 36.6 22.9 36.4 41.5 42.4 23.0 31.8 31.6 29.5 27.8 29.5 48.1 59.8 18.3 10.4 14.9 20.6 15.0 9.9 11.6 9.4 21.5 22.0 16.0 11.5 12.4 10.7 12.7 19.6 15.9 10.0 16.5 7.0 17.9 22.7 20.6 33.2 18.7 18.5 19.7 21.3 18.2 18.1 SGSM3 "DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3" ENSG00000100359 "Small G protein signaling modulator 3" Q96HU1 22 40370591-40410289 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048980 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA048980: " "unprognostic (4.63e-2)" "unprognostic (7.51e-3)" "unprognostic (3.02e-2)" "prognostic favourable (4.47e-5)" "unprognostic (1.81e-1)" "unprognostic (6.83e-3)" "unprognostic (5.70e-3)" "unprognostic (7.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.67e-2)" "unprognostic (1.71e-3)" "unprognostic (1.93e-1)" "unprognostic (2.97e-1)" "unprognostic (4.08e-3)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.98e-3)" 10.5 17.2 18.2 15.9 19.4 11.4 12.0 27.2 29.9 18.7 21.5 13.7 27.2 21.5 13.6 14.9 19.7 17.0 34.5 14.1 17.7 17.3 14.6 14.4 13.3 20.0 16.1 26.3 13.2 51.6 16.4 22.3 14.5 18.5 24.2 16.4 14.4 43.9 22.9 20.5 17.7 20.6 11.7 11.9 19.8 51.5 20.6 14.2 13.3 19.8 11.1 20.9 15.3 13.9 15.7 21.0 10.2 10.1 20.9 13.0 9.9 16.8 9.6 14.3 15.7 15.8 8.8 20.3 16.1 10.5 12.1 15.9 5.4 14.2 10.5 11.2 17.2 13.7 13.4 19.5 4.8 26.0 31.9 7.1 23.9 5.0 15.2 10.2 15.6 14.4 13.8 13.6 8.2 21.2 8.7 14.6 8.9 27.0 14.2 10.5 9.5 6.5 26.5 9.0 22.8 12.4 15.0 8.8 11.4 17.7 25.7 12.1 21.4 17.5 18.4 4.2 15.3 10.9 9.2 22.1 10.1 13.7 17.6 8.6 10.5 0.7 9.4 10.2 13.0 10.1 10.9 12.1 8.1 10.4 12.3 15.7 10.0 8.0 2.2 20.9 7.2 21.0 7.5 9.9 18.2 19.4 27.2 29.9 17.7 17.3 16.1 26.3 18.5 14.2 SH3GLB1 "Bif-1, CGI-61, KIAA0491, PPP1R70" ENSG00000097033 "SH3 domain containing GRB2 like, endophilin B1" Q9Y371 1 86704570-86748184 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004650, HPA015608, HPA019900" Enhanced Supported Cytosol 18000 Cytosol "CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356" "unprognostic (1.72e-2)" "unprognostic (1.76e-1)" "unprognostic (5.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (2.90e-5)" "unprognostic (8.34e-2)" "unprognostic (1.75e-1)" "unprognostic (4.29e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (1.56e-1)" "unprognostic (4.04e-3)" "unprognostic (7.70e-2)" "unprognostic (2.65e-1)" "unprognostic (1.88e-2)" "unprognostic (1.69e-1)" 42.3 19.9 15.0 22.1 18.8 23.7 50.5 13.7 16.9 20.1 24.1 17.8 25.7 20.0 19.9 25.6 42.4 15.2 20.0 48.1 15.4 12.6 22.4 24.0 27.6 40.2 18.2 14.8 18.0 28.5 18.2 18.4 23.7 20.3 19.7 24.8 11.7 30.2 24.5 89.7 19.4 24.4 26.6 24.5 33.6 16.1 45.4 16.2 19.0 20.0 29.7 20.8 28.5 35.6 8.9 10.4 69.7 16.3 13.9 14.5 10.0 19.1 7.0 11.3 10.3 47.4 41.2 18.6 29.0 29.1 27.6 29.3 20.3 16.0 9.8 18.7 35.9 11.2 10.0 18.9 26.3 21.1 7.1 23.4 10.8 21.5 28.7 12.5 23.9 29.4 22.0 30.4 33.5 43.5 8.7 27.7 36.9 5.7 11.3 8.0 11.0 12.1 13.0 47.5 7.2 23.7 33.1 12.4 9.0 16.3 21.1 34.5 8.3 12.8 38.0 26.6 16.1 33.2 23.9 14.6 13.5 14.5 13.2 12.9 16.1 29.4 13.7 14.7 10.6 14.5 10.4 8.9 9.9 10.6 10.4 8.1 4.8 8.5 69.7 13.9 16.3 10.2 14.5 10.0 15.0 18.8 13.7 16.9 15.4 12.6 18.2 14.8 20.3 16.2 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Cell line enriched" "Detected in some" 7 "NTERA-2: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023440 Uncertain "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavourable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain "HPA059173: " "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "EFO-21: 29.1;LHCN-M2: 23.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favourable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.1 0.1 0.4 0.1 0.1 0.1 0.5 0.1 0.7 0.6 0.2 0.0 0.5 0.7 0.9 0.0 0.1 2.0 0.1 0.3 1.1 23.7 3.2 0.4 0.7 6.3 0.3 0.5 0.4 0.3 6.5 1.1 6.2 0.5 0.3 1.0 0.3 0.8 0.3 0.4 0.6 3.8 0.6 0.3 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 SIGMAR1 "OPRS1, SR-BP1" ENSG00000147955 "Sigma non-opioid intracellular receptor 1" Q99720 9 34634722-34637809 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Receptor "Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013470, HPA018002, HPA024071" Approved "CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (8.06e-2)" "unprognostic (3.71e-2)" "unprognostic (4.89e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" "unprognostic (2.01e-3)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.44e-3)" "prognostic unfavourable (3.42e-4)" 15.3 19.7 9.2 9.8 14.5 8.5 13.0 9.4 16.1 17.0 18.2 13.4 13.3 23.0 18.6 13.4 18.6 17.4 17.1 12.1 9.4 12.0 14.2 89.1 9.6 14.5 10.7 10.7 20.1 22.9 15.0 8.3 17.8 14.0 18.9 13.2 15.7 12.0 19.6 7.7 16.8 24.9 15.1 9.2 9.8 14.6 9.4 9.3 9.6 11.8 15.0 15.8 16.4 15.2 14.0 23.8 12.4 19.3 13.1 32.6 20.1 40.7 36.2 12.5 41.0 46.5 32.3 16.2 29.7 20.1 26.2 24.3 22.6 17.8 20.0 17.7 32.2 25.5 16.0 33.7 5.7 34.8 43.3 19.1 53.9 24.7 30.6 32.8 16.6 32.6 36.1 28.9 35.9 19.8 7.1 37.1 28.1 0.2 19.9 47.6 15.8 47.0 23.3 14.0 56.2 23.9 8.1 14.8 16.6 29.5 21.1 15.6 25.0 22.4 16.7 21.8 17.5 22.9 4.4 10.3 16.2 0.5 22.5 28.6 45.0 10.5 19.1 12.4 22.2 18.4 24.2 14.0 32.6 26.7 23.8 10.8 27.8 22.6 5.4 13.1 19.3 17.5 29.9 20.1 9.2 14.5 9.4 16.1 9.4 12.0 10.7 10.7 14.0 9.3 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 48.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA038360: , HPA071102: " "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favourable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 48.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 129.8;SiHa: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 210000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB010455: AB_638288, HPA017980: " "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favourable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavourable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.1 68.1 6.9 21.6 8.4 6.8 64.4 28.1 10.8 14.8 13.0 65.1 30.6 17.8 31.2 16.5 56.0 12.7 55.1 7.9 32.3 12.0 12.7 49.6 28.7 78.4 14.9 18.6 14.8 129.8 18.0 55.0 8.6 24.6 39.4 9.0 77.8 15.3 19.0 11.6 23.0 15.9 10.5 34.7 10.3 9.0 11.9 5.7 132.3 49.6 95.4 17.8 19.6 15.7 15.0 22.4 22.0 19.8 49.0 54.3 56.4 14.7 23.5 42.8 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748652-74769353 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 9600000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 5.4 33.3 19.8 9.9 23.3 22.6 15.2 21.9 15.1 12.5 30.6 15.2 35.9 57.6 5.4 12.0 74.3 20.5 30.8 5.6 14.2 8.8 36.1 64.9 8.6 13.5 14.3 14.0 5.0 26.5 12.5 4.9 8.3 12.8 10.1 13.4 22.9 41.8 23.3 1.5 11.2 73.3 3.1 12.1 13.8 14.8 5.4 14.1 18.4 5.6 24.3 30.3 7.1 20.3 9.8 14.3 72.7 24.8 45.1 70.4 44.3 13.7 11.3 5.6 5.8 3.4 2.5 25.5 3.3 3.1 8.5 8.3 35.4 8.2 3.0 3.4 7.0 19.7 9.7 6.4 4.0 3.6 9.3 22.6 30.6 47.1 7.0 14.7 15.3 2.0 3.6 6.7 2.9 7.0 7.1 16.2 13.0 77.3 34.7 33.1 5.0 6.7 3.8 6.3 13.6 11.7 9.8 4.9 6.4 3.4 63.1 7.1 122.1 11.8 2.3 2.6 7.7 6.1 5.4 28.2 12.7 5.5 4.3 19.7 1.5 72.7 14.1 65.3 70.4 20.6 46.6 9.8 43.2 59.3 13.7 8.6 25.5 45.2 50.3 45.1 24.8 14.3 47.0 44.3 19.8 23.3 21.9 15.1 14.2 8.8 14.3 14.0 12.8 14.1 SLC9A3R2 "E3KARP, NHERF-2, SIP-1, TKA-1" ENSG00000065054 "SLC9A3 regulator 2" Q15599 16 2025356-2039026 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;PC-3: 56.1;WM-115: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 6.8;monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001672, HPA066520" Enhanced Supported "Plasma membrane" 120000 "Plasma membrane" "HPA001672: AB_1080017, HPA066520: " "unprognostic (6.99e-2)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "prognostic favourable (1.03e-4)" "unprognostic (1.41e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-3)" "unprognostic (9.17e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.70e-2)" "unprognostic (2.20e-2)" "unprognostic (6.20e-3)" "unprognostic (9.10e-2)" "unprognostic (2.40e-1)" "unprognostic (2.80e-2)" 51.5 19.4 20.0 10.0 25.4 1.1 41.0 15.5 26.6 29.7 13.1 15.2 13.5 13.5 28.7 10.3 16.1 20.9 30.4 65.1 18.4 15.7 40.7 80.9 51.2 11.1 21.0 15.9 18.3 14.0 5.3 17.4 25.1 17.8 25.5 6.5 37.5 76.3 22.9 60.9 7.1 15.7 9.9 12.2 39.0 35.0 8.8 13.5 2.5 32.7 21.5 12.3 13.3 25.0 0.1 6.8 0.0 3.6 0.1 0.9 1.0 6.2 37.3 1.0 7.7 1.2 1.7 1.1 27.2 16.5 13.8 4.5 4.9 8.3 0.0 12.9 11.6 6.1 2.9 2.7 1.4 0.0 8.9 0.6 16.1 11.8 9.2 0.1 2.8 1.9 2.7 4.0 1.2 13.7 4.5 0.5 0.9 59.5 0.1 6.9 1.5 56.1 5.3 1.6 9.8 3.0 0.5 7.1 6.7 1.9 37.8 2.4 30.6 3.2 34.8 4.3 6.3 0.3 37.6 1.0 0.8 0.1 0.5 0.7 40.3 0.0 3.6 0.0 0.9 2.7 0.3 0.0 0.2 0.2 6.8 0.1 0.9 0.9 0.0 0.1 0.9 5.0 0.2 1.0 20.0 25.4 15.5 26.6 18.4 15.7 21.0 15.9 17.8 13.5 SLURP1 "ANUP, ARS, ArsB, LY6LS, MDM" ENSG00000126233 "Secreted LY6/PLAUR domain containing 1" P55000 8 142740944-142742411 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Cytokine "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5" "Group enriched" "Detected in some" 4 "HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 66.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050967 Approved "Secreted in other tissues" 5400000 "HPA050967: " "unprognostic (1.22e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.42e-2)" "unprognostic (1.84e-1)" "unprognostic (7.32e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-4)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (1.43e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 2.5 0.1 0.1 17.3 0.1 0.1 0.1 0.1 1.1 0.1 137.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 7.7 0.1 0.4 91.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 107.5 93.7 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.8 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 3.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: " "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favourable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favourable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favourable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.0 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 2.5 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.2 5.0 3.1 5.1 3.5 5.8 4.9 5.3 1.1 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.3;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.0;monocytes: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Plasma membrane,Cell Junctions,Cytosol" 20000000 "Plasma membrane, Cell Junctions" Cytosol "CAB004023: AB_2106059, HPA030875: " "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavourable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (1.63e-4)" "prognostic unfavourable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favourable (5.22e-5)" 6.9 17.5 12.8 11.1 12.0 5.4 9.9 6.4 16.0 16.0 16.4 3.5 15.1 29.5 20.3 9.7 16.2 14.2 42.1 5.8 11.3 6.6 13.4 2.9 10.4 7.0 3.3 9.9 15.8 19.1 6.6 11.3 6.3 5.1 19.9 13.1 13.1 7.5 22.5 3.4 7.7 28.1 27.2 3.6 12.2 29.8 27.3 4.8 4.0 6.6 10.5 10.4 26.4 20.0 0.3 3.0 0.1 5.3 0.6 0.1 1.6 7.6 35.5 8.1 7.3 3.1 4.9 17.0 7.1 6.1 8.6 5.5 13.3 6.9 0.2 4.4 12.8 14.0 4.9 33.0 3.4 0.0 4.4 1.9 1.2 20.7 7.4 0.1 3.0 5.3 11.2 5.6 7.5 7.8 0.2 0.0 1.4 5.2 1.8 0.2 3.8 32.1 8.3 2.1 0.2 3.6 34.0 7.6 27.5 8.0 11.3 8.8 10.1 2.8 11.5 10.4 7.0 3.8 6.3 0.1 0.2 0.1 7.3 0.0 7.7 0.0 2.6 0.0 0.0 5.3 0.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.1 0.6 4.4 3.0 0.1 1.6 12.8 12.0 6.4 16.0 11.3 6.6 3.3 9.9 5.1 4.8 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380344-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.9;HaCaT: 16.1;SH-SY5Y: 23.1;U-251 MG: 14.0;U-87 MG: 23.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 21.3" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 3.7 6.4 1.4 1.1 5.4 0.6 5.7 21.3 0.8 9.2 4.6 1.2 4.7 0.3 9.0 2.2 3.3 4.0 5.1 0.7 0.9 3.9 3.3 1.8 15.0 0.7 1.6 0.2 3.2 0.6 18.8 1.8 0.6 5.2 17.2 1.1 1.9 1.8 5.7 4.0 1.6 0.6 12.5 1.2 0.9 1.5 2.4 0.2 0.7 1.0 4.4 0.5 8.4 15.5 0.0 0.6 3.2 0.4 2.8 3.8 0.2 3.5 1.5 0.8 0.0 3.2 1.0 0.0 8.9 0.2 1.9 2.2 0.0 0.0 0.0 3.7 21.9 16.1 1.1 3.9 2.0 0.0 2.8 0.5 4.8 0.1 0.0 8.9 0.1 1.2 0.1 0.0 0.3 0.0 0.0 0.2 0.2 0.0 1.8 0.1 6.7 1.4 0.0 0.0 0.0 5.1 0.0 3.0 23.1 3.6 2.5 0.0 0.0 0.9 4.0 0.2 9.3 0.3 14.0 0.0 0.0 0.0 23.8 3.5 3.9 0.0 0.1 3.2 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.1 0.0 3.8 0.2 1.4 5.4 21.3 0.8 0.9 3.9 1.6 0.2 5.2 0.2 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897596 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA051855 Uncertain Approved Cytosol Cytosol "HPA051855: " "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 12.0 13.0 8.9 12.0 13.9 26.4 12.8 11.6 16.1 12.5 10.7 17.8 8.8 7.8 14.4 7.9 9.2 17.7 9.6 8.3 9.5 6.7 9.9 34.7 15.2 18.1 9.9 8.1 12.2 19.2 7.7 8.9 7.8 13.0 10.2 6.7 13.0 12.8 11.5 17.9 10.5 10.1 16.5 10.2 14.9 11.2 8.4 9.5 18.0 11.8 6.8 13.2 12.5 12.5 1.7 4.0 1.7 5.8 0.7 4.6 1.4 6.8 5.9 9.1 15.7 20.7 13.1 18.3 10.0 11.2 13.6 12.4 7.3 7.1 6.7 2.0 11.4 6.4 10.7 9.7 9.5 14.7 8.2 10.8 7.5 11.2 13.8 16.2 8.3 10.4 13.5 15.1 6.8 11.0 3.7 6.7 11.3 5.6 8.8 9.1 8.2 12.2 4.8 7.0 4.5 6.4 8.8 2.0 6.8 10.1 6.9 9.4 5.9 14.1 11.1 10.8 6.4 14.1 11.8 12.9 8.3 6.2 9.4 16.4 8.2 0.0 3.3 1.7 2.2 5.8 1.8 1.7 3.5 2.4 4.0 1.5 1.9 1.4 0.3 0.7 5.5 2.3 4.6 1.4 8.9 13.9 11.6 16.1 9.5 6.7 9.9 8.1 13.0 9.5 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 104.0;hTCEpi: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.4 9.7 0.8 4.4 104.0 29.9 0.0 25.9 25.7 7.3 11.5 1.2 1.9 11.8 6.4 32.2 2.5 5.4 24.0 13.0 7.2 2.2 27.4 21.3 3.7 56.4 10.1 5.8 49.5 85.0 11.4 15.2 26.0 5.9 15.8 15.8 7.7 0.3 7.7 11.8 3.0 1.4 0.0 25.6 5.7 0.2 1.0 0.1 21.6 19.2 11.1 6.5 8.4 33.0 16.9 5.3 16.8 2.4 6.7 7.3 0.7 6.5 10.2 9.0 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell line enriched" "Detected in single" 39 "AF22: 18.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA012892: AB_1857610, HPA071011: " "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favourable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.9;U-87 MG: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced "Intracellular and membrane" "CAB008372: AB_592786, HPA069176: " "unprognostic (5.12e-3)" "prognostic unfavourable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.5 7.3 1.2 3.5 1.6 4.2 0.8 5.0 3.3 2.1 1.4 2.5 4.3 1.9 0.7 3.5 1.3 1.7 3.1 1.6 3.4 1.3 0.6 2.6 1.4 1.8 0.8 1.8 2.5 1.4 14.6 5.1 3.6 1.6 2.3 3.9 3.7 0.6 7.1 0.9 16.7 0.0 0.8 1.9 1.7 1.3 49.9 7.9 1.5 4.2 1.0 1.4 0.6 13.6 10.3 3.4 7.9 13.3 1.3 0.8 0.9 33.2 0.7 12.1 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell line enhanced" "Detected in some" "Karpas-707: 8.0;RH-30: 22.8;RPMI-8226: 21.6;SCLC-21H: 5.3;U-87 MG: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles Vesicles "HPA044271: , HPA059267: " "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 22.8 21.6 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366496-70417061 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favourable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 12.0 13.8 10.8 8.2 13.0 1.7 11.2 15.8 13.7 11.8 20.1 14.1 14.1 21.0 12.5 10.4 16.3 9.5 11.7 15.7 10.5 8.9 32.0 25.9 10.4 6.8 11.0 6.4 10.3 11.0 28.9 22.2 12.0 13.4 15.3 16.7 11.6 13.2 15.0 27.4 6.7 32.2 15.2 12.4 11.3 16.8 16.9 9.9 7.0 16.9 14.4 7.9 15.4 9.1 4.6 5.1 0.6 5.3 3.8 7.4 1.9 9.6 6.2 10.9 7.3 8.4 9.8 7.6 7.4 7.7 5.3 6.0 6.0 9.1 0.0 7.1 8.5 8.3 10.9 8.1 12.6 1.3 5.5 3.5 9.5 7.8 7.4 0.0 1.2 7.6 6.7 6.6 3.7 11.5 2.0 2.0 9.4 6.9 4.9 1.4 7.9 7.6 6.2 15.8 2.6 11.5 14.5 8.0 13.9 10.2 8.6 6.0 16.0 2.5 12.6 12.6 8.8 4.8 6.0 2.7 10.1 0.0 11.2 1.2 10.4 0.6 5.3 0.1 4.3 5.1 4.9 4.6 5.2 5.0 5.1 3.9 7.4 5.9 0.6 3.8 3.3 3.2 3.9 1.9 10.8 13.0 15.8 13.7 10.5 8.9 11.0 6.4 13.4 9.9 TBC1D1 "KIAA1108, TBC, TBC1" ENSG00000065882 "TBC1 domain family member 1" Q86TI0 4 37891087-38139175 "Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041816, HPA058158" Approved Approved Nucleoli Nucleoli "HPA041816: AB_10796784, HPA058158: " "unprognostic (3.77e-2)" "unprognostic (3.44e-1)" "unprognostic (1.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "prognostic favourable (1.47e-8)" "unprognostic (1.49e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.21e-1)" 13.6 3.7 9.3 19.8 8.3 19.0 9.8 9.5 8.4 36.0 48.9 7.1 24.5 10.2 63.4 16.5 14.9 22.9 30.6 24.0 7.5 6.0 29.0 8.8 13.3 16.6 7.0 7.6 16.1 9.4 55.9 8.0 32.4 7.4 18.0 9.8 18.2 8.3 28.1 41.9 5.6 15.1 31.6 7.4 21.2 18.1 15.6 5.4 30.4 26.1 23.1 13.3 27.2 26.8 6.0 4.8 14.0 16.7 6.2 4.3 2.2 5.7 6.5 12.0 12.9 4.3 12.1 10.4 15.6 26.3 14.8 15.1 3.7 18.8 29.4 3.9 10.4 0.3 9.1 11.3 22.8 2.3 5.1 11.3 4.5 7.8 6.9 20.9 13.0 14.6 2.3 9.1 6.3 22.7 13.8 5.1 15.3 4.4 29.0 19.8 6.8 6.0 25.9 19.5 8.5 12.2 10.6 10.5 9.4 5.8 5.4 6.5 5.2 16.2 15.5 19.6 22.3 4.9 22.6 12.5 15.3 77.4 8.5 19.2 17.3 1.9 5.0 14.0 2.6 15.6 4.3 4.8 2.6 2.2 4.8 6.0 2.4 3.0 13.9 6.2 16.7 4.2 2.1 2.2 9.3 8.3 9.5 8.4 7.5 6.0 7.0 7.6 7.4 5.4 TBC1D4 "AS160, DKFZp779C0666, KIAA0603" ENSG00000136111 "TBC1 domain family member 4" O60343 13 75284665-75482114 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "GTPase activation" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;HUVEC TERT2: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 17.4" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;T-cells: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040145, HPA059885" Approved Supported Cytosol Cytosol "HPA040145: , HPA059885: " "unprognostic (5.44e-3)" "unprognostic (5.23e-1)" "unprognostic (9.85e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-2)" "unprognostic (9.54e-3)" "unprognostic (1.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.87e-1)" "unprognostic (5.02e-2)" "unprognostic (7.53e-2)" "unprognostic (2.64e-1)" "prognostic favourable (1.07e-11)" "unprognostic (6.40e-2)" "unprognostic (3.16e-1)" "unprognostic (8.88e-2)" "unprognostic (3.45e-1)" 12.0 43.9 6.7 6.7 7.0 1.2 17.5 9.3 10.7 6.9 5.7 4.6 4.2 1.9 5.4 10.1 6.1 5.9 8.5 25.5 8.0 4.1 15.6 5.3 8.5 14.9 5.4 7.0 22.5 8.5 9.5 4.2 9.5 11.1 7.4 4.9 2.0 20.8 2.4 40.1 10.8 6.3 4.7 4.8 9.6 6.1 3.3 4.4 1.1 17.7 17.3 14.8 4.7 8.7 0.5 7.2 2.6 0.3 0.3 17.4 1.8 5.5 6.5 4.1 0.2 9.7 10.5 5.3 4.8 2.5 3.9 4.3 36.9 6.8 1.1 1.1 6.8 5.2 10.4 4.8 4.1 18.3 10.5 18.0 8.8 11.1 2.4 8.5 0.2 11.4 8.9 4.3 10.2 27.3 5.0 0.6 4.4 2.6 12.4 1.5 5.8 3.9 11.2 3.9 6.5 3.8 4.0 7.6 2.3 2.1 6.5 3.5 2.2 0.2 11.4 4.4 5.5 2.3 5.6 0.3 0.0 0.1 7.9 8.0 6.5 2.6 0.3 0.0 0.5 0.1 0.0 0.5 8.6 1.8 0.4 0.4 8.0 3.7 0.3 0.3 0.1 7.2 17.4 1.8 6.7 7.0 9.3 10.7 8.0 4.1 5.4 7.0 11.1 4.4 TJP1 "DKFZp686M05161, MGC133289, ZO-1" ENSG00000104067 "Tight junction protein 1" Q07157 15 29699367-29968865 "Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA001636, HPA001637, CAB010822" Enhanced Enhanced "Cell Junctions" "Cell Junctions" "CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760" "unprognostic (2.11e-2)" "unprognostic (6.83e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-2)" "unprognostic (9.43e-2)" "unprognostic (1.21e-1)" "unprognostic (4.54e-2)" "unprognostic (6.71e-3)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.86e-3)" "unprognostic (3.54e-1)" "prognostic favourable (1.72e-4)" "unprognostic (2.85e-3)" "unprognostic (3.02e-1)" "unprognostic (5.04e-2)" "unprognostic (1.20e-1)" 22.1 11.7 27.5 9.2 32.8 2.2 18.0 12.0 36.3 24.8 16.9 37.5 10.7 10.9 29.5 27.6 45.7 22.9 18.2 26.0 28.3 19.1 20.4 20.8 31.1 7.8 29.3 21.3 23.6 19.4 30.1 17.7 38.3 23.4 17.8 15.5 15.2 18.5 15.4 16.4 17.8 14.4 29.4 31.7 10.1 16.7 25.9 32.6 1.2 23.1 17.9 13.2 18.5 27.3 0.7 0.2 0.3 0.4 1.0 0.2 0.1 26.0 19.2 10.6 8.6 9.4 13.1 12.0 8.1 7.2 6.8 7.7 26.5 10.5 0.1 11.0 10.8 19.6 6.5 9.1 8.7 0.2 7.2 0.1 10.3 11.2 25.2 0.0 0.3 7.2 6.5 8.3 16.2 15.0 9.7 5.4 5.2 14.4 0.1 0.2 9.7 6.1 0.0 14.9 0.0 13.6 16.0 5.2 7.4 16.7 7.3 6.9 5.0 0.3 23.6 7.0 10.6 4.8 11.1 1.9 1.8 0.1 7.9 0.1 3.9 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.2 0.2 0.3 1.0 0.4 0.2 0.2 0.1 27.5 32.8 12.0 26.1 28.3 19.1 29.3 21.3 23.4 32.6 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724730 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" Receptor "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 29.1;TIME: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 30.1" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: " "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favourable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavourable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 29.2 12.1 15.5 23.5 12.5 17.8 21.9 9.4 10.3 6.9 6.8 10.6 3.0 4.4 5.8 7.7 5.0 6.8 10.6 10.9 19.9 7.5 9.0 16.5 16.0 30.9 12.4 11.4 6.7 3.0 2.9 3.8 22.8 10.5 5.7 7.4 7.2 9.0 3.6 7.4 5.2 6.6 10.4 11.1 41.4 4.5 2.4 13.0 1.1 8.3 5.6 7.5 12.1 16.1 0.6 7.5 30.1 21.4 0.0 0.0 6.9 0.0 0.0 12.5 0.0 5.8 11.8 0.1 5.0 8.7 1.2 0.7 0.0 1.2 1.7 0.2 12.8 0.0 0.0 1.1 1.8 0.0 0.0 2.6 2.6 0.1 4.4 9.0 0.0 7.3 0.0 2.7 0.3 15.2 0.0 29.1 15.2 0.0 0.0 1.8 1.5 0.6 0.0 14.1 9.1 0.5 14.6 0.0 0.0 3.1 0.0 0.5 0.0 4.9 21.1 0.6 9.5 0.0 2.3 0.0 0.0 0.0 0.4 9.5 7.4 17.6 21.4 7.2 0.0 19.6 0.0 0.6 0.0 0.0 7.5 0.2 0.0 0.0 30.1 0.0 20.2 0.3 0.0 6.9 15.5 12.5 9.4 10.3 19.9 7.5 12.4 11.4 10.5 13.0 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.1;EFO-21: 61.5;HUVEC TERT2: 20.3;NTERA-2: 14.6" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA053639: , HPA069378: " "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favourable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.3 0.0 0.0 1.9 0.2 0.0 0.0 14.6 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "adipose tissue: 69.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 11.6;hTERT-HME1: 19.6;PC-3: 22.2;U-138 MG: 11.8;U-87 MG: 12.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4" "Lineage enriched" "Detected in single" 19 "T-cells: 14.8" "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 69.9 0.4 0.4 0.7 0.4 0.9 4.5 0.4 0.5 2.1 0.4 0.4 0.4 0.0 0.4 0.6 5.0 0.3 0.8 0.4 0.4 0.1 0.4 0.8 4.9 0.6 0.4 0.4 1.2 0.4 0.0 0.4 1.1 0.4 0.6 0.1 0.4 2.2 0.4 2.1 3.2 0.4 0.4 0.4 0.8 0.6 8.2 0.4 0.5 1.0 2.0 1.3 0.9 2.1 0.3 0.5 0.6 0.4 0.8 14.8 1.4 9.1 4.3 0.2 0.3 0.5 3.0 0.3 0.0 2.7 1.0 1.8 0.1 5.0 0.1 1.6 0.0 1.3 0.0 1.0 0.7 0.3 0.1 0.3 1.2 0.0 0.6 0.5 0.3 0.3 0.8 11.6 19.6 0.0 5.7 0.5 2.9 0.7 0.1 0.5 0.0 22.2 0.1 2.0 0.5 0.0 0.2 0.2 0.0 1.6 0.0 0.4 0.4 0.1 0.8 11.8 9.7 1.8 5.4 0.3 3.1 0.2 12.6 0.4 0.3 0.6 0.3 0.4 14.8 0.4 0.1 0.1 1.4 3.8 0.1 0.3 0.8 5.4 0.6 0.8 0.1 0.5 0.3 1.4 0.4 0.4 0.4 0.5 0.4 0.1 0.4 0.4 0.4 0.4 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell line enhanced" "Detected in some" "A549: 7.1;RPMI-8226: 4.4" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA051838: , HPA063184: , HPA065531: " "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.1 0.2 0.1 0.0 0.0 1.3 0.8 0.1 0.0 0.0 1.3 0.5 0.2 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.4 0.1 4.4 0.1 0.3 0.6 1.7 1.0 0.1 0.0 0.3 0.1 0.3 0.6 0.3 1.9 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Group enriched" "Detected in some" 6 "A549: 15.9;RPTEC TERT1: 24.6" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA046430: " "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.4 0.2 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.0 0.3 0.9 24.6 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107407-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.3;skeletal muscle: 37.8" "Cell line enhanced" "Detected in some" "HEL: 9.4;HHSteC: 22.3;HUVEC TERT2: 11.7;THP-1: 6.5;TIME: 30.6;U-698: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 44.3;neutrophil: 26.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain "HPA016051: AB_2203924, HPA056857: " "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favourable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 9.6 3.4 4.9 4.9 6.8 4.7 11.2 4.4 13.9 4.0 3.0 6.8 0.9 2.3 3.2 4.1 2.4 3.4 3.9 9.2 7.2 6.7 2.9 2.5 10.6 9.0 8.0 7.1 2.1 1.5 1.8 1.7 7.2 10.0 2.5 2.9 3.4 3.2 1.9 37.8 1.7 2.6 3.8 12.5 5.2 2.1 4.1 3.7 0.6 9.9 3.5 3.0 4.9 2.4 0.2 4.6 44.3 7.8 1.0 1.2 2.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.2 9.4 0.0 0.0 22.3 0.5 0.0 0.1 0.0 0.0 0.0 11.7 0.4 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.0 6.5 30.6 0.3 0.4 0.0 0.1 0.9 0.0 7.0 0.0 1.2 0.0 14.1 7.8 44.3 1.2 3.3 0.0 0.0 0.1 0.1 4.6 0.2 0.0 0.1 26.4 1.0 1.4 0.6 0.0 2.8 4.9 6.8 4.4 13.9 7.2 6.7 8.0 7.1 10.0 3.7 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189143-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" "Golgi apparatus" "HPA059249: " "unprognostic (3.27e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 13.3 20.4 6.3 10.9 6.6 3.4 14.0 5.4 8.1 18.5 15.6 10.4 33.1 10.7 17.7 21.8 14.1 23.4 18.4 14.6 6.2 6.0 24.5 46.4 17.0 14.6 6.2 7.1 17.6 39.9 27.4 12.3 25.1 6.5 16.9 9.4 15.6 31.8 36.0 10.1 12.0 16.8 13.6 5.9 12.7 14.7 10.3 5.6 9.6 32.3 12.9 12.1 12.8 12.4 10.6 25.8 18.0 13.6 14.5 10.8 8.6 9.4 15.8 7.0 5.4 14.0 10.9 11.0 18.6 21.1 22.2 25.1 7.9 18.4 5.6 12.4 15.7 21.3 4.4 11.2 12.2 9.4 7.4 4.3 8.3 16.3 9.8 8.1 10.2 12.7 15.7 14.0 8.1 12.6 5.2 10.9 13.3 14.9 4.7 5.5 3.2 18.7 7.1 10.4 9.4 7.8 12.8 7.1 8.2 22.4 10.1 9.0 9.6 3.6 12.7 19.5 8.9 10.2 11.6 15.3 11.7 4.1 6.5 4.5 13.2 17.2 13.6 15.2 10.0 10.9 10.8 10.2 9.9 8.7 15.0 10.6 9.2 8.7 18.0 14.5 10.4 25.8 9.9 8.6 6.3 6.6 5.4 8.1 6.2 6.0 6.2 7.1 6.5 5.6 TM9SF2 P76 ENSG00000125304 "Transmembrane 9 superfamily member 2" Q99805 13 99446311-99564006 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005657 Supported "HPA005657: AB_1080303" "unprognostic (9.77e-3)" "unprognostic (3.51e-2)" "unprognostic (2.85e-2)" "unprognostic (1.09e-2)" "unprognostic (3.76e-1)" "prognostic unfavourable (6.40e-4)" "unprognostic (5.96e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.19e-2)" "prognostic favourable (5.21e-7)" "unprognostic (6.49e-2)" "unprognostic (8.55e-2)" "unprognostic (2.20e-2)" "unprognostic (2.21e-1)" 28.8 35.4 24.0 23.3 30.0 20.6 34.6 22.0 33.1 40.5 42.6 28.4 44.4 43.8 33.1 46.5 34.5 29.5 30.2 25.7 22.7 26.8 44.9 83.9 42.6 49.6 21.4 24.9 28.0 65.6 42.0 47.4 60.9 26.6 38.2 47.1 31.4 59.2 48.4 22.5 28.3 57.4 24.9 27.9 36.5 38.2 36.3 21.7 29.4 47.6 24.8 33.8 40.8 28.7 22.4 38.9 61.9 43.5 17.5 26.1 35.9 40.7 12.6 17.3 24.4 52.1 31.8 24.8 27.9 34.8 19.8 31.1 20.6 52.7 15.8 23.1 33.4 41.1 18.3 24.3 27.2 17.6 13.2 19.6 22.2 21.9 27.7 51.0 22.9 24.8 30.4 17.2 17.7 24.9 19.5 15.8 23.2 13.7 12.7 19.9 15.0 16.0 10.7 13.9 17.1 41.0 30.5 16.4 20.1 16.0 64.9 20.2 39.6 61.7 24.4 16.0 11.8 16.1 17.1 22.1 25.8 6.4 37.7 26.5 23.1 38.1 38.5 41.3 15.1 43.5 18.9 22.4 18.3 16.9 34.2 14.6 17.1 15.6 61.9 17.5 41.3 38.9 26.1 35.9 24.0 30.0 22.0 33.1 22.7 26.8 21.4 24.9 26.6 21.7 TM9SF4 "dJ836N17.2, KIAA0255" ENSG00000101337 "Transmembrane 9 superfamily member 4" Q92544 20 32109506-32167258 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064099 Approved "HPA064099: " "unprognostic (3.10e-2)" "unprognostic (9.03e-3)" "unprognostic (1.02e-1)" "prognostic unfavourable (6.37e-6)" "unprognostic (3.85e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (1.37e-1)" "unprognostic (3.23e-3)" "unprognostic (1.91e-1)" "unprognostic (6.65e-2)" "unprognostic (7.68e-2)" "unprognostic (6.98e-3)" "unprognostic (7.66e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" 20.3 26.2 18.1 23.5 27.7 11.6 21.1 29.8 38.5 23.4 25.7 25.4 21.8 23.7 31.4 25.7 34.4 29.3 22.2 24.1 16.0 20.6 22.5 36.9 21.7 17.7 14.7 20.9 26.8 28.2 52.4 26.6 34.6 21.3 23.9 30.8 22.4 39.6 32.2 26.4 29.4 24.7 26.2 14.9 21.4 23.6 27.2 15.7 18.7 21.6 19.0 24.1 25.9 25.0 7.8 19.3 9.9 28.9 8.3 12.1 13.9 18.8 13.4 15.4 17.6 30.4 24.9 19.9 15.7 23.8 22.1 21.6 39.8 23.5 13.2 29.8 25.5 31.3 17.3 33.5 19.1 7.5 9.7 30.4 11.6 29.8 26.9 14.6 17.5 26.1 25.6 16.6 26.9 19.5 19.1 24.8 17.2 20.0 14.7 11.0 13.8 16.6 14.1 21.9 16.5 19.1 13.4 13.2 15.4 29.2 19.2 16.7 24.1 16.8 15.9 40.5 12.6 21.3 19.0 25.2 20.6 12.5 32.0 48.6 18.1 9.9 21.7 4.4 9.9 23.3 12.1 7.8 8.8 11.2 19.3 6.8 9.8 8.3 5.6 8.3 28.9 6.3 8.5 13.9 18.1 27.7 29.8 38.5 16.0 20.6 14.7 20.9 21.3 15.7 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell line enhanced" "Detected in some" "A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favourable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.5 0.7 0.1 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 2.2 17.9 0.1 12.6 0.0 8.1 0.0 4.1 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.6 0.4 0.0 0.7 0.1 0.1 0.0 31.5 2.4 0.1 0.0 0.4 11.1 0.0 30.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 TMEM170A "FLJ37611, TMEM170" ENSG00000166822 "Transmembrane protein 170A" Q8WVE7 16 75443054-75465497 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "unprognostic (3.49e-1)" "unprognostic (1.18e-1)" "unprognostic (2.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (1.02e-2)" "unprognostic (8.62e-2)" "unprognostic (7.97e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-1)" "unprognostic (7.15e-2)" "prognostic favourable (2.36e-9)" "unprognostic (4.37e-2)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (1.53e-3)" 10.2 12.6 14.8 14.1 18.1 39.9 16.2 11.5 14.7 10.0 16.3 18.9 11.3 20.5 11.3 8.5 10.8 10.5 10.5 8.7 15.1 13.6 10.6 15.2 10.1 15.2 20.5 9.2 13.8 12.5 5.5 11.8 18.8 17.3 9.9 15.0 13.3 8.5 8.5 4.7 9.4 20.4 8.8 23.7 13.2 10.3 20.1 18.7 10.7 14.4 4.2 12.9 9.9 10.0 22.8 20.6 28.5 22.9 18.2 29.6 16.6 7.2 8.8 12.9 11.7 6.3 4.6 22.3 4.8 3.4 5.0 7.2 18.6 15.7 11.5 9.2 2.6 13.1 12.3 4.8 8.9 6.7 7.2 6.2 7.3 12.1 4.4 15.4 16.4 3.3 3.9 7.9 6.4 4.4 11.9 7.3 2.6 15.0 12.7 10.8 16.6 4.9 24.1 4.7 8.7 2.9 9.8 8.0 7.8 12.8 3.6 6.2 4.8 6.7 5.2 7.2 10.7 5.2 5.2 6.7 8.0 32.6 5.5 8.6 6.9 9.8 21.0 28.5 22.3 22.9 29.6 22.8 23.7 25.0 18.5 22.2 25.5 22.4 25.7 18.2 20.0 20.6 17.1 16.6 14.8 18.1 11.5 12.1 15.1 13.6 20.5 9.2 17.3 18.7 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398273-72408029 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 219 "testis: 23.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM203 "HBEBP1, MGC14327" ENSG00000187713 "Transmembrane protein 203" Q969S6 9 137204082-137205638 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.31e-1)" "unprognostic (2.65e-2)" "unprognostic (4.53e-2)" "unprognostic (8.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.54e-2)" "unprognostic (2.72e-2)" "unprognostic (1.78e-1)" "unprognostic (1.43e-1)" "unprognostic (7.16e-2)" "prognostic favourable (4.78e-6)" "unprognostic (2.94e-1)" "prognostic favourable (1.50e-5)" "unprognostic (3.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.04e-2)" "unprognostic (1.19e-1)" 15.3 21.1 20.6 13.5 22.4 7.6 19.2 18.2 34.1 16.8 20.0 19.0 17.6 18.5 20.0 23.5 19.2 20.2 20.0 31.4 19.7 18.2 23.7 35.5 15.6 20.5 20.0 17.0 24.8 17.4 20.9 16.9 16.5 19.1 17.1 15.8 19.7 22.3 20.0 33.2 26.2 22.8 18.8 14.5 20.0 18.0 17.5 16.3 21.4 25.2 15.6 18.4 15.9 16.9 9.9 6.5 6.4 5.8 9.2 12.7 3.5 17.1 18.2 17.3 28.5 25.8 20.1 20.7 22.4 21.8 26.2 19.7 15.0 15.5 17.8 21.8 19.5 33.8 21.2 22.3 15.4 32.2 20.4 12.3 21.7 16.9 21.6 28.4 12.7 19.2 35.8 17.1 22.7 16.8 28.7 20.9 20.2 29.6 22.5 24.7 28.7 29.7 24.6 24.2 35.5 22.0 12.6 23.0 22.5 17.9 23.0 17.7 32.4 23.1 14.8 27.0 14.4 30.1 25.1 11.3 35.3 22.4 20.8 21.2 22.1 6.4 5.3 5.3 7.4 5.8 9.2 9.9 8.5 9.2 6.1 7.1 12.7 8.7 2.8 9.2 5.0 6.5 5.2 3.5 20.6 22.4 18.2 34.1 19.7 18.2 20.0 17.0 19.1 16.3 TMEM263 "C12orf23, MGC17943" ENSG00000151135 "Transmembrane protein 263" Q8WUH6 12 106955719-106978778 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042339 Uncertain "HPA042339: AB_10795503" "unprognostic (2.56e-2)" "unprognostic (1.41e-1)" "unprognostic (8.99e-2)" "unprognostic (5.65e-2)" "unprognostic (3.90e-1)" "unprognostic (3.46e-2)" "prognostic unfavourable (7.84e-4)" "unprognostic (4.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.11e-2)" "unprognostic (7.07e-2)" "unprognostic (1.19e-1)" "unprognostic (3.05e-3)" "unprognostic (3.49e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (1.53e-1)" 14.5 17.6 13.7 15.1 14.7 4.0 25.9 10.6 12.4 29.0 13.9 5.2 26.7 10.8 22.6 27.9 13.2 12.8 19.6 25.3 10.9 16.0 24.4 44.8 12.9 18.2 11.3 10.4 24.0 28.1 12.8 65.3 40.9 11.6 21.1 12.3 10.0 25.2 26.8 10.1 5.6 15.0 18.9 10.4 15.0 18.9 12.4 6.9 32.1 32.8 7.0 12.1 21.2 23.2 11.9 9.1 5.9 0.9 11.5 17.9 8.3 8.9 8.0 15.5 10.4 36.3 41.1 6.5 34.1 32.0 16.9 21.4 8.5 3.9 0.8 10.6 48.6 4.2 9.7 13.6 23.4 16.1 9.8 12.4 12.7 17.8 18.6 0.6 8.0 28.6 6.4 18.4 15.3 20.5 5.8 3.4 23.0 7.3 9.4 5.7 4.9 15.5 20.8 11.5 2.0 16.8 7.6 7.9 10.8 18.2 8.6 13.5 10.2 3.6 23.9 14.3 8.8 18.7 8.6 14.3 8.1 8.3 11.3 2.1 22.4 5.9 0.8 0.9 10.2 0.9 12.0 9.2 9.9 8.7 2.6 11.9 17.9 16.0 0.7 11.5 0.3 9.1 10.2 8.3 13.7 14.7 10.6 11.0 10.9 16.0 11.3 10.4 11.6 6.9 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284968 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved Supported Mitochondria Mitochondria "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 29.9 29.6 42.7 28.3 63.3 23.8 27.2 40.3 55.1 33.4 31.3 36.8 22.3 21.2 31.9 25.7 30.1 24.6 30.6 22.9 45.6 48.2 39.6 48.1 45.0 23.9 43.8 41.0 25.2 41.0 57.0 45.5 29.4 50.5 33.6 36.8 20.5 31.9 31.7 18.6 19.4 22.5 39.8 45.3 28.9 28.0 14.1 40.3 21.1 43.1 17.0 29.3 32.8 22.8 9.1 24.3 42.7 26.8 13.1 16.3 16.7 10.4 10.1 18.7 15.6 47.1 44.3 15.4 42.6 33.5 16.6 25.4 10.8 24.4 12.2 29.5 37.4 12.3 8.3 23.7 44.4 15.6 12.3 11.7 11.0 11.1 26.9 14.1 20.6 41.0 23.5 23.0 12.9 52.7 11.4 21.6 32.3 6.9 4.9 10.2 6.6 8.7 8.2 13.2 15.3 64.3 25.7 13.1 12.8 21.6 10.7 14.3 11.8 44.1 45.7 21.0 23.5 13.1 30.0 17.8 24.2 5.2 16.6 27.2 32.9 12.3 26.8 17.7 12.7 26.6 15.3 9.1 13.0 12.2 24.3 7.5 12.5 12.6 42.7 13.1 25.6 10.6 16.3 16.7 42.7 63.3 40.3 52.7 45.6 48.2 43.8 41.0 50.5 40.3 TMEM30B CDC50B ENSG00000182107 "Transmembrane protein 30B" Q3MIR4 14 61277370-61281840 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 50.3" "Cell line enhanced" "Detected in some" "A-431: 24.5;CAPAN-2: 20.1;HaCaT: 11.7;HBEC3-KT: 14.2;hTCEpi: 10.8;MCF7: 15.8;RT4: 34.4;T-47d: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043162 Uncertain "HPA043162: AB_10796688" "unprognostic (4.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.72e-1)" "unprognostic (3.47e-2)" "unprognostic (2.01e-1)" "unprognostic (6.20e-2)" "unprognostic (2.45e-3)" "unprognostic (3.43e-2)" "unprognostic (9.10e-2)" "unprognostic (2.20e-1)" "unprognostic (5.10e-2)" "unprognostic (2.26e-1)" "prognostic favourable (5.89e-5)" "unprognostic (2.21e-1)" "unprognostic (2.89e-1)" "unprognostic (2.60e-1)" "unprognostic (1.85e-1)" 3.7 1.2 0.8 1.6 1.3 0.0 4.7 0.7 1.0 5.4 11.5 0.5 18.0 14.1 3.9 14.6 8.1 4.8 10.6 1.5 0.8 0.8 6.7 5.5 6.4 0.4 0.8 0.7 4.8 23.3 20.3 27.3 11.6 3.4 9.1 8.4 1.0 18.9 14.4 1.6 3.9 19.5 2.0 1.7 0.9 13.3 6.3 0.2 2.3 50.3 6.2 4.7 9.6 5.7 0.0 0.0 0.0 0.0 0.7 2.8 0.5 24.5 0.0 0.0 0.0 2.8 0.6 0.0 0.0 0.0 0.0 0.0 4.2 20.1 0.0 0.0 0.0 11.7 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.0 34.4 4.1 0.0 0.3 9.5 0.0 11.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 1.2 0.6 0.0 0.0 2.8 1.8 0.0 0.7 0.0 0.0 0.0 0.5 0.8 1.3 0.7 1.0 0.8 0.8 0.8 0.7 3.4 0.2 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM60 "C7orf35, DC32" ENSG00000135211 "Transmembrane protein 60" Q9H2L4 7 77793728-77798580 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062625 Approved "HPA062625: " "prognostic favourable (3.09e-4)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-3)" "unprognostic (3.91e-2)" "unprognostic (5.28e-3)" "unprognostic (2.73e-3)" "unprognostic (3.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (2.72e-2)" "unprognostic (9.44e-2)" "unprognostic (2.07e-3)" "unprognostic (4.43e-3)" 16.4 19.7 14.6 16.2 14.8 6.9 22.8 8.6 21.3 17.4 18.0 10.0 17.1 13.3 16.4 23.1 15.0 14.5 13.6 15.1 14.6 17.8 25.5 25.8 19.3 18.8 15.7 12.2 18.6 24.1 33.9 30.6 20.1 19.7 17.9 18.4 16.0 27.5 21.3 19.2 15.1 19.6 14.7 15.3 22.7 14.2 20.3 9.8 18.8 30.9 17.2 20.5 14.0 14.1 25.9 15.6 48.3 17.2 8.8 23.1 12.2 17.6 11.8 18.8 21.8 25.1 22.3 8.5 16.7 31.4 17.6 28.2 10.9 22.6 13.7 4.1 15.3 18.6 17.4 9.6 19.9 10.5 16.5 7.3 11.1 15.1 17.8 10.3 13.9 16.3 13.9 13.1 16.0 12.5 17.2 27.5 27.5 18.7 7.8 26.5 13.1 15.5 9.5 14.8 19.5 20.8 13.1 9.4 15.2 12.4 17.6 24.8 21.2 19.1 8.3 22.8 16.0 19.8 12.2 11.3 17.2 19.6 17.3 21.6 20.1 48.3 16.0 28.6 9.4 17.2 10.1 25.9 16.5 11.6 11.9 20.9 14.0 11.8 15.6 8.8 15.7 15.6 23.1 12.2 14.6 14.8 8.6 21.3 14.6 17.8 15.7 12.2 19.7 9.8 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: " "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.0 8.8 7.1 7.4 8.4 7.2 7.3 9.4 8.6 10.6 8.6 8.3 6.4 15.0 8.2 6.4 10.1 13.6 9.1 12.0 9.7 9.3 15.0 5.8 11.0 8.4 8.1 8.0 6.7 8.4 6.7 3.6 8.9 11.2 7.4 11.2 8.2 18.5 15.4 6.6 11.0 13.1 7.0 12.7 11.2 10.5 16.2 7.2 5.8 42.5 11.9 8.8 7.5 5.6 6.2 7.5 11.2 8.9 11.0 9.4 14.7 9.0 6.4 6.8 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 TMEM91 "FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.1;HSkMC: 16.2;TIME: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 51.9" "Low region specificity" "Detected in all" HPA053240 Uncertain "HPA053240: " "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favourable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 10.5 6.2 12.1 9.2 42.0 35.5 22.0 5.2 13.0 12.1 9.8 9.5 12.9 4.3 17.3 12.8 11.2 15.8 9.7 7.2 11.3 22.9 8.3 4.2 13.9 6.8 9.3 13.7 9.7 12.9 4.3 19.2 10.8 11.6 12.3 5.1 12.3 8.6 13.5 4.0 29.7 5.4 10.9 8.1 15.7 6.0 15.2 14.7 6.0 10.7 3.8 8.6 14.4 12.1 0.4 3.4 51.9 12.5 0.3 2.0 11.0 2.2 5.5 4.1 1.9 5.1 11.0 3.7 1.7 2.5 0.9 1.7 0.4 2.0 1.1 1.6 2.2 0.7 1.1 1.9 2.3 1.6 2.5 15.1 3.6 8.1 9.3 2.5 4.1 16.2 9.6 3.1 7.0 6.9 2.8 4.5 1.6 5.0 1.4 4.5 1.7 3.3 3.0 1.1 1.0 2.6 1.3 1.2 2.3 3.9 0.8 2.5 0.7 7.0 15.2 2.6 2.3 2.3 2.1 3.0 0.4 0.9 5.0 3.1 0.9 7.1 12.5 0.9 1.5 2.6 1.8 0.1 0.8 0.7 2.1 0.4 2.0 0.9 51.9 0.3 1.8 3.4 1.0 11.0 12.1 42.0 5.2 13.0 11.3 22.9 9.3 13.7 11.6 14.7 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319095-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 228.7" "Cell line enhanced" "Detected in all" "CACO-2: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 2.0 11.5 3.1 2.8 3.3 1.7 3.4 2.9 4.9 2.6 4.2 2.2 1.2 4.7 2.9 1.9 3.1 4.0 8.1 1.6 2.4 3.0 2.2 33.7 12.5 3.4 2.4 2.7 8.2 228.7 1.7 0.6 2.0 7.7 6.9 3.8 3.2 1.5 2.8 5.7 3.6 3.2 3.4 4.0 1.7 13.2 31.5 1.3 4.6 1.3 3.9 2.5 12.5 6.0 9.0 13.8 1.7 2.3 8.2 10.0 4.6 9.9 25.1 48.1 23.7 6.4 9.2 15.8 9.6 6.2 15.3 20.5 71.0 7.6 27.3 10.6 3.7 10.7 30.5 16.4 12.1 12.8 21.4 10.2 13.1 30.2 5.8 16.2 8.2 18.7 2.1 15.0 6.2 4.6 21.4 20.6 5.1 16.8 25.3 15.3 21.2 6.5 20.4 52.9 24.6 18.8 45.4 34.7 15.2 15.4 12.3 7.8 21.6 7.5 3.0 16.5 13.1 14.1 17.6 16.6 32.7 24.9 3.3 11.7 9.7 0.4 2.0 1.7 7.3 2.3 8.5 9.0 6.2 8.8 13.8 5.1 10.0 9.3 0.9 8.2 0.8 8.0 5.8 4.6 3.1 3.3 2.9 4.2 2.4 3.0 2.4 2.7 7.7 1.3 TMTC3 "FLJ90492, SMILE" ENSG00000139324 "Transmembrane and tetratricopeptide repeat containing 3" Q6ZXV5 12 88142296-88199887 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transferase "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038550 Approved "HPA038550: AB_10672715" "unprognostic (1.05e-1)" "unprognostic (6.16e-2)" "unprognostic (1.50e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (5.28e-2)" "unprognostic (3.62e-3)" "unprognostic (1.71e-2)" "unprognostic (1.46e-1)" "unprognostic (4.44e-1)" "unprognostic (8.07e-3)" "unprognostic (2.56e-2)" "unprognostic (2.28e-1)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" 12.4 7.8 9.9 6.3 9.4 2.8 14.0 15.1 12.0 13.8 9.6 5.7 10.7 8.5 12.0 9.2 18.4 8.1 9.8 7.4 8.3 9.5 14.0 18.1 8.8 4.6 8.3 7.9 9.7 6.6 12.6 18.3 18.5 10.1 13.0 8.3 8.3 11.0 11.4 5.1 20.4 10.5 15.3 9.5 6.6 8.2 7.4 7.7 6.1 10.7 10.5 7.4 13.2 12.2 4.1 1.7 9.5 2.7 2.2 4.8 1.4 7.2 7.8 7.2 6.8 16.9 15.0 12.8 15.2 14.7 9.1 9.8 11.3 5.1 2.2 2.9 14.1 16.2 7.6 12.5 15.3 1.3 5.7 2.2 5.8 5.1 8.8 2.3 1.4 12.7 6.8 17.5 6.9 14.0 4.8 0.8 10.0 4.3 1.6 3.0 5.5 4.1 1.4 15.6 2.2 7.9 11.8 6.1 6.1 12.8 9.0 4.0 14.6 2.3 14.7 12.6 7.0 11.1 7.5 2.6 3.3 2.6 3.9 2.7 9.3 9.5 2.5 4.0 3.6 2.2 4.4 4.1 4.1 2.8 1.7 3.7 4.8 3.9 2.4 2.2 2.7 1.7 3.0 1.4 9.9 9.4 15.1 12.0 8.3 9.5 8.3 7.9 10.1 7.7 TMUB1 "C7orf21, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081080-151083546 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 10.6 15.2 10.3 16.1 11.0 13.7 17.8 9.1 16.0 9.7 27.5 9.0 17.0 31.8 10.4 15.4 21.6 9.6 18.0 17.3 10.6 9.6 25.5 35.5 12.9 15.6 10.2 10.0 13.1 51.5 9.5 21.1 18.9 8.3 16.1 6.0 12.7 29.6 12.9 33.8 15.1 39.2 12.8 8.7 16.1 24.0 11.5 8.5 23.9 23.6 12.9 19.1 18.7 11.8 8.0 4.2 18.2 3.6 3.1 9.5 1.8 24.1 21.8 5.1 26.5 3.4 4.2 19.3 9.9 8.3 8.8 9.9 18.8 29.5 16.2 21.3 4.8 16.5 5.7 8.7 1.9 29.6 20.2 6.9 20.2 28.4 8.6 8.5 24.5 6.4 7.3 7.4 2.0 6.5 43.0 22.1 3.9 39.0 28.3 36.7 22.0 13.2 17.7 6.5 29.9 9.1 18.8 18.9 21.0 8.0 12.4 12.9 9.7 11.9 7.9 11.3 8.2 14.1 16.3 34.9 19.1 11.1 26.0 16.0 14.2 3.5 2.7 18.2 5.4 3.6 4.7 4.4 8.0 5.8 2.8 8.0 7.8 4.5 4.7 3.1 2.2 4.2 9.5 1.8 10.3 11.0 9.1 16.0 10.6 9.6 10.2 10.0 8.3 8.5 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Cell line enhanced" "Detected in some" "HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: " "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 20.8;HUVEC TERT2: 23.2;RH-30: 21.3;RPTEC TERT1: 34.0;RT4: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 6.8 40.9 3.1 4.3 3.9 0.0 4.5 2.2 3.3 8.1 19.3 2.1 36.8 13.5 6.1 8.7 3.6 3.7 13.6 22.2 3.2 2.7 40.7 12.6 16.9 1.6 2.7 2.3 2.5 12.8 1.1 10.3 9.9 3.3 7.9 7.1 2.9 33.7 15.1 2.3 1.2 31.0 4.1 1.8 18.4 7.6 3.0 2.2 0.5 18.7 3.5 3.2 10.4 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 6.1 0.1 1.3 0.4 5.9 0.1 0.2 0.5 2.0 0.9 1.5 0.0 4.2 0.1 0.1 3.1 0.6 0.7 0.0 20.8 1.1 6.1 0.8 3.3 0.0 1.0 0.1 0.0 0.1 0.1 23.2 0.2 0.7 2.7 0.7 0.0 0.1 9.7 3.7 0.0 21.3 0.7 34.0 25.9 5.0 2.9 0.2 0.5 0.0 3.1 0.7 1.0 5.0 1.5 0.0 2.5 6.4 0.0 0.0 0.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.9 2.2 3.3 3.2 2.7 2.7 2.3 3.3 2.2 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533123 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles 170000 Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favourable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 56.8 10.3 15.4 17.2 14.1 22.0 45.1 5.2 16.8 30.0 14.1 15.1 28.1 13.3 18.9 22.4 44.6 22.2 15.1 15.2 13.4 7.7 22.9 16.0 32.9 47.4 18.8 10.8 21.7 14.4 12.3 7.4 39.0 13.0 20.0 12.3 22.7 24.8 16.5 11.3 33.3 17.3 15.3 16.5 28.2 12.6 12.9 14.5 16.0 26.2 19.1 26.7 30.5 28.4 4.4 10.1 16.2 47.7 26.1 29.0 21.3 21.5 31.9 29.6 10.2 45.7 14.6 13.9 11.1 21.3 12.1 8.9 30.7 12.6 7.0 21.4 6.0 22.5 8.3 20.1 9.9 12.3 3.2 19.7 3.8 26.3 15.3 7.3 4.8 14.0 17.9 12.2 22.3 45.0 10.9 5.1 3.4 18.5 10.6 5.2 6.7 0.0 36.8 3.4 1.1 47.4 31.0 6.4 9.7 4.4 30.9 34.2 12.5 17.7 63.6 3.0 12.7 2.9 7.7 2.5 9.1 2.5 10.1 14.9 13.3 3.8 14.8 16.0 29.0 30.4 13.2 4.4 22.7 25.7 10.1 4.2 27.1 25.2 16.2 26.1 47.7 4.0 17.9 21.3 15.4 14.1 5.2 16.8 13.4 7.7 18.8 10.8 13.0 14.5 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.8;EFO-21: 48.5;MCF7: 36.6;PC-3: 60.3;SK-BR-3: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044657 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044657: AB_10967927" "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavourable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.1 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 9.9 34.8 0.0 48.5 0.5 22.7 1.6 2.5 0.7 9.1 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 8.9 0.2 0.0 0.2 36.6 0.1 0.2 0.6 60.3 0.8 0.4 0.4 6.7 20.6 7.9 3.0 0.1 30.6 3.8 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 21.0 57.5 47.8 30.1 84.0 51.7 15.8 33.8 36.8 41.7 45.6 35.0 44.1 20.7 50.3 34.8 47.9 45.3 23.1 31.4 23.2 68.7 14.8 44.1 33.1 40.8 19.0 10.9 48.7 28.0 23.0 20.5 50.9 15.6 18.3 40.7 8.0 16.8 18.1 33.8 25.6 21.2 59.4 21.8 68.5 12.0 43.4 48.0 23.1 19.6 62.8 21.0 36.1 48.2 38.7 15.1 23.3 47.2 40.3 54.8 11.0 34.3 28.5 22.0 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144892-129169697 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 56.8" "Cell line enhanced" "Detected in many" "AN3-CA: 20.6;HEL: 32.1;U-266/70: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.3;naive B-cell: 6.4" "Group enriched" "Detected in many" 5 "B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favourable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favourable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 2.8 3.5 7.4 13.4 7.7 3.8 3.5 7.5 10.0 1.9 4.3 9.9 8.7 3.8 1.5 15.9 3.4 2.6 3.8 5.4 7.2 12.4 56.8 17.2 3.2 15.9 12.1 6.5 1.8 13.0 9.4 13.0 4.6 7.9 8.0 4.8 5.5 20.5 9.5 7.1 4.5 7.1 2.8 8.0 13.7 4.3 6.8 6.0 10.4 8.5 2.9 19.6 6.2 2.4 6.4 2.8 0.2 3.2 0.4 0.9 2.1 1.1 2.7 0.8 20.6 0.0 0.0 0.9 0.0 0.2 0.5 0.2 0.4 1.9 15.5 1.6 0.5 1.4 10.7 3.3 0.8 13.2 8.1 32.1 0.8 5.8 0.8 4.4 0.6 0.6 3.2 0.1 1.1 0.5 0.3 1.9 0.0 3.6 9.3 0.1 5.9 2.8 2.9 0.4 0.4 1.7 3.9 4.9 5.8 1.9 0.6 10.8 4.4 1.9 0.0 0.0 1.5 1.7 0.5 38.0 4.5 6.7 0.3 14.3 1.9 0.0 1.1 0.0 0.1 3.2 0.0 5.3 0.1 0.0 2.8 6.4 0.9 0.1 0.2 0.4 0.2 1.1 0.0 2.1 7.4 7.7 7.5 10.0 7.2 12.4 12.1 6.5 7.9 6.0 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561370-38688920 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.1" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.9" "Low lineage specificity" "Detected in single" "HPA003140, CAB062566, CAB068245" Enhanced "CAB062566: , CAB068245: , HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favourable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 15.2 28.7 39.6 3.5 83.0 0.8 7.3 83.8 131.1 12.4 18.5 11.5 2.3 7.9 11.6 9.2 7.9 10.5 5.8 17.1 34.5 30.7 15.8 12.0 16.2 8.8 19.4 37.7 5.2 4.4 4.1 11.4 6.6 23.8 5.6 17.3 8.1 3.3 7.4 17.9 4.9 7.8 14.5 11.9 21.3 4.6 1.7 9.5 0.0 11.8 5.4 8.2 8.2 4.2 0.9 0.5 0.3 0.2 0.3 2.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.9 0.3 0.0 13.3 2.5 0.0 0.0 10.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 55.3 0.0 2.9 0.0 2.7 1.1 0.0 1.4 0.2 31.0 3.2 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.2 20.5 5.8 0.0 1.3 0.1 0.4 0.2 0.1 0.0 0.6 0.2 0.7 0.4 1.1 2.9 0.1 0.9 2.1 1.8 0.3 0.3 0.0 0.5 0.0 0.1 39.6 83.0 83.8 86.3 34.5 30.7 19.4 37.7 23.8 9.5 UBQLN4 "A1U, C1orf6, UBIN" ENSG00000160803 "Ubiquilin 4" Q9NRR5 1 156035301-156053794 "Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061797 Approved Supported Nucleoplasm Nucleoplasm "HPA061797: " "unprognostic (3.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-3)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-2)" "unprognostic (1.91e-2)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "unprognostic (7.25e-3)" "unprognostic (7.65e-2)" "unprognostic (4.73e-1)" "unprognostic (1.57e-1)" 7.1 6.7 13.8 7.4 19.9 3.9 12.4 23.1 25.2 9.9 7.8 6.5 4.2 7.2 11.9 8.9 11.6 10.2 6.2 9.3 17.7 9.7 7.9 10.2 8.5 7.3 15.0 18.7 15.1 14.1 10.6 3.6 8.4 12.4 8.9 8.8 6.4 12.4 11.8 24.3 11.6 7.4 13.1 8.7 6.8 9.4 6.9 13.7 7.9 6.8 6.6 8.9 8.2 8.4 1.9 2.0 9.7 1.2 1.7 3.2 1.1 16.7 20.2 19.4 19.1 13.4 8.3 19.2 14.2 7.8 14.3 10.8 18.1 15.3 28.7 13.1 12.9 18.9 19.6 15.3 13.7 24.1 20.8 15.7 11.6 17.5 8.6 16.9 29.8 6.2 19.8 19.7 16.1 16.9 29.4 16.0 12.9 20.7 18.5 17.0 26.6 18.9 23.8 14.3 28.3 11.6 17.1 14.3 41.6 14.2 35.5 14.6 34.2 18.6 16.3 13.3 17.5 13.4 15.2 35.7 28.3 31.2 8.1 17.0 18.5 9.7 1.1 0.6 2.5 1.2 3.2 1.9 2.0 2.7 0.9 1.5 1.5 2.1 0.0 1.7 0.2 2.0 1.6 1.1 13.8 19.9 23.1 25.2 17.7 9.7 15.0 18.7 12.4 13.7 UPK1A TSPAN21 ENSG00000105668 "Uroplakin 1A" O00322 19 35666516-35678483 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 20.3;urinary bladder: 80.6" "Cell line enriched" "Detected in some" 11 "RT4: 29.2" "Cancer enriched" "Detected in many" 41 "urothelial cancer: 148.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA049879 Enhanced "HPA049879: " "unprognostic (3.29e-1)" "unprognostic (1.78e-1)" "unprognostic (1.19e-3)" "unprognostic (3.40e-4)" "unprognostic (4.05e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-2)" "unprognostic (3.11e-3)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (2.34e-1)" "unprognostic (2.48e-9)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (2.45e-2)" "unprognostic (1.72e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.0 0.1 0.1 0.1 0.0 0.4 0.1 12.8 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 20.3 0.0 0.1 0.9 0.1 0.1 6.7 0.1 4.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.1 1.0 80.6 8.6 1.7 0.5 1.8 0.5 1.6 2.0 0.8 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.2 0.0 0.1 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.7 0.7 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.4 0.2 0.0 0.1 0.0 0.0 29.2 0.1 0.3 0.4 0.3 0.5 0.2 0.3 0.9 0.0 1.2 0.1 0.2 0.1 0.4 0.0 0.1 0.1 0.2 1.1 0.5 0.2 0.3 0.4 0.5 0.6 2.0 0.6 0.2 1.7 0.1 0.6 1.8 1.6 0.1 0.5 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205153 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.4;urinary bladder: 41.9" "Group enriched" "Detected in some" 4 "CACO-2: 15.0;RPTEC TERT1: 14.0;RT4: 54.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031799, HPA031800" Enhanced "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favourable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavourable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 6.1 0.2 0.2 0.2 1.2 0.0 0.2 0.2 0.3 3.6 0.7 0.0 0.0 0.0 1.5 0.3 2.4 5.1 12.9 1.8 0.2 0.2 6.6 0.6 1.4 0.0 0.2 0.1 0.8 11.6 0.0 0.4 56.4 1.1 15.4 0.0 0.0 0.4 0.0 0.2 0.6 0.2 4.3 1.8 0.2 22.9 0.7 0.0 1.4 0.2 1.4 12.9 41.9 1.1 0.7 1.1 2.5 0.5 0.6 1.9 0.5 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.0 0.0 0.0 2.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.0 54.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.5 0.3 0.3 0.2 0.4 0.2 0.3 0.5 0.7 1.9 0.3 1.8 0.6 0.4 1.1 0.2 0.5 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.1 1.1 0.0 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "prostate: 39.0;urinary bladder: 52.4;vagina: 25.9" "Group enriched" "Detected in some" 6 "MCF7: 45.9;RT4: 51.8" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.0;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavourable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavourable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.8 0.0 39.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 6.8 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 1.3 52.4 25.9 0.7 0.6 0.0 0.1 2.0 1.9 0.2 1.2 0.1 0.0 0.1 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.6 1.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Group enriched" "Detected in some" 5 "Hep G2: 18.3;RT4: 30.6" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 30.6 0.1 0.0 0.1 0.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell line enhanced" "Detected in some" "A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" HPA010506 Approved "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.8 0.0 0.2 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.2 2.3 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: " "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.4 41.2 13.4 20.7 28.7 17.7 21.6 32.6 23.3 20.4 27.4 27.0 29.5 11.8 48.8 22.0 25.5 15.5 18.7 25.4 30.2 19.5 15.1 23.6 28.4 28.0 17.1 18.6 27.0 16.0 26.2 22.3 21.6 19.8 20.9 21.0 56.4 15.9 9.0 15.1 21.3 8.8 23.5 24.3 25.2 23.9 9.6 21.9 18.6 15.8 21.6 32.8 14.7 30.4 27.4 26.2 21.7 26.9 32.4 37.2 16.4 30.2 10.5 27.6 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favourable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (3.64e-2)" 28.5 13.3 17.9 7.0 52.5 1.5 16.5 9.4 24.2 22.3 15.5 13.2 21.9 12.0 31.2 15.1 12.1 28.9 24.0 27.8 19.4 12.2 7.1 7.6 30.2 7.4 13.5 16.5 51.0 12.4 8.8 20.7 25.4 13.6 22.6 4.5 16.6 12.1 39.0 10.3 10.0 11.1 28.1 14.2 16.9 12.5 18.3 14.9 1.3 23.4 4.4 3.2 24.2 12.2 4.4 0.6 0.0 1.6 2.5 6.9 2.4 5.3 10.9 3.7 13.3 15.2 4.0 40.1 9.5 12.5 6.5 5.7 9.4 14.6 2.4 14.0 10.2 2.4 2.7 5.3 2.7 2.1 5.5 0.0 4.8 29.0 13.6 0.0 0.4 13.5 7.5 5.6 5.3 10.0 0.1 9.8 3.8 9.9 0.4 0.1 5.2 15.5 1.2 3.7 2.7 2.6 23.2 2.3 6.2 5.5 6.8 5.1 11.9 0.1 8.2 7.5 9.7 7.3 5.7 10.8 3.5 0.0 9.5 0.0 7.5 0.0 1.0 0.0 4.9 1.6 6.9 4.4 2.6 3.5 0.3 2.3 2.3 2.8 0.0 2.5 1.6 0.6 1.3 2.4 17.9 52.5 9.4 24.2 19.4 12.2 13.5 16.5 13.6 14.9 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 71.8;ASC TERT1: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA069520: " "prognostic favourable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favourable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favourable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 2.0 3.0 71.8 0.0 39.8 55.6 41.6 9.9 24.5 13.9 19.3 4.3 4.7 0.0 10.0 2.8 20.8 16.1 16.3 11.8 0.1 12.0 0.0 8.6 0.0 34.8 0.0 0.1 39.7 11.0 34.0 11.2 32.5 0.0 0.1 20.4 0.3 0.0 0.2 3.2 4.8 0.0 15.1 0.0 2.4 10.7 4.0 8.4 9.1 0.4 11.9 1.9 0.3 37.7 13.3 10.7 21.3 13.4 4.8 0.1 0.0 30.7 0.3 24.3 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved Nucleoplasm,Nucleoli,Cytosol 760000000 Cytosol "Nucleoplasm, Nucleoli" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavourable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (2.28e-5)" "prognostic unfavourable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 138.9 67.6 129.0 37.0 32.1 40.8 63.9 65.3 85.0 88.5 86.2 47.0 91.2 62.5 70.9 103.7 60.5 81.1 93.1 134.8 55.3 32.0 59.0 51.2 30.4 42.3 24.6 67.7 37.8 126.9 73.1 116.5 79.4 67.0 61.3 75.6 50.5 101.6 43.7 43.6 70.9 43.3 37.6 42.9 85.1 78.5 72.2 51.5 49.7 49.3 103.4 71.4 29.1 64.6 44.9 65.9 54.1 58.5 39.1 46.4 76.7 74.3 46.5 183.7 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5